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Modern biotechnological tools are making microbial production of chemicals, 
fuels, and pharmaceuticals increasingly practical and economically feasible. The field of 
metabolic engineering aims to enable this production by hijacking cellular systems to 
modify metabolism, converting each cell into an efficient chemical reactor.  
Traditionally, this has been accomplished through combining various knockouts and/or 
overexpressions of metabolic genes, but directed evolution strategies are often critical for 
improving metabolic pathways beyond native activity.  Due to the complexity of cellular 
metabolism, simply evolving single genetic parts in a stepwise fashion can be limiting. In 
this work, we develop novel and powerful methods for applying directed evolution to the 
engineering of metabolic pathways in the yeast Saccharomyces cerevisiae.  
First, we develop a method for in vivo Continuous Evolution (ICE), which uses a 
synthetic retrotransposon element to allow generation of the largest mutant libraries of 
any in vivo mutational generation approach in yeast.  This method is then validated by 
using it to rapidly evolve a variety of diverse genetic systems, including single enzymes, 
global transcriptional regulators, and multi-gene pathways. Next, we apply a modeling 
approach to create novel biosensors that can rapidly screen for production and secretion 
phenotypes in these large mutant libraries. These biosensors are then imported into 
 ix 
microfluidic droplet systems to apply this screen in a high-throughput manner, creating a 
novel platform for screening libraries finally commensurate with the high level of 
diversity generation previously enabled. This method is validated by evolving an 
overproduction and secretion phenotype, resulting in strains that produce significantly 
elevated levels of aromatic amino acids. Finally, we develop and characterize new tools 
to enable the expression and evolution of multiple genes in a single genetic cassette. 
Taken together, these novel technologies significantly advance the state of the art for 
evolutionary engineering of metabolic pathways and will enable the evolution of 
pathways of enzymes for rapidly improving production of a number of desirable high-
value biochemicals.  
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 1 
Chapter 1:  Introduction  1 
Sustainable bio-based production of chemicals, fuels, and pharmaceuticals can be 
accomplished in part due to the extraordinary features and versatility of cellular 
metabolism.  The field of metabolic engineering seeks to introduce genetic manipulations 
to rewire and reprogram microbes into cellular factories capable of producing a variety of 
high-value chemicals [1-5].  In doing so, metabolites must be rerouted, regulation must 
be altered, and new enzymatic pathways must be introduced and balanced.  Traditionally, 
this rewiring has been accomplished through combining various knockouts and/or 
overexpressions of metabolic genes, resulting in an improved flux through either 
homologous or heterologous pathways.  This approach has been highly successful in 
diversifying the chemical palate of a cell to produce key pharmaceuticals and 
nutraceuticals, fuels, commodity/specialty chemicals, polymer precursors and even 
complex, full-length polymers [6].  Although most metabolic engineering studies have 
utilized either Escherichia coli or Saccharomyces cerevisiae [7], there has been an 
increasing interest in exploring non-conventional hosts including fungi such as Yarrowia 
lipolytica, Ashbya gossypii, Phaffia rhodozyma, and Hansenula polymorpha [8].  
Regardless of the host, the field has seen a rapid explosion in the number of systems-level 
approaches and molecular capabilities.  Both synthetic and systems biology have 
improved our ability to tune cellular behavior aided by metabolic models, “omics” 
studies, and engineered synthetic parts such as promoters and transcription factor binding 
sites [9].   Additionally, the application of systems biology combined with metabolic 
engineering has enabled a Systems Metabolic Engineering paradigm that uses model-
                                                 
1 Adapted from Abatemarco, J., Hill, A., & Alper, H. S. (2013). Expanding the metabolic engineering 
toolbox with directed evolution. Biotechnology Journal, 8(12), 1397-1410. doi: 10.1002/biot.201300021. 
Joseph Abatemarco and Andrew Hill contributed equally to this work. 
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guided approaches and ‘omics data to rewire cellular systems [10, 11]. Regardless of the 
exact approach, diverse techniques improve the capability of metabolic engineering and 
enable microorganisms to sustainably produce high value chemicals from renewable 
substrates.  However, there are occasions when metabolic engineering strategies require 
more than simple gene deletions and overexpressions.  In this context, directed evolution 
is rapidly being adopted for many metabolic engineering and synthetic biology 
applications to introduce improved or novel functions that address complex cellular 
challenges. 
 
1.1 DIRECTED EVOLUTION IS CRITICAL TO METABOLIC ENGINEERING 
Directed protein evolution has been applied in a variety of situations to effectively 
change the function of a starting protein or DNA scaffold.  The basic premise behind this 
approach is that due to the complexity of protein dynamics, small changes in amino acid 
sequence can lead to radically different folding behavior, function, and/or net catalytic 
activity.  Hence, the overall “evolvability” of any genetically encoded part can be 
exploited by creating a large library of mutants followed by screening for a variant 
possessing the desired function.  While many approaches for diversification and selection 
have been described, the most common, unguided approach involves in vitro mutant 
generation using error-prone PCR followed by in vivo screening using a binding assay, 
fluorescence sorting screen, or serially culturing the cells in specific growth conditions 
[12].   
However, a directed evolution approach is predicated upon two successful 
attributes: sufficient library diversity and an accurate, high-throughput screen.  Library 
diversity is critical considering the vast, unsearchable number of possible mutations; in a 
 3 
small polypeptide of only 100 amino acids, there are 20100 possible variants (>10130).  
More sophisticated means of protein library design can be incorporated to enrich the 
library with more functional, desirable mutants, such as using models and/or 
phylogenetic relationships to identify specific regions or residues to target for 
mutagenesis [13-15]. In addition, iterative searches of protein-wide and focused 
mutagenesis can help identify key beneficial mutations that influence and optimize 
activity [16-18].  Taken together, these approaches can improve the quality of random 
libraries and increase the probability that a desirable mutation can be identified.   
Beyond library generation, screen design is the current major limitation of 
directed evolution in the context of metabolic engineering.  Although larger library sizes 
improve the chance of discovering beneficial mutations, current high-throughput 
screening techniques are limited in how meaningfully they characterize those mutants 
[19].  While growth-based screens are effective at improving catabolic enzymes, many 
metabolic enzymes of interest are not related to growth (and often, the growth objective 
and biotechnological objective are at odds).  As a result, lower throughput assays such as 
GC, MS, or capillary electrophoresis are necessary to accurately determine a 
mutagenized enzyme’s fitness [20], and thus place a severe limitation on the library size 
sampled using a directed evolution approach. The development of a generic, high-
throughput and accurate assessment of desired protein functions is still lacking.  
Despite these limitations, directed evolution has been applied in a number of 
metabolic engineering applications including identifying mutants that modify enzyme 
productivity [17, 21], substrate specificity [16, 22, 23], cofactor requirements [24]  [25], 
and protein stability [26]. Furthermore, directed evolution has been applied to non-
catalytic entities in an effort to modify metabolic regulation [27, 28], adjust binding 
kinetics [16] [29], and rapidly evolve the entire genome [30-34]. These examples are 
 4 
among a growing list which highlights recent approaches of utilizing directed protein 
evolution to accomplish metabolic engineering goals.   
 
1.1.1 Directed Evolution of Enzymes for Metabolic Engineering 
As described above, one goal of metabolic engineering is to improve pathway 
flux which is usually accomplished through the amplification of enzyme levels.  
However, simple examination of Michaelis-Menten kinetics reveals at least two possible 
routes to improve overall productivity:  (1) altering the amount of available enzyme or (2) 
altering the catalytic properties (ie kcat/Km).  While the first alteration can be achieved 
through gene overexpression, the second type of alteration requires directed evolution 
and protein engineering to augment catalytic properties.  To examine this further, 
consider a pathway exclusively controlled by a single enzyme.  A 10-fold improvement 
in a flux through this hypothetical pathway can be achieved either through a 10-fold 
overexpression or through a 10-fold activity increase.  In the latter case, pathway flux can 
be improved independent of gene overexpression and protein level and thus would 
impose a lower overall metabolic burden.  As a result, controlling pathways through 
altering enzyme kinetics would have a greater impact on overall productivity.  However, 
cellular environments present numerous complex interactions and thus catalytic activity 
may also be influenced through phenomena such as allostery.  Forms of enzyme 
inhibition must be overcome to provide the greatest impact in large-scale bioreactor 
production of small molecules [35].  Thus, directed evolution and protein engineering can 
solve a number of flux control problems inherent in metabolic pathways as depicted in 
Figure 1-1. 
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Figure 1-1: Illustrations of ways in which directed enzyme evolution can improve 
metabolic flux.   
 
Directed evolution can improve metabolic flux through: A) Increasing a rate-limiting 
enzyme’s kinetic properties, B) Reducing the production of byproducts, C) Altering an 
enzyme’s cofactor preference, or D) Removing product inhibition.   
 
Directed evolution can help alleviate rate limiting steps by increasing the catalytic 
rate of enzymes.  As an example, pentose catabolic pathways (in particular, xylose 
catabolism) are a rate limiting step in the utilization of lignocellulose by the yeast S. 
cerevisiae.  A xylose isomerase-based heterologous pathway demonstrated limited 
success and directed evolution was used to improve the catalytic rate and hence pathway 
functions.  Specifically, a mutant xylose isomerase was identified with a 77% 
improvement in Vmax in vitro. Overexpression of this mutant in S. cerevisiae increased 
the growth rate in xylose by 61-fold and the production of ethanol by 8-fold when 
combined with the overexpression of a xylulokinase enzyme [17].  In another example, 
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directed evolution has been applied to overcome a bottleneck present in carotenoid 
biosynthesis in E. coli.  Specifically, geranylgeranyl diphosphate (GGPP) synthase 
(GAS) from Archaeoglobus fulgidus was subjected to directed evolution and random 
mutagenesis libraries were screened to isolate a variant that increased lycopene 
production by 100% [21].  These examples demonstrate that metabolic flux control of 
rate-limiting steps can be alleviated through directed evolution as demonstrated in Figure 
1-1a.  
Beyond enhancing native catalytic function, directed evolution is a powerful tool 
for introducing novel catalytic functions in promiscuous enzymes.  Examples include the 
isolation of a cytochrome P450 monooxygenase mutant capable of oxidizing octane with 
a kcat/Km of 3.5 x 104 M-1s-1 compared to the kcat/Km of 6.0 x 107 M-1s-1 the enzyme 
possesses towards its optimal substrate [16].  Another directed evolution study of the 
same enzyme sought to produce a mutant capable of performing olefin cyclopropanation, 
an important reaction in organic synthesis that is not present in a biological context.  
Mutants isolated from this study were able to provide yields greater than 30% with strong 
diastereomer preferences (>80:1) [36]. Additionally, a galactose oxidase with glucose 6-
oxidase activity was isolated using only one round of mutagenesis [22].  Similarly, the 
metal binding site of the paraoxonase-1 enzyme was restructured using mutagenesis to 
reduce lactonase activity (100-600-fold) while improving organophosphate hydrolase 
activity (~300-fold for parathiol) [37].  In another example, DNA shuffling was 
employed to improve 3-isopropylmalate dehydrogenase activity 65-fold for a bacterial 
homoisocitrate dehydrogenase [38]. This approach has the potential to be extended to 
various attractive metabolic engineering targets such as alcohol dehydrogenases, zinc 
finger transcription factors, cytochromes, and hydrogenases.   
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Significant product diversification via directed evolution is exemplified by 
engineering the various carotenoid enzymes to create pathways for producing novel C40, 
C45, and C50 carotenoids in E. coli [39, 40].  One study sought to diversify the variety of 
available extender units for polyketide synthesis by using directed evolution to increase 
the promiscuity of a malonyl-CoA synthetase.  This study produced several variants that 
were able to produce acyl-CoAs using 9 different malonate analogues with activities 
comparable to the native enzyme [23].  From these advances, polyketide synthases that 
can recognize non-natural extender units may be used to increase the diversity of 
producible polyketides.  In addition, directed evolution can be used to alter the specificity 
of promiscuous enzymes (Fig 1-1b), such as γ-humulene synthase, which can natively 
produce 52 different sesquesterpines with low specificity.  Saturation mutagenesis 
yielded several mutants which not only improved both the total yield and the specificity 
for different products, but also substantially increased the titers for Z,E-α-farnesene and 
α-ylangene [41]. 
  Beyond catalytic rate, an important property of enzymes is their dependency on 
cofactors, especially in the context of metabolic engineering.  Traditional methods for 
cofactor engineering have proven beneficial in overcoming this problem; for example, the 
overexpression of an NADH Oxidase from Streptococcus pneumonia in Klebsilla 
pneumonia improved the glucose flux to Acetoin (mol/mol glucose) by 189% [42].  As 
an alternative approach, directed evolution can be used to change the cofactor 
dependencies of enzymes, as shown in Figure 1-1c.  For the case of isobutanol 
production, a ketol-acid reductoisomerase mutant was identified that improves the 
enzyme’s relative catalytic efficiency for NADH/NADPH from 0.003 to 185 (~6.2 x 104-
fold) without sacrificing enzymatic activity.  Overexpression of this mutant with an 
active NADH-dependent alcohol dehydrogenase improved isobutanol productivity from 
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1g/L to 13.4 g/L and at 100% theoretical yield whereas the expression of a 
transhydrogenase to restore NADPH only improved productivity 8.5-fold [24].  In 
another example relevant to metabolic engineering, a mutated acetohydroxy acid 
isomeroreductase that prefers NADH to NADPH was introduced into Corynebacterium 
glutamicum to resolve the cofactor imbalance caused by valine synthesis.  
Overexpression of this mutant resolved the NAD+/NADH imbalance, consequently 
improving the organism’s fitness and increasing valine productivity by nearly 40% [43].  
In another study, the cofactor requirement for a Cytochrome P450 monooxygenase was 
changed, using directed evolution, from NADH to hydrogen peroxide, which is 
drastically different in size and structure.  This enzyme was subsequently utilized to 
improve the hydroxylation of naphthalene by 20-fold in E. coli by taking advantage of 
the ‘peroxide shunt’ [25].   
A final aspect of enzymes that may be altered through directed evolution is 
allosteric interactions and feedback inhibition, illustrated in Figure 1-1d.  The importance 
of addressing metabolite inhibition in metabolic engineering was demonstrated in the 
evolution of a tomato peel 4-coumarate:CoA ligase for enhanced phenylpropanoid 
production.  In this study, two of six highly active variants isolated from fifty thousand 
colonies were shown to possess mutations that either greatly diminished or eliminated 
feedback inhibition [44].  Another study which applied directed evolution to address such 
regulation eliminated the feedback inhibition of chorismate mutase-prephenate 
dehydratase (CM-PDT) in order to increase production of L-phenylalanine in E. coli. A 
truncated version of CM-PDT insensitive to phenylalanine inhibition but with a 3-fold 
lower catalytic efficiency was subjected to directed evolution in order to improve 
activity. The resulting variant, when expressed with other genetic modifications, 
increased the phenylalanine yield from glucose to 60% of the theoretical maximum, 
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which was the highest yield coefficient reported [45].  In another example, citramalate 
synthase (CimA), which converts pyruvate and acetyl coenzyme A (CoA) into 2-
ketobutyrate, was introduced into E. coli to enhance n-propanol and n-butanol 
production.  While employing directed evolution to improve the thermophilic enzyme’s 
activity at lower temperatures, researchers isolated a variant which also eliminated the 
wild-type enzyme’s sensitivity to L-isoleucine inhibition.  When this variant was 
overexpressed with additional pathway enzymes, production of n-propanol and n-butanol 
were subsequently increased by 9.2-Fold and 21.9-fold respectively [46].  These results 
highlight yet another strategy for increasing yields in metabolically engineered organisms 
through directed evolution to remove regulatory inhibition while retaining activity. 
 Collectively, these examples demonstrate that directed evolution of enzyme 
function can provide a means for fine-tuning alterations of cellular metabolism to address 
problems that gene knockouts and overexpressions cannot readily solve.  While 
challenges still remain in selection and differences between in vitro and in vivo function, 
it is clear that directed evolution of enzymes is a potent approach for metabolic 
engineering.   
 
1.1.2 Directed Evolution of Non-Catalytic Components of a Cell 
While enzymes conduct the essential function of a metabolic pathway, additional 
non-catalytic components such as regulatory elements, binding proteins, transcription 
factors, and transporter proteins serve a critical role in defining cellular function.  In each 
of these cases, directed evolution techniques may be used to improve function and hence 
utility in metabolic engineering applications, as illustrated in Figure 1-2.  We highlight 
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several advances in metabolic engineering in the context of applying directed evolution to 
these non-catalytic components of a cell. 
 
Figure 1-2: Illustrations of several approaches in which directed evolution of non-
catalytic components can improve metabolic flux.   
 
Directed evolution can improve non-catalytic aspects in cells through: A) Creating 
libraries of promoters of various strengths can allow precise modulation of expression 
and increase overall productivity, B) Transcriptional controllers or biosensors can be 
evolved to bind with high specificity and activate transcription of a target gene, C) 
Molecular transporter proteins can be evolved to increase flux of a desired substrate into 
a cell and/or products and toxins out, or D) Evolving global transcription factors can alter 
the expression levels of many genes simultaneously, leading to complex phenotypes that 
could not be engineered rationally. 
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1.1.2.1 Evolving regulatory elements 
Regulatory elements, especially promoters, are a critical component of any 
metabolic engineering effort, especially when considering the engineering of entire 
pathways.  Previous studies have demonstrated that directed evolution of promoters, in an 
approach termed promoter engineering, is an effective manner for diversifying promoter 
activity, as depicted in Figure 1-2a.  This approach was first demonstrated by 
mutagenizing the constitutive bacteriophage promoter PL-λ and demonstrating a 200-fold 
range in expression.  This library was then used to modulate expression of the E. coli 
gene dxs, which encodes an enzyme in the isoprenoid pathway.  These results uncovered 
an optimum promoter strength for maximized lycopene production whereby stronger 
promoters were actually detrimental to productivity [47].    
These results highlight the importance of modulating gene expression while 
engineering cellular metabolism. Constitutive overexpressions and gene knockouts are 
the two most commonly used genetic modifications, but these represent two polar 
extremes of a continuum, whereas the optimal level of expression is almost certainly 
somewhere between the two, requiring tunable levels of expression [48]. This is 
especially true when a knockout of a gene is lethal, but a “knockdown” could beneficially 
influence productivity.  This concept was demonstrated using the S. cerevisiae TEF 
promoter where a mutagenesis approach resulted in a library of yeast promoters with a 
wide dynamic range.  Variants from this TEF library were then used to modulate 
expression of GPD1 in S. cerevisiae.  By replacing the native GPD1 promoter with the 
mutant TEF promoter library, the specific level of control GPD1 exerts on glycerol flux 
was quantified.  Furthermore, the integration of a stronger mutant TEF increased glycerol 
production without the negative effect on growth rate observed in multicopy GPD1 
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overexpression, validating the idea that precise modulation can be useful in metabolic 
engineering efforts [49]. 
A similar approach was applied to the oxygen-responsive S. cerevisiae DAN1 
promoter. Random mutagenesis created two variants that could be induced under less-
stringent anaerobiosis than the wild-type promoter, which would enable gene expression 
to be induced in yeast fermentations simply by oxygen depletion. Furthermore, both 
variants were stronger than the native DAN1, with higher maximal expression [50]. 
In addition to engineering inducible promoters, constitutive regulatory elements 
can also be created or altered with this approach. One such study utilized four rounds of 
random mutagenesis and selection to generate an E. coli promoter approximately 2-Fold 
stronger than the commonly used tac promoter. Interestingly, randomly selected 
eukaryotic DNA was used as a template, indicating that it may be relatively easy to 
generate strong constitutive promoter activity in prokaryotes [51].  
Proteins may influence metabolic pathways by serving as cis-acting regulators 
and likewise can be altered via directed evolution.  For example, the XylS transcription 
factor in E. coli activates the inducible Pm promoter in the presence of benzoic acid. 
Random mutagenesis of the xylS gene followed by gene shuffling resulted in a XylS 
variant that demonstrated 10-fold higher expression under induction [52]. Similarly, the 
AraC protein in E. coli natively activates the ara operon only in the presence of L-
arabinose. By using both saturated mutagenesis of amino acids in the arabinose binding 
site and global error-prone PCR, a variant was isolated that activates transcription in the 
presence of D-arabinose with a sensitivity to concentrations as low as 0.1 mM, while 
displaying no activity in up to 100 mM of L-arabinose [28].  Another study constructed a 
similar library of araC mutants, and isolated a variant that was significantly less sensitive 
to inhibition by IPTG, thus eliminating the possibility of “cross-talk” [53].  This new 
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construct will allow dual-control of pathways through multiple inducers.  These studies 
collectively demonstrate the utility of directed evolution of inducible regulatory proteins 
to modify activation or inhibition of expression in specific ways.  
A similar example applying directed evolution to cis-regulators is the evolution of 
tyrR, a prokaryotic tyrosine-inducible transcription factor that activates tp1 in E. 
herbicola, encoding for an enzyme used in the production of L-dopa.  Using random 
mutagenesis, a variant of tyrR was identified that demonstrated 30-fold higher expression 
levels of Tp1 without the addition of tyrosine—a component that ruins purification [54].  
This example demonstrates how directed evolution can be used to eliminate the need for 
inducible expression. 
Another important tool for developing complex phenotypes is global 
Transcription Machinery Engineering (gTME), which applies directed evolution 
strategies to a transcription factor regulating the expression of many genes, as depicted in 
Figure 1-2d.  In this approach, the expression levels of many genes are altered 
simultaneously, allowing the combinatorial optimization of a desired phenotype.  By 
applying this concept to spt15, the gene encoding TATA-box binding protein, a strain of 
S. cerevisiae was evolved for ethanol tolerance by serially culturing cells containing 
mutated spt15 genes in 6% ethanol.  A variant was isolated that conferred significantly 
higher tolerance, resulting in 70% increase in specific productivity of ethanol, close to the 
theoretical maximum [27].  A similar approach has been demonstrated across organisms 
such as E. coli [55-57], L. planarum [58], and even in the plant species Arabidopsis 
thaliana, where one study used directed evolution of the plant transcription factor ERF to 
isolate a variant which significantly improved cold tolerance in transgenic plants, an 
important factor for growth and production [59].   Simultaneous changes to multiple gene 
expression levels would be impossible to predict or rationally explore.  However, directed 
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evolution of regulatory machinery can achieve such complex phenotypes and is therefore 
a potent tool for metabolic engineering. 
 
1.1.2.2 Evolving binding optimization 
Directed evolution has been proven effective at modifying binding affinity.  Such 
activity can be essential for metabolic engineering, as interactions between two proteins 
or between proteins and small molecules can be engineered to provide a desired response.  
For example, engineered interactions can be used to create sensitive and accurate 
biosensors that can detect changes in metabolite concentrations.  Shifts in metabolic flux 
can also be actuated upon the presence of a hormone or metabolite using this approach, 
by the establishment of molecular and genetic “switches”.  Thus, binding affinity is an 
important property for synthetic engineering of organisms, as illustrated in Figure 1-2b. 
One crucial application of the evolution of binding properties is developing 
sensitive and accurate biosensors.  For example, one study increased production of 
lycopene in E. coli by engineering the Ntr regulon to detect intracellular concentration of 
a metabolite, acetyl phosphate, and activate enzyme pathways [60].  In a more complex 
biosensor system, metabolite-sensitive transcription factors can be utilized to maximize 
productivity by real-time adjustment of enzyme levels based on signals such as 
intermediate accumulation or nutrient availability [61]. To achieve this system, however, 
it is necessary to engineer proteins with specific binding properties, and directed 
evolution is an essential tool in creating these systems. 
One approach to creating accurate biosensors through directed evolution is to 
detect binding affinity using fluorescence as a reporter, which can then be used as a 
selection screen. An example of this approach was demonstrated by linking an alkane-
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activated transcription factor (AlkS) to GFP expression, then generating a random library 
of AlkS mutants through error prone PCR.  Variants were identified that enabled a 5-fold 
improvement in detection signal in the presence of hexane [62].  Similarly, the LuxR 
transcription factor in V. fischeri was mutagenized to create variants that activated in the 
presence of a broad range of straight-chain acyl-HSLs, but not in the presence of the 
native signaling factor, 3-oxo-hexanoyl-homoserine lactone (3OC6-HSL). The variants 
were screened using a dual selection system consisting of alternating rounds of selective 
pressure.  Ultimately, this method resulted in a mutant transcription factor with over 
50,000-fold change in specificity compared to the wild-type [63]. 
 
1.1.2.3 Evolution of transporter proteins 
A final non-catalytic, yet essential, metabolic function is the transport of small 
molecules into and out of the cell.  This often overlooked step in metabolic pathways 
inherently limits the maximal potential productivity of a small molecule by reducing 
substrate availability or constricting product secretion.  Flux control exerted by substrate 
transport is especially problematic when engineering cells to catabolize less natural 
substrates, such as the pentose sugars that make up a large proportion of lignocellulosic 
biomass. Consequently, efficient transport and utilization of exogenous sugars is a 
limiting factor in the conversion of biomass to fuels or chemicals in S. cerevisiae [64]. To 
address this problem, several recent efforts have applied directed evolution to transporter 
proteins to significantly improve productivity, shown in Figure 1-2c. 
One such effort employed directed evolution to improve heterologous xylose 
transporters in S. cerevisiae.  Major facilitator superfamily transporters were subjected to 
error prone PCR and improved mutant transporters were identified by selecting the 
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largest colonies on xylose plates.  In this study, the best variant improved the growth rate 
by 70% when cultured in xylose, and in vitro enzymatic assays confirmed that the Vmax of 
the mutant transporter was nearly 50% higher. These results suggest that applying 
directed evolution to engineer molecular transporters can alone improve the overall 
growth rate and catabolic rate using non-native substrates [65]. 
 
1.2. CURRENT LIMITATIONS OF EVOLUTIONARY ENGINEERING 
While many successful examples exist, future efforts to apply directed evolution 
to metabolic engineering must rely on engineering entire pathways together—in essence, 
a metabolic pathway protein engineering approach. This simultaneous optimization will 
allow for synergies between pathway steps to be discovered and enhanced.  Side-
reactions, flux of intermediates to other pathways, and co-factor dependencies are all 
difficult or impossible to consider when engineering only a single rate-limiting step.  Yet, 
the challenges of pathway protein engineering are exponentially more difficult than that 
of engineering a single enzyme.  
 
1.2.1 Library Size Limitations 
Although directed evolution has proven successful in its ability to improve and 
alter enzyme activity, the larger endeavor of pathway engineering requires an extremely 
large library of mutations.  In engineering an entire pathway, the library of variants 
required to combinatorially explore the interactions and synergies between enzymes is 
orders of magnitude higher. Currently, traditional in vitro mutagenesis is encumbered by 
intrinsic limitations of host transformation efficiency, especially in more industrially- and 
medically-relevant eukaryotic systems. Next-generation evolution techniques aim to 
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accelerate the discovery of improved variants through continuous rounds of 
mutagenesis/selection on specific DNA cargo with reduced costs using in vivo diversity 
generation [66].  It has been demonstrated that mutational throughput can be increased in 
E. coli in an in vivo continuous process using phage, enabling the rapid evolution of parts 
[67-70].  However, this approach is best suited for phenotypes linkable to phage growth 
(e.g.  DNA-binding proteins) and cannot be applied to eukaryotes.  No current methods 
are well-suited for the deep meso-scale optimization (i.e. generation of all single-
nucleotide substitutions to multi-kb pathways and gene networks) necessary for evolution 
of complex multi-part systems, or continuous evolution in eukaryotes.   
 
1.2.2 Pathway Assembly Limitations 
In order to effectively engineer pathways of enzymes, novel tools will also need 
to be developed for the efficient simultaneous expression of multiple proteins. 
Commonly, heterologous pathways constructed in yeast use a promoter and terminator 
motif for each individual gene, often using multiple vectors. This can be highly 
disadvantageous for several reasons, including lack of multiple well-characterized 
regulatory elements available, genomic instability due to recombination, and the cost and 
difficulty in synthesizing non-coding DNA.  
For evolutionary approaches, this multiple vector approach is especially 
problematic. In order to simultaneously mutagenize multiple genes, they must be 
assembled in a single cassette. With each gene requiring its own promoter, this results in 
mutagenesis of large stretches of non-coding DNA, reducing the frequency of coding 
mutations proportionally.  For directed evolution, it is highly preferable to minimize the 
entire pathway sequence in order to increase the likelihood of generating beneficial 
 18 
mutations. Alternatively, each gene can be mutagenized independently and assembled 
prior to transformation [71], although this introduces the potential of bias during each 
cloning step. 
One promising approach is the utilization of viral 2A sequences. These short 
sequences are about 20 amino acids in length and are found encoded in viral genomes to 
allow translation of single large polypeptides, which self-cleave into multiple smaller 
proteins. When a ribosome translates a 2A sequence, the nascent polypeptide quickly 
cleaves to form a separate protein, while translation continues downstream to form a 
second protein [72]. In this way, 2A sequences allow a single promoter to drive 
expression of an open reading frame encoding multiple proteins. Furthermore, such 
sequences have been previously shown to be active in yeast, making them a potentially 
useful tool in the evolution of multi-gene pathways [73, 74]. 
 
1.2.3 High-throughput Screening Limitations 
Metabolic pathway engineering approaches are unquestionably still limited by our 
current screening capacity.  Screens for improved enzymatic activity performed in vitro 
(also via cell free biological systems) may be able to screen large libraries of enzyme 
quickly, but are subject to a large number of false positives that do not necessarily 
function in vivo.  Traditional techniques such as GC, HPLC, and MS can provide 
excellent data allowing for the selection of mutants improving product generation; 
however, they are low-throughput when compared to in vitro assays [20].  The rapid use 
of aptamers and other binding proteins linked to a fluorescent protein can enable higher-
throughput techniques such as FACS to be used.  In addition, approaches coupling cell 
growth to the specific production of the desired metabolite have demonstrated success 
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without the need for additional screening. For example, one approach coupled cell growth 
with succinate production in E. coli by knocking out genes encoding other NADH 
oxidizing pathways; in this strain, growth rate alone selected for mutations beneficial to 
succinate production without additional selection or screening [75]. Furthermore, 
modeling can guide this approach to maximize desirable evolutionary outcomes [76-78].  
However, in order for directed evolution to fully benefit metabolic engineering, screening 
technology needs to be improved significantly to better match our ability to create 
sequence diversity. 
This is especially relevant for production phenotypes, which, unlike growth 
phenotypes, are significantly more challenging to screen in a high-throughput manner.  
Specifically, it is usually difficult and slow to accurately measure the quantity of the 
desired product which an isolated strain produces. Although a relatively large library of 
variants can be created with traditional methods, only a small fraction can be tested in a 
reasonable time frame. Instead, growth-based selection is often used, by placing the 
library of variants in conditions such that desired phenotypes will naturally grow faster.  
However, this has been difficult or impossible to do for most production phenotypes 
because production of a desired product is often antithetical to growth. 
Several recent advances in screening and mutation technologies demonstrate how 
such challenges will be met in the future. One approach for accurate and high-throughput 
screening being developed harnesses the power of microfluidics, where thousands of 
picoliter-sized drops can be analyzed per second. This miniaturization may represent the 
future of high-throughput screening, since significantly less time and material is needed.  
One such approach was used in the directed evolution of horseradish peroxidase enzyme, 
in which over 108 individual variants were screened in only 10 hours. It is estimated that 
such technologies already represent 1000-fold increases in speed and over 1-million-fold 
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reductions in cost [79].  When coupled with new analytic capacities, these microfluidic 
approaches may enable the future of metabolic pathway protein engineering as well as 
high-throughput synthetic biology [80]. 
Taken together, it is quite clear that as screening and mutation technology 
continues to improve, directed evolution will certainly play an ever greater role in the 
metabolic engineering of microorganisms. Protein engineering can solve many of the 
problems of metabolic engineering in a more efficient, fine-tuned manner.  As techniques 
continue to be refined by increasing variant library size and enabling more accurate high-
throughput screening, increasingly complex and less understood systems can be studied.  
Directed evolution of pathways will enable the next generation of metabolic engineering 
and industrial production in microorganisms. 
The work described in the remainder of this document represents a significant 
contribution to the development of these techniques, and will address some of the most 
significant limitations discussed above. Chapter 2 describes a novel approach for in vivo 
Continuous Evolution (ICE), which allows the rapid creation of unprecedentedly large 
libraries in yeast. Chapter 3 discusses further characterization and investigation of this 
technology, and explores ways it could be improved or expanded upon. Chapter 4 delves 
into a new method for the creation of RNA biosensors that could enable high-throughput 
screening, in order to effectively search these large libraries. In Chapter 5, these new 
biosensors are applied in microfluidic systems, in an approach called RNA Aptamer In 
Droplet Screening, or RAPID Screening, to demonstrate how such a high-throughput 
screening method can be used in a relevant context. In Chapter 6, viral 2A sequences are 
characterized and developed to allow poly-protein expression from a single genetic 
cassette, which can be essential for the evolution of entire pathways. Finally, in Chapter 7 
the conclusions and future directions of this research are explored, and it is discussed 
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how the novel approaches developed and validated here will make a significant 
contribution to the fields of directed evolution and metabolic engineering and to 
industrial production in microorganisms. 
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Chapter 2:  in vivo Continuous Evolution of Genes and Pathways in 
Yeast 2 
2.1 CHAPTER SUMMARY 
Directed evolution remains a powerful, highly generalizable approach for 
improving the performance of biological systems.  However, implementations in 
eukaryotes rely either on in vitro diversity generation or limited mutational capacities.  
Here, we synthetically optimize the retrotransposon Ty1 to enable in vivo generation of 
mutant libraries up to 1.6*107 L-1 round-1, which is the highest of any in vivo mutational 
generation approach in yeast.  We demonstrate this approach by utilizing in vivo-
generated libraries to evolve single enzymes, global transcriptional regulators, and multi-
gene pathways.  When coupled to growth selection, this approach enables in vivo 
continuous evolution (ICE) of genes and pathways.  Through a head-to-head comparison, 
we find that ICE libraries yield higher-performing variants faster than error-prone-PCR-
derived libraries.  Finally, we demonstrate transferability of ICE to divergent yeasts, 
including Kluyveromyces lactis and alternative S. cerevisiae strains.  Collectively, this 
work establishes a generic platform for rapid eukaryotic directed evolution across an 
array of target cargo. 
 
2.2 INTRODUCTION 
While directed evolution [81, 82] has generated solutions to engineering problems 
[27, 83], established novel functions [84, 85], and provided insights into evolution [68, 
86], traditional in vitro mutagenesis techniques are encumbered by long and costly 
design-build-test cycles, restrictive requirements for hands-on manipulation of nucleic 
                                                 
2 Adapted from Crook, N., et al., In vivo continuous evolution of genes and pathways in yeast. Nature 
Communications, 2016. 7: p. 13051. Nathan Crook, Joseph Abatemarco & Jie Sun all contributed equally 
to this work.  
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acids, and intrinsic limitations of host transformation efficiency. These limitations 
become especially poignant when attempting to optimize larger genetic systems (e.g. 
entire pathways including regulatory DNA), especially in more industrially- and 
medically-relevant eukaryotic systems.  Indeed, the throughput of novel microfluidics-
based screening technologies currently outpaces throughput for generation of genetic 
diversity in these systems [80].  Next-generation evolution techniques aim to accelerate 
the discovery of improved variants through continuous rounds of mutagenesis/selection 
on specific DNA cargo with reduced costs using in vivo diversity generation.  It has been 
demonstrated that mutational throughput can be increased in E. coli in an in vivo 
continuous process using phage, enabling the rapid evolution of parts [67-70].  However, 
this approach is best suited for phenotypes linkable to phage growth (e.g.  DNA-binding 
proteins) and cannot be applied to eukaryotes.  Genome-editing technologies (such as 
MAGE [87] and CRISPR-Cas9 [88, 89] have enabled discovery of sequence-function 
relationships across a wide range of species but remain, at least at present, a method for 
introducing finite, defined mutations across several base pairs (ideal when important 
structural features are known) and are not well-suited for kilobase-scale directed 
evolution applications (which are necessary when structural features are largely 
unknown).  In yeast, recent proof-of-concept demonstrations of continuous evolution (1) 
have suffered from low mutagenic rates and the necessity for mutant expression from 
weak promoters [90], or (2) require in vitro library generation [91].  None of these new 
methods are well-suited for evolution of multiple metabolic pathway genes 
simultaneously. 
To fill this gap, a scalable, in vivo mutagenesis system was established in yeast by 
engineering its native retroelement Ty1 (Fig 2-1).  The replication cycle of Ty1 proceeds 
via an RNA intermediate that is converted into cDNA through an encoded reverse 
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transcriptase [92].  Importantly, retrotransposons like Ty1 are found in all eukaryotic 
genomes, making this approach potentially generalizable to multiple cell hosts of interest  
[92]. Previous studies have demonstrated the potential for heterologous gene expression 
from Ty1 when inserted between Ty1RT and the 3’LTR [93, 94].  Thus, the error-prone 
nature of Ty1 replication [95, 96] coupled with the capacity for continuous 
retrotransposon cycling could enable a unique mechanism for in vivo directed 
mutagenesis of synthetic DNA (denoted here as “cargo”) in eukaryotes a manner that is 
scalable with cell count (Fig 2-1a).  In such a scheme, one cycle of in vivo mutagenesis is 
defined as the per-cell process of Ty1-cargo transcription, reverse transcription, and re-
integration to a stable genetic context (Fig 2-1b).  Since yeast cell densities can routinely 
exceed 1010 per liter (and even 1012 per liter in controlled fermentations), library size can 
easily exceed that of current in vitro techniques even with low mutation or transposition 
rates.  A complete round of in vivo Continuous Evolution (ICE), in analogy to traditional 
directed evolution, is achieved at the culture level by allowing multiple cycles to occur 
through simple cell outgrowth, screening the resulting in vivo library, and isolating the 
best variant.  As such, this approach can enable high-throughput, hands-off, scalable 
mutagenesis of desired parts and pathways (Fig 2-1c).  For some applications, rounds 
may occur continuously and growth-associated phenotypes can be selected in tandem 
with mutagenesis, thus enabling ICE.  In other applications, independent rounds may be 
desirable to segregate dominant mutations from background genetic drift.  
By tuning the expression of key regulators of Ty1 transposition, we increase 
library size achievable using this system and confirm its ability to impart a useful error 
rate to an encoded cargo gene.  Here, we apply this system to the directed evolution of a 
variety of synthetic parts, including single enzymes, regulatory factors, and multi-enzyme 
pathways, realizing substantial and significant improvements to performance in each 
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case.  We further demonstrate that ICE enables the recovery of superior mutants more 
quickly than error-prone PCR.  Finally, we show that ICE enables in vivo mutant 
generation across divergent strains of yeast, indicating its applicability toward a wide 
range of eukaryotic systems. 
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Figure 2-1: Rationale and schematic for in vivo continuous evolution (ICE) in yeast.   
 
In the operational scheme of ICE: A) genetic cargo of interest is cloned into the genome 
of an inducible Ty1 retrotransposon; B) upon induction of retroelement transcription, the 
encoded reverse transcriptase is expressed, converts the Ty1 genome (including the 
cargo) into cDNA in an error-prone manner, and then this cassette is re-integrated into a 
stable genomic locus.  This process is defined as one cycle; C) the procedure of inducing 
mutagenesis to a bulk culture and selecting for improved variants is analogously defined 
as one round.  In this work, we D) apply this approach to several divergent strains and 
species of yeast, E) iteratively improve the efficiency of Ty1 retrotransposition through 
deletion of rrm3, reducing temperature, increasing cell density, and increasing expression 
of limiting cellular components, and F) apply this improved system to the evolution of 
transcriptional activators, single enzymes, and multi-enzyme pathways. 
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2.3 RESULTS 
2.3.1 Engineering Increased Transposition Rate 
After demonstrating basal functionality of the plasmid-based synthetic 
retroelement through induction at low cell density, we wished to develop strategies for 
increasing transposition rate of Ty1.  To this end, we investigated cargo expression level, 
gene knockouts, cell density, induction temperature, and initiator methionine tRNA 
expression level as potential drivers of increased transposition rate.   
 
2.3.1.1 Tuning Cargo Expression Increases Transposition Rate 
We first investigated the effect of cargo transcription rate on Ty1 transposition. 
Although strong promoters (such as pTDH3) are desirable for cargo overexpression, their 
high transcription rate may interfere with that of pGAL1, thus lowering transposition rate 
and library size. Out of 3 yeast promoters (pCYC1, pTEF1, and pTDH3, representing low, 
medium, and high transcriptional output, respectively [97] (Fig 2-2a)), we observed the 
highest transposition rate when the pTEF1 drove expression of URA3 (Fig 2-3b and Fig 
2-4a). We used this promoter in future benchmarking experiments. 
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Figure 2-2: Improvement of Ty1 Transposition.   
 
A) Promoters used in this study.  Indicated promoters were used to drive yellow 
fluorescent protein and fluorescence was measured using flow cytometry.  B) 
Transposition of RT-containing and RT-less retroelements in a genomic context at 22ºC.  
C) The effect of terminators on transposition rate.  No transpositions were observed for 
Tsynth1 or Tsynth5.  Strains containing the appropriate retroelement were exposed to 
galactose at high OD for (B) and (C) for three days and then plated on uracil-deficient 
media to count transposants.  Error bars in (B) and (C) represent the standard deviation of 
biological triplicates.    
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Figure 2-3: Iterative improvement of synthetic Ty1 transposition rate and scheme for 
detection of retrotransposition using an intron-marked, URA3-containing 
retroelement.   
 
A) URA3 is inserted into the retroelement in the reverse orientation relative to 
transcription from the pGAL1 promoter.  The presence of an intron in the same 
transcriptional direction as pGAL1 prevents mRNA originating from the URA3 promoter 
from being correctly spliced and initiating Ura3p synthesis.  Upon transcription from 
pGAL1, the intron is spliced.  This mRNA cannot give rise to Ura3p due to URA3 being 
present in the reverse orientation on this transcript.  However, once mRNA is converted 
into cDNA, a functional URA3 expression cassette is formed, and integration of this 
cDNA into the genome ensures a heritable URA3+ phenotype. B) Strain background, 
induction conditions, and expression of critical Ty1 components were modified to 
improve transposition rates of the synthetic retroelement.  Error bars for the plasmid 
version represent 95% confidence intervals obtained via fluctuation analysis of biological 
triplicates, and error bars for the genomic version represent the standard deviation of 
biological triplicates.  
 
2.3.1.2 rrm3 Deletion Increases Transposition Rate 
 Ty1 replication is known to be highly regulated by various host factors [98].  To 
evaluate a coupling between genotype and function, we performed an extensive literature 
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search and used the yeast haploid knockout collection to identify knockout phenotypes 
which enabled increased rates of Ty1 replication [98-100].  Of the various genotypes 
tested (Fig 2-4b), deletion of rrm3 most significantly increased transposition rates in S. 
cerevisiae BY4741 (Fig 2-3b).  Rrm3p plays a role in DNA repair, which may influence 
retrotransposition as it is dependent on homologous recombination [98].  Several other 
combinations of targets were evaluated, but these combinations did not exceed the 
transposition rate beyond that of ∆rrm3 alone (Fig 2-4b). Therefore, S. cerevisiae 
BY4741 ∆rrm3 was used for all subsequent experiments. 
 
2.3.1.3 Genomic Integration of Ty1 Decreases Transposition 
Subsequently, we elected to move the retroelement into the genome in order to 
gain a more accurate picture of retroelement behavior in its final context. We utilized 
BY4741 ∆rrm3 with a genomically-integrated, pTEF1-containing retroelement at high 
OD, and determined that the transposition rate was significantly inhibited compared to 
the plasmid-based retroelement (Fig 2-3b). 
 
2.3.1.4 Inducing Transposition at High Cell Density Increases Library Size 
In all initial experiments, Ty1 transposition was induced when cells were at a low 
optical density and continued as cells divided. However, this growth can significantly 
reduce effective library sizes as mutations that occur early during growth can dominate 
the resulting culture during outgrowth [101]. We aimed to increase library sizes by 
inducing transposition for the same length of time (3 days), but at a much higher initial 
cell density (OD600=1).  In this condition, additional cell growth would have a greatly 
reduced effect on library size. This condition significantly increased the 
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retrotransposition rate (Fig 2-3b), and all subsequent inductions were carried out at high 
cell density. 
 
2.3.1.5 Reducing Induction Temperature Increases Transposition 
We next made use of the known temperature sensitivity of Ty1 [102] by inducing 
transposition at a lower temperature (22 ºC). This modification greatly improved 
transposition rate (Fig 2-3b). Interestingly, it also increased basal activation of our 
inducible Ty1 retroelement in the absence of a cis-encoded reverse transcriptase (Fig 2-
2b), which could be due to the activation of endogenous Ty1 elements that are natively 
repressed at 30 ºC. 
 
2.3.1.6 Increasing tRNAiMet Expression Increases Transposition 
Based on real-time PCR experiments (Fig 2-4c and 2-4d), we noted that induction 
of Ty1 RNA levels by pGAL1 greatly exceeded resulting cDNA levels produced by 
Ty1RT. As Ty1 replication is primed by the yeast initiator methionine tRNA (tRNAiMet), 
we hypothesized that the concentration of this tRNA may be limiting transposition rates. 
By overexpressing tRNAiMet from several promoters, we observed greatly improved 
transposition rates (Fig 2-3b, Fig 2-2e). In particular, by overexpressing tRNAiMet using 
its native promoter and terminator on a high-copy plasmid, transposition rate could be 
improved by ~3.5-fold, and this increase was accompanied by a corresponding increase 
in cDNA levels (Fig 2-2f).  All subsequent experiments used this overexpression strategy. 
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Figure 2-4: Improvement of Ty1 transposition.   
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Figure 2-4 (continued): A) Substitution of alternative promoters in retroelement.  
“Distinct transposants” refers to the number of unique cells in which Ty1 underwent a 
full retrotransposition cycle at least once.  This uniqueness explicitly excludes daughter 
cells arising from the original transposed variant.  B) Transposition rates for BY4741 
knockout strains.  Transcript C) and cDNA levels D) of engineered Ty1 retroelements.  
E) Transposition rate of strains overexpressing the initiator methionine tRNA IMT4.  F) 
tRNAiMet overexpression improves cDNA synthesis.  Low copy and High copy data were 
collected on different days and hence are normalized to their respective “with tRNA Glc” 
values.  G), Transposition rate and mutation rate conferred by retroelements containing 
cargo of various sizes.  “Max distinct mutants” refers to the maximum number of mutants 
attainable in a cargo of a particular length, given a 0.15 kb-1 mutation rate and the 
maximum number of distinct transposants attainable for a particular cargo size 
(maximum is calculated over 3, 5, and 7-day induction times).  Strains containing the 
appropriate retroelement were exposed to galactose at high OD for (G) and low OD for 
(A) and (B) for three days and then plated on uracil-deficient media to count 
transposants.  For (C) and (D), cells were exposed to the appropriate carbon source at 
high OD for three days.  Total DNA and RNA was extracted after induction, and nucleic 
acid levels were quantified using qRT-PCR.  For (E) and (F), strains containing a 
genomically-integrated retroelement were exposed to galactose at 22°C at high OD for 
three days.  Error bars in (A) and (B) represent 95% confidence intervals from biological 
triplicates.  Error bars in (E) and (G) represent the standard deviation of biological 
triplicates.  For (C), (D), and (F) error bars represent the standard deviation of technical 
triplicates.   
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2.3.2 Characterization of ICE Transposition 
2.3.2.1 Characterizing the Effect of Cargo Length on Transposition 
Since it is highly desirable to include long sequences consisting of multi-gene 
pathways in the inducible retroelement, the effect of transcript length on transposition 
rate was characterized.  Specifically, we inserted gene fragments as additional cargo 
between the URA3 reporter gene and the reverse transcriptase gene and then measured 
the resulting transposition rates.  In addition, we measured transposition rates after 3, 5, 
and 7 days of high cell density induction in S. cerevisiae BY4741 Δrrm3. These 
experiments clearly revealed a negative correlation between cargo length and 
retrotransposition rate.  However, lengthening the induction time from 3 to 7 days 
increased the number of retrotransposition events, especially for constructs containing the 
longest sequences (Fig 2-4g). Importantly, relatively high transposition rates were 
maintained within approximately an order of magnitude as cargo size increased to 
roughly 5 kb, indicating that Ty1 is capable of generating diversity to a multi-gene 
pathway.  It should be noted that this experiment combined each pathway element on the 
same mutagenesis cassette.  However, it is also possible to distribute several multi-gene 
mutagenesis cassettes across the genome to enable simultaneous evolution on multiple 
segments of longer cargo. 
 
2.3.2.2 Characterizing the Effect of Terminators on Transposition 
When expressing multi-gene pathways in yeast, it is common to include a 
promoter before each gene and a terminator afterward. When inserting a multi-gene 
pathway into the Ty1 mutagenesis cassette, however, a terminator with bidirectional 
activity can significantly affect transposition, since the entire retroelement must be 
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transcribed prior to reverse transcription. To characterize this effect, several native and 
synthetic terminators were inserted after the URA3 reporter gene in the synthetic 
retroelement [103]. These experiments showed that including terminators inside the 
retroelement can lower the rate of transposition, with several terminators eliminating 
activity altogether (Fig 2-2c).  
While we did identify several terminators that reduced transposition rate to within 
one order of magnitude, we instead opted to utilize 2A sites, which allow a single 
promoter to drive expression of a fusion peptide that then self-cleaves during translation 
[74]. This strategy allowed the evolution of multi-gene pathways, such as the xylose 
pathway evolved here, without including any terminators between genes. In addition, it 
allows multi-gene pathways to be expressed from a single promoter, reducing the length 
of DNA needed in the cargo and thus increasing the rate of transposition (Fig 2-4g). 
Including 2A sequences as opposed to terminators thus allows our approach to attain a 
significantly higher library size for multi-gene pathways through two mechanisms: it 
avoids terminators and it reduces cargo length by only requiring a single promoter.  
However, it should be noted that 2A sites are as of yet unoptimized for use in yeast, such 
that cleavage efficiency may not be 100% in all contexts and thus may pose an issue for 
pathways in which the generation of fusion proteins would be undesirable (see Chapter 6 
for further discussion).  For these cases, we recommend the integration of multiple 
distinct mutagenesis cassettes into the same strain to enable the simultaneous directed 
evolution of pathway components. 
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2.3.2.3 Measurement of Mutation Rate Enabled by ICE 
Next, we undertook a mutation reversion experiment to investigate the error rate 
of this approach in comparison to random drift/mutation.  To do so, a non-functional 
KanMX antibiotic marker was constructed by inserting an artificial stop codon 
(generating dKanMX).  Cells containing either a genomically-integrated copy of dKanMX 
(as a control for random drift / adaptive evolution) or a copy integrated as cargo in the 
optimized Ty1 retroelement (the “mutagenesis cassette”) were exposed to galactose and 
plated on G418-containing media.  The number of G418-resistant colonies observed 
conservatively demonstrated a 20-fold higher reversion rate using in vivo mutagenesis 
over random drift (Fig 2-5a).  Additionally, sequencing isolated colonies from this 
experiment demonstrated that out of 49 sequenced resistant colonies, 43 were found to 
have a mutation reverting the artificial stop codon, thus demonstrating in vivo-generated 
mutations as the mode of action.  
In order to directly compare the rates of Ty1-induced mutations and background 
genetic drift, the dKanMX marker was constructed for use in a mutation reversion assay, 
containing two point mutations that together prevent functional activity. The first is 
T405A, which introduces an artificial stop codon at the 135th residue, in the middle of 
the proposed active site [104]. Interestingly, this mutation alone does not inactivate 
KanMX, and expression of this variant confers G418 resistance. The second mutation, 
T530A, is a missense variant resulting in Trp177Leu. Together, these mutations inactivate 
KanMX, and do not allow growth in the presence of G418. 
To separate the effect of background genetic drift absent the optimized Ty1 
retroelement, dKanMX was either integrated directly into the genome (g-dKanMX) or 
incorporated into a Ty1 mutagenesis cassette, which was also integrated into the genome 
(ICE-dKanMX). Both strains were grown to stationary phase and exposed to galactose, 
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then plated on media containing G418. The rate of reversion mutations could then be 
measured by counting G418-resistant colonies. Genomic DNA from 39 colonies of both 
strains was extracted, a PCR designed to amplify position 135 of dKanMX was 
performed, and amplicons were sequenced via Sanger sequencing. In 34 of 39 resistant 
colonies sequenced, mutations at position 135 reverted the artificial stop codon to one of 
several non-stop codons, thus activating the gene and conferring a G418-resistant 
phenotype.  We hypothesize that the 5 remaining colonies displaying a G418-resistant 
phenotype in the absence of a mutation at residue 135 may be due to a mutation 
elsewhere in KanMX (e.g. position 177), or a mutation elsewhere in the yeast genome 
(e.g. a mutation generating an amber suppressor tRNA).  To this end, we repeated this 
experiment with an additional 10 colonies, this time amplifying and sequencing both 
mutated loci (position 135 and 177). Of these 10, 9 have mutations at position 135 that 
were previously observed. However, no other mutations in dKanMX were observed, 
including at position 177, in any of the 10 sequenced revertants.  As stated above, the 
generation of an amber suppressor tRNA may be the cause of the remaining resistant 
isolate. We therefore conservatively conclude that at least 88% (43/49) of G418-resistant 
colonies appeared as a result of direct Ty1-mediated mutagenesis to dKanMX. 
Next, we evaluated the full mutational rate and spectrum conferred during a single 
round of in vivo mutagenesis using next-generation sequencing. Yeast cells containing 
URA3-containing, Ty1 retrotransposons were induced in galactose for three days, after 
which intron-less URA3 amplicons were generated via PCR of total DNA.  As a negative 
control encompassing background genetic drift, PCR error rate, and sequencing error, a 
region of the Ampicillin resistance gene (Amp) of the same length (which is not reverse 
transcribed) was also amplified.  These amplicons were then sequenced. Analysis of 
identified mutants showed a uniform error distribution across each amplicon, with URA3 
 38 
consistently showing a higher mutation rate (0.28 kb-1) than Amp (0.13 kb-1) (Fig 2-5b).  
This 0.15 kb-1 increase in error rate above the combined effects of drift, PCR error, and 
sequencing error was thus due to Ty1 and was also reflected in an increased frequency of 
observing a given number of mutations per 200bp read in URA3 versus Amp (Fig 2-5c). 
Finally, Ty1 exhibited a mutational spectrum commensurate with other commonly-used 
error-prone polymerases and displayed an error rate which is useful for directed evolution 
of genes and pathways (Table 2-1).  Collectively, this analysis indicated that the Ty1 
retrotransposon is a useful vehicle for introducing mutations to defined genes and 
pathways in vivo. This analysis that URA3 was mutated at rates of 0.15 kb-1 (Fig 2-5b and 
2-5c) generally agrees with previously-reported in vitro values for transcription/reverse 
transcription in Ty1 (0.05-0.25 kb-1) [95, 96].  This mutation rate indicates that this 
system can effectively sample up to 1.6*107 distinct mutants per liter (Fig 2-4g).  This 
library potential is the highest reported for any in vivo, continuous directed evolution 
approach in yeast.  This result demonstrates that the increase in mutation frequency 
achieved in this work is effective at evolving cargo of interest in a manner previously 
unexplored for eukaryotic systems. 
The two methods (reversion mutation assay and next-generation sequencing) were 
also compared. With this established rate of 0.15 point mutations per bp, each 
transposition of the 717 bp dKanMX gene will result in an average of 0.10755 mutations. 
Given an approximate transposition rate of 108 per liter of culture (based on the length of 
the cargo cassette), 1.0 mL of culture plated on G418-containing media is expected to 
contain 10,755 mutations in dKanMX. Neglecting indel mutations, there are 8 mutations 
out of the 2151 possible that will eliminate the stop codon from dKanMX; assuming the 
mutations are distributed randomly and uniformly throughout the gene, this results in 
approximately 40 reversion mutations per 1.0 mL of culture that will be able to grow on 
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the G418 plate. This matches remarkably closely to the rate of colony formation observed 
(0.88*58 colonies per mL of culture= 51 per mL of culture), confirming the utility of this 
assay and the rate of mutation in ICE cargo. 
 
Figure 2-5:  Measurement of Ty1 Mutagenesis 
 
A) Characterization of dKanMX reversion with or without ICE retroelement integrated in 
the genome.  Cells were exposed to galactose and then plated on G418-containing media 
to count colonies.  For (A), error bars represent standard deviation of technical triplicates.  
Mutation rates in Ty1 cDNA were determined through next-generation sequencing. 
Spatial distribution of mutation rates (B) and frequencies of observing a given number of 
mutations (C) of sequenced Ty1 cargo (URA3) as well as DNA not exposed to Ty1RT 
(Amp).   
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Table 2-1: Mutation spectrum of Ty1RT-RNAPII compared with other polymerases 
 Ty1RT 
-
RNAPII 
Mutazyme 
II 
Taq DNAQ926 TP-
DNAP1Y427A 
Yeast 
DNAP 
Bias Indicators       
Ts/Tv 1.06 0.9 0.8 1.4 0.17 0.98 
AT->GC/GC-
>AT 
0.28 0.6 1.9 0.3 0.44 0.48 
A,T->N (%) 28.8 50.7 75.9 30 44.3 31.7 
G,C->N (%) 69.4 43.8 19.6 70 55.7 68.3 
Indels       
Insertions (%) 0.08 0.7 0.3 N.R. N.R. 3.01 Deletions (%) 1.6 4.8 4.2 
Mutation 
Frequency 
      
Mutations per kb 0.15 3-16 4.9 0.05 0.00004 0.0000002 
N.R. = Not Reported.  DNAQ data taken from [67, 105]; TP-DNAP1Y427 data taken 
from[90]; Yeast DNAP data taken from [106] 
 
 
2.3.2.4 Comparison of ICE to Error-Prone PCR 
Finally, we sought to further compare the results obtained using in vivo derived 
mutagenesis with traditional in vitro mutagenesis.  To this end, we generated two 
libraries of ura3 variants through error-prone PCR using standard approaches, resulting in 
libraries of two differing mutagenic rates each roughly 105 in size.  These libraries were 
selected head-to-head with the in vivo mutagenesis libraries in uracil-deficient, 5-FOA-
containing media with equivalent cell density trigger thresholds for subculturing (Fig 2-
6a, see Methods).  On the basis of bulk growth rate and subculturing frequency, it was 
clear that the in vivo mutagenesis derived libraries outperformed the error-prone libraries 
(reaching the threshold for subculturing 4 times versus 2 over the experimental 
timecourse) (Fig 2-5b).  We next isolated 5 clones from each library/subculture and 
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compared their growth in 5-FOA concentrations ranging from 0 g L-1 to 1 g L-1 (Fig2-6c, 
Fig 2-7a,b).  We found that the isolated strains derived from in vivo mutagenesis 
significantly (p<0.05, Mann-Whitney U test) outperformed those derived from in vitro 
mutagenesis in the majority (125/240) of possible comparisons (growth rate, maximum 
OD600, and lag time).  In 232/240 comparisons, in vivo mutagenesis was on par or better 
than traditional in vitro mutagenesis.  This combined result is highly significant (p<10-13, 
Fisher’s method), demonstrating the utility of an in vivo mutagenesis approach. These 
two results indicated (1) that Ty1-generated libraries yield improved variants faster than 
error-prone PCR and (2) that Ty1-derived mutants significantly outperform those derived 
from error-prone PCR. 
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Figure 2-6: Comparison of ICE to error-prone PCR.   
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Figure 2-6 (continued): The ability of ICE to generate 5-FOA-resistant mutants of 
URA3 was evaluated in parallel with error-prone PCR.  a, workflow for parallel evolution 
experiment is diagrammed.  b, culture cell densities were monitored as selections 
progressed.  Each time the OD600 of the culture exceeded 3, a portion was transferred to a 
new flask containing a 0.25 g L-1 increased concentration of 5-FOA (denoted by the 
presence of a colored arrow).  c, 5 random clones were isolated from each subculture 
(denoted by the number after the dash, eg. ICE-3 refers to clones isolated from the ICE 
library in subculture 3) and their growth was compared in varying concentrations of 5-
FOA.  Lines on boxplots in c represent, from top to bottom, maximum observed value, 
75th percentile, median, 25th percentile, and minimum observed value.  P-values used to 
generate heatmaps were computed using a Mann-Whitney U-test. 
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Figure 2-7: Comparison of Lag time and Max OD of ICE-derived and EP-PCR-derived 
mutants 
 
A) Lag time.  B) Max OD.  Lines on boxplots represent, from top to bottom, maximum 
observed value, 75th percentile, median, 25th percentile, and minimum observed value.  P-
values used to generate heatmaps were computed using a Mann-Whitney U-test. 
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2.3.3 Applying ICE to Evolve Novel Phenotypes  
With the in vivo mutagenesis system in place, we next investigated the utility of in 
vivo-generated libraries (along with different modes of selection) in the directed 
evolution of 3 broad classes of genetic cargo: small-molecule-converting enzymes, 
transcriptional regulators, and multi-enzyme pathways (Fig 2-1f).  In these experiments, 
both regulatory regions and coding regions were subjected to mutation and selection (in 
contrast to common in vitro searches) to enable the evolutionary process to alter both 
expression and protein properties in its search for improved phenotypes, and to take 
advantage of the expanded library size afforded by this method.  In each case, we utilized 
a genomically-integrated Ty1 element in a BY4741 ∆rrm3 strain background, in which 
the cargo of interest was integrated between Ty1RT and the 3’LTR in the reverse 
orientation relative to Ty1 transcription and interrupted by an intron to facilitate mutant 
recovery.  During evolution of URA3 and SPT15, top mutants from each round were 
isolated and re-introduced to a fresh strain to eliminate any concurrent strain adaptation, 
while evolution of xylose catabolism proceeded in a continuous manner, demonstrating in 
vivo continuous evolution (ICE).  The intent of these experiments was to investigate the 
breadth of evolvable cargo and the variety of experimental designs compatible with 
retrotransposon-generated libraries.  It is clear that each of these experiments can serve as 
a launching point for further in-depth mechanistic analyses of mutant function as well as 
testing of different and subsequent evolutionary trajectories.  As a mutagenesis technique, 
this approach is inherently phenotype-agnostic and could be further applied to additional 
targets which require alternative screening modalities. 
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2.3.3.1 Evolution of Improved Ura3p Substrate Specificity 
Our first target involved engineering the substrate specificity of URA3, which 
encodes orotidine-5’-phosphate decarboxylase.  Ura3p is an efficient catalyst which 
converts orotidine-5’-phosphate to uridine-5’-phosphate, yet also converts 5-fluoro-orotic 
acid (5-FOA) into 5-fluorouracil, a toxic compound.  As a means to demonstrate the 
ability to modify enzyme promiscuity in a novel manner, we sought to isolate ura3 
variants with a decreased ability to convert 5-FOA to 5-fluorouracil while maintaining 
their ability to enable uracil biosynthesis.  Such variants have not, to our knowledge, been 
reported.  To improve enzyme specificity for orotidine-5’-phosphate, we undertook 
simultaneous induction of mutagenesis and selection in uracil-deficient, 5-FOA-
containing media, after which top variants were re-transformed into a fresh strain to 
exclude any adaptive, genomic mutations (see Methods).  After two rounds, we isolated 
the best mutant, ura3(3-5-2), which significantly outperformed wild-type (p<10-5, 
Fisher’s method), and which conferred a 2.5-fold increased IC50 on 5-FOA to a fresh 
strain relative to a strain expressing the wild-type enzyme (Fig 2-9a).  This variant 
contained two coding mutations (Arg145Ile and Arg186Lys).   
The first-round mutant ura3(3-5) contained a single coding mutation (Arg145Ile) 
that resides on an outer loop of the URA3p (β/α)8 barrel and which is distal to both the 
homodimer interface and catalytic site. After isolation and sequencing of ura3 mutants 
enriched by the first round of screening, the capacities of each  ura3 variant to convert 5-
FOA to 5-fluorouracil, while maintaining activity in the uracil biosynthesis pathway, 
were performed by integrating each variant into a low-copy vector and transformed this 
expression cassette into BY4741 ∆rrm3. Cells containing either a mutant ura3 or wild-
type URA3 were then plated on solid media lacking uracil and containing 5-FOA, and 
relative growth rate was quickly determined by comparing colony size. Strains expressing 
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ura3(3-5) enabled over 3-fold increases to colony area relative to those expressing the 
wild-type gene, indicating a decreased propensity of these mutants to convert 5-FOA into 
5-fluorouracil while retaining their function in the uracil biosynthesis pathway (Fig 2-8b). 
Importantly, cells containing this mutant did not exhibit decreased growth rate relative to 
those containing wild-type URA3 in uracil-deficient media without 5-FOA, indicating 
that their increased specificity came with no observable fitness tradeoff under these 
conditions.   
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Figure 2-8:  Characterization of ICE mutants 
 
 49 
Figure 2-8 (continued): A) Transcriptional rates of SPT15 mutants.  SPT15 expression 
levels were measured through qRT-PCR.  B) Growth of URA3(3-5)-containing strains in 
media lacking uracil and containing 5-FOA.  Indicated strains were plated on solid media 
lacking uracil and containing the indicated concentration of 5-FOA.  Colony area was 
measured using automated image analysis software.  Error bars represent standard 
deviation observed among ~100 analyzed colonies.  C) Activity of pGAL1 in xylose-
containing media.  Strains containing a fluorescent reporter driven by pGAL1 were 
cultured in the appropriate medium for several days, then re-seeded in a different carbon 
source overnight before measurement of fluorescence.  Growth test of xylA (D) and 
xylA3* (E) pathway mutants.  Indicated strains were inoculated into 1 mL of xylose-
containing minimal media at a starting optical density of 0.01 and optical density was 
measured over the course of 3 days.  F), Growth test of spt15 mutants in 1.2% 1-butanol, 
G) 1.3% 1-butanol, H) 1.4% 1-butanol, I) 1.5% 1-butanol. For (A), error bars represent 
standard deviation of technical triplicates.  For (B-I), error bars represent the standard 
deviation of biological triplicates.   
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ura3(3-5-2), the best-performing mutant from the second round, contained a 
second coding mutation (Arg186Lys) that was likewise distal to the active site and the 
homodimer interface.  ura3(3-5-2) was also cloned into a low-copy vector and 
transformed into BY4741. Cells containing either ura3(3-5), ura3(3-5-2), or wild-type 
URA3 were then subjected to growth assays in liquid media lacking uracil but containing 
from 0 g L-1 5-FOA to 1 g L-1 5-FOA (which is the concentration generally used for 
efficient counter-selection of the URA3 marker [107]. Maximum exponential growth 
rates at each condition were measured in order to compare the relative specificity of each 
enzyme.  In all conditions, strains containing ura3(3-5-2) grew the fastest followed by 
ura3(3-5) and finally URA3. In particular, cells containing ura3(3-5) and ura3(3-5-2) 
attained IC50 values for 5-FOA 1.6- and 2.5-fold higher than strains expressing wild-type 
URA3, respectively (Fig 2-9a).  Again, neither mutant strain exhibited decreased growth 
rate relative to those containing wild-type URA3 in uracil-deficient media without 5-
FOA, confirming this increased specificity did not practically affect native activity. 
While further in vitro analysis of these variants may reveal the underlying 
mechanistic basis for improved specificity, this experiment indicated that in vivo-
generated libraries can be used to evolve substrate specificities using simultaneous 
mutagenesis and selection. 
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Figure 2-9: Implementation of in vivo-generated libraries for directed evolution of three 
distinct classes of genetic cargo 
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Figure 2-9 (continued): Three broad classes of genetic cargo: transcriptional regulators, 
single enzymes, and multi-gene pathways were used as targets for in vivo mutagenesis.  
A) ura3 variants with altered specificity were characterized by growth rate in uracil-
deficient, 5-FOA containing media.  B) spt15 variants were characterized by survival in 
killing concentrations of 1-butanol.  C and D) Xylose pathway variants were 
characterized through growth rate in xylose-containing media.  IK pathway variants are 
pictured in (C), and I3K pathway variants are pictured in (D).  In panels (A) and (B), 
error bars represent the standard error of the mean derived from biological triplicates, one 
grey star indicates significantly higher values for the first round mutant versus wild-type 
at p<0.05 via a Mann-Whitney U test, two grey stars indicate significantly higher values 
for the first round mutant versus wild-type at p<0.005 via a Mann-Whitney U test, one 
red star indicates significantly higher values for the second round mutant versus wild-
type at p<0.05 via a Mann-Whitney U test, and two red stars indicate significantly higher 
values for the second round mutant versus wild-type at p<0.005 via a Mann-Whitney U 
test.  In panels (C) and (D), shaded areas represent the standard deviation of biological 
triplicates.  
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2.3.3.2 Spt15p Evolution for Improved 1-Butanol Tolerance 
Our second target was the gene encoding the global transcriptional regulator 
Spt15p, the TATA-box binding protein [108].  Traditional in vitro-based evolution of this 
master transcriptional regulator has successfully improved complex phenotypes such as 
ethanol tolerance [27], but no mutants have been reported which confer increased butanol 
tolerance.  Here, we aimed to use retrotransposon-generated libraries of spt15 to identify 
dominant mutants conferring increased tolerance to 1-butanol (see Methods) with each 
round consisting of mutagenesis in a fresh strain background and selection in non-
inducing conditions.  Through two subsequent, iterative rounds, we were able to identify 
a variant (spt15-B6-1) that improved the tolerance of a fresh strain nearly 2-Fold after 1 
hr in 3.5% 1-butanol (Fig 2-9b, p<0.05, Mann-Whitney U test).  This mutant also 
improved growth of a fresh strain of yeast upwards of 44% in 1.4% 1-butanol (Fig 2-8h, 
p<0.05, Mann-Whitney U test).  Although we selected for tolerance, not growth rate, the 
collective performance of this mutant indicated that it significantly outperformed wild-
type (p<0.01, Fisher’s method) in both tolerance and growth characteristics.  This mutant 
contained two coding mutations (Arg98His and Gly192Ser) near the DNA-binding domain 
and two indel mutations in the promoter region (Fig 2-9b).  These results indicate the 
potential of our approach to simultaneously mutate coding and regulatory elements.  
Moreover, this approach also generated these input libraries in a single, highly 
automatable step (transfer to galactose-containing media) with significantly reduced labor 
intensity compared to prior in vitro approaches with this transcription factor [27]. 
 The best-performing mutant isolated from the first round, spt15-B6, contains a 
single coding mutation (Arg98His) near the DNA-binding domain of this protein, 
suggesting a putative mode of action. Spt15-B6-1, the best-performing mutant from the 
second round of ICE contained a second coding mutation (Gly192Ser) along with two 
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indels in the TEF1 promoter (Fig 2-9b).  This coding sequence mutation, like that of 
spt15-B6, resides in the DNA-binding domain.   
After isolation and sequencing of spt15 mutants enriched by our initial screening, 
viability analyses of spt15 mutants were performed by integrating each spt15 mutant into 
a low-copy vector and transforming this expression cassette into wild-type BY4741. 
These strains, along with controls expressing either wild-type SPT15 or an empty vector, 
were grown to stationary phase and then subjected to a killing concentration of 1-butanol 
(3.5% by volume). After 0, 1, 2, and 3.5 hours, a small volume of each culture was plated 
to determine the number of viable cells remaining (see Chapter 8: Materials and 
Methods).  This analysis indicated that cells containing spt15-B6 exhibited a 1.7-fold 
higher viability in lethal 1-butanol concentrations compared to wild-type, while cells 
containing spt15-B6-1 exhibited up to 1.95-fold higher viability relative to wild-type 
under the same conditions (Fig 2-9b).  
These mutants were then further tested for any potential growth improvements in 
butanol-containing media. The same strains, along with controls expressing either wild-
type SPT15 or an empty vector, were grown to stationary phase and then resuspended at a 
low OD in media containing between 1.2% and 1.5% butanol. These were then grown in 
anaerobic sealed culture tubes.  Spt15-B6-1 conferred 32% and 44% increased growth 
over wild-type at 1.3% and 1.4% 1-butanol, respectively (p<0.05).  As spt15-B6-1 also 
contained mutations to pTEF1, a qRT-PCR experiment was carried out to investigate 
potential changes to transcription levels in order to provide insights into the observed 
phenotype. However, expression measurements indicated no difference between the rate 
of transcription enabled by pTEF1 and the promoter contained in spt15-B6-1 (Fig 2-8a) 
under these test-tube, exponential growth conditions. 
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2.3.3.3 Pathway Evolution for Improved Xylose Catabolism 
Our third and most complex target was the optimization of a multi-enzyme 
pathway containing a promoter, an isomerase, and a kinase to enable increased xylose 
catabolism.  Xylose catabolism is an industrially important phenotype for lignocellulose 
conversion [109] and functional pathways have been established using an evolved xylose 
isomerase gene from Piromyces spp.  (xylA) [17] and enhanced through overexpression 
of xylulokinase (XKS1) [110].  As either of these two enzymes could serve as rate-
limiting steps in this pathway, we established a multi-gene cassette encompassing a 
strong hybrid TDH3 promoter (UASTEF-UASCIT-UASCLB-pTDH3, referred to here as 
pTDH3*) [111] driving these two coding regions through the use of a P2A site [74] (See 
Chapter 6).  In a second, parallel evolution experiment, we substituted wild-type XylA for 
a previously-identified mutant, xylA3*, that was shown to confer a 77% increase in 
xylose consumption rate [17].  These pathway constructs are named IK and I3K, 
respectively.  Although XylA has been the focus of prior directed evolution studies, in no 
case has directed evolution been reported on the entire XylA-XKS1 pathway 
simultaneously.  For both arrangements, we aimed to identify mutations in a purely in 
vivo, continuous fashion without intermediate re-transformation steps to demonstrate full 
continuous evolution.  Thus, one continuous round of simultaneous mutagenesis and 
selection in ICE comprised many potential independent cycles.  
After in vivo continuous evolution of the IK multi-gene cassette over the course of 
one week, a superior isolate emerged, IK-34, which contains one coding mutation, 
Glu164Lys, in xks1.  This isolate displayed a 21% increase in exponential growth rate (Fig 
2-9c) over the control as well as an 18-hour shorter lag phase (Fig 2-9c and Fig 2-8d).  
For I3K, two similarly-performing, superior isolates, I3K-66 and I3K-20, emerged that 
both contain coding mutations in xylA3*.  In these isolates, xylA3* contains one 
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(Ile433Val, in addition to A1029G, a silent nucleotide change) and three (Ala48Ser, 
Ile433Val, Met435Ile) amino acid substitutions, respectively, and they display 14% and 
16% improvements to exponential growth rate, respectively, (Fig 2-9d) concomitantly 
with a 6-hour decrease in lag time over wild-type I3K.  It is interesting to note that the 
best mutants emerging from these two multi-gene cassettes were distinct (favoring xylose 
isomerase in one case and xylulokinase in the other) indicating the context-specific nature 
inherent to directed evolution.  We then demonstrated through in vitro kinetic assays 
differences in the function of these mutant enzymes, which indicated isolated mutants 
indicated increased Vmax values (0.126 ± 0.008 and 0.134 ± 0.003 µmol min-1 mg protein-
1 for I3K-66 and I3K-20, respectively) compared to wild-type (0.118 ± 0.007 µmol min-1 
mg protein-1). 
Taken together, performing ICE on entire catabolic pathways resulted in several 
proficient strains containing multiple mutations which span the entire 4.6 kb pathway 
after just one week of continuous mutagenesis and selection, which is currently the 
longest pathway for which in vivo continuous directed evolution has been undertaken.  
As a result, we realized a significant acceleration to the process of creating pathway-wide 
mutants as compared to classical directed evolution techniques that require creating 
separate libraries of each gene and reassembling pathways in vivo [71].  
 
2.3.4 Implementation of ICE in Alternative Yeast Strains 
Finally, we wished to investigate the portability of the retrotransposon-assisted 
mutagenesis approach across divergent species of yeast.  Specifically, we observed that 
alternative strains of S. cerevisiae such as CEN.PK2, as well as divergent species of yeast 
such as Kluyveromyces lactis were also able to support replication of the synthetic 
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retroelement with only minimal modifications (Fig 2-10).  However, beneficial knockouts 
found in S. cerevisiae BY4741 did not transfer to CEN.PK2, and the lack of a knockout 
collection in this strain prohibited us from exploring this organism for further improved 
backgrounds.  As Ty1 activity in K. lactis has only been recently demonstrated [112] and 
the precise mechanism of Ty1 transposition in K. lactis is still uncharacterized, these 
preliminary results motivate future work investigating the species-dependence of Ty1.  
Nevertheless, this result indicates that the general approach of utilizing retrotransposons 
to undertake in vivo mutagenesis may be expanded to any other eukaryote which 
supports LTR retrotransposon activity [92], making this a potentially powerful, broad-
host approach. 
 
Figure 2-10: Transposition rates for alternate yeast strains 
 
Transposition rates for wild type BY4741 (low OD plasmid induction), CEN.PK2 (low 
OD plasmid induction), and K. lactis (high OD genomic induction).  Error bars at the low 
OD condition represent 95% confidence intervals obtained from biological triplicates, 
while error bars at the high OD condition represent the standard deviation of biological 
triplicates.  
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2.4 DISCUSSION AND CONCLUSIONS 
In this work, we developed an in vivo mutagenesis system for yeast and applied it 
to the directed evolution of small-molecule-converting enzymes, regulatory proteins, and 
metabolic pathways.  Significantly, we have shown that this enables large, diverse mutant 
libraries in a continuous process which is significantly faster, more effective, cheaper, 
and less labor-intensive than traditional in vitro techniques. Moreover, we have 
demonstrated that the ICE approach can surpass a traditional error-prone PCR library in 
both library and clone performance.  Motivated by its utility demonstrated by this work, 
several challenges of ICE in its current form can be addressed to further its speed and 
effectiveness.  Specifically, increasing the error rate for small cargo, increasing library 
sizes when evolving more than 5 kb, reducing the reintegration of mutants into alternative 
loci, and reducing the potential for concurrent strain adaptation under certain modes of 
selection are goals for future designs.  Nevertheless, this approach in its current 
instantiation is capable of supporting continuous evolution of parts and pathways as 
demonstrated here.  This ICE approach complements powerful continuous and genome-
scale engineering techniques in other organisms [67, 87, 90], can interface with any 
screening/selection technique, and is the first demonstration of an in vivo continuous 
evolution approach for optimization of small-molecule-converting enzymes and pathways 
(of which XylA-XKS1 is the longest yet reported for any in vivo continuous directed 
evolution approach).  Taken together, this work introduces the retroelement-assisted 
continuous evolution paradigm, demonstrates its utility for the directed evolution of a 
wide variety of phenotypes, and indicates its unique potential to enable powerful new 
applications for the rapid evolution of cellular components across varied eukaryotic hosts. 
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Chapter 3: Further Development and Characterization of in vivo 
Continuous Evolution 
3.1 CHAPTER SUMMARY 
 The utility and range of in vivo Continuous Evolution was validated by rapidly 
evolving several novel phenotypes. Several limitations remain, however, especially the 
relatively low rates of retrotransposition and errors on a per-cell basis. Additional 
experiments focused on improving this system by increasing the potential library size, 
either by increasing the rate of retrotransposition or by increasing the error rate of the 
cargo DNA. In addition, novel elements with potential to improve the system were 
incorporated and tested. Primary efforts involved the reverse transcriptase, either through 
protein engineering or by replacing it wholesale with the well-characterized and error-
prone HIV reverse transcriptase. Furthermore, concurrent overexpression of other factors, 
including native genes known to influence retrotransposition and trans-acting Ty1 
elements, was investigated. Finally, the effects of various parts of the ICE system 
previously validated, such as the artificial intron and the galactose induction conditions, 
were more fully characterized. While no significant improvements over the original ICE 
system were found in these experiments, they served to more fully characterize how ICE 
operates and identify several unique opportunities for further investigations. 
 
3.2 INTRODUCTION 
Collectively, the results of the previous chapter indicate that in vivo Continuous 
Evolution (ICE) is a powerful and easy-to-implement method for undertaking directed 
evolution in yeast. Significantly, large and diverse mutant libraries are generated in only 
3 days, using a process significantly faster and less labor-intensive than traditional in 
vitro approaches. Additionally, ICE seamlessly interfaces with any downstream screening 
 60 
and isolation methods and is thus applicable to any screenable phenotype. This approach 
complements high-throughput engineering techniques in other organisms and is the first 
demonstration of a continuous evolution approach for improvement of catalytic enzymes.  
However, several targets for improvement were also identified. First, ICE 
throughput seems to be currently limited by the reverse transcriptase activity and fidelity, 
as a relatively low rate of retrotransposition and mutation rate results in the vast majority 
of cells in a library culture not containing a mutant variant. If the Ty1RT enzyme could 
be engineered for higher processivity or decreased fidelity, it could potentially increase 
the library size obtainable. It may also be possible that the overall performance of ICE 
may be improved by replacing it with a more error-prone reverse transcriptase such as 
that of HIV [96]. It may also be possible to incorporate exogenous elements to better 
control the ICE cycle, such as Cas9 or T7 RNA polymerase. 
In addition, there are several other factors to be investigated that may identify 
potential bottlenecks and areas for improvement. Such factors, including the effects of the 
artificial intron, the culturing conditions during ICE induction, and the termination of the 
ICE mRNA produced during initial transcription, need to be further studied beyond the 
initial validation. Exploring these effects more fully can reveal simple ways to improve 
the utility of an ICE approach. 
 
3.3 RESULTS 
3.3.1 Incorporating HIV Reverse Transcriptase into ICE 
The first and most extensive effort to more fully control ICE mutagenesis was the 
incorporation of the HIV reverse transcriptase in place of the native Ty1 enzyme. Prior 
reports have suggested that the Ty1 reverse transcriptase is modular, and that it is 
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possible to simply replace the native enzyme with the HIV version [113]. Since the HIV 
reverse transcriptase is well-characterized and known to be significantly more error-prone 
than the native Ty1 enzyme [96], it was hypothesized that imported HIV into the ICE 
system could increase the potential library size achievable by enabling a higher error-rate 
during reverse transcription. However, during initial tests, this HIV-ICE construct 
exhibited significantly lower activity than the ICE construct based on the native enzymes 
(Fig 3-1). 
 
Figure 3-1: Transposition rate with different reverse transcriptase 
 
ICE constructs were made using the HIV reverse transcriptase (left) or the native Ty1 
reverse transcriptase (right). Each were induced in galactose-containing media for 3-7 
days, and plated on uracil-dropout media to test transposition rate. Those strains 
incorporating the HIV reverse transcriptase exhibited significantly reduced levels of 
retrotransposition 
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One possible explanation for this lack of activity was hypothesized to be 
inefficient polypeptide cleavage of the integrase/reverse transcriptase system. While this 
cleavage is required for both HIV and Ty1 systems, the cleavage site is different, and Ty1 
is not known to act efficiently on the HIV sequence [114]. 
In an effort to create a retroelement system incorporating HIV RT with a higher 
retrotransposition activity, several variants of the HIV-ICE construct were made. First, 
two variants of HIV RT were made, both a wild-type and one containing mutations 
known to influence fidelity [115]. Next, the retroelement RT primer binding sites were 
changed from those native to Ty1 into those native to HIV. Finally, the sequence between 
the integrase gene and the reverse transcriptase gene, coding for the protease cleavage 
site wherein the polypeptide is cleaved to form the two mature enzymes, was altered to 
code for the native Ty1 cleavage site with either 0, 3, or 6 additional amino acids from 
the Ty1 RT gene downstream. It was hypothesized that if the HIV RT was inactive due to 
improper protease cleavage, including more native Ty1 RT amino acids at this site would 
facilitate more effective cleavage and thus more active enzyme. Sixteen constructs were 
made through combinations of each of these factors; each was then transformed into a 
By4741 strain and the transposition rate under galactose induction was measured. 
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Figure 3-2: Transposition rate with various HIV Reverse Transcriptase variants 
 
Mutant and WT HIV RT was cloned into ICE with several variations: different primer 
binding sites and different protein cleavage site. There was no clear trend with a 
significantly higher rate of retrotransposition 
 
No clear pattern was found in the retrotransposition activity of these HIV 
constructs (Fig 3-2). There was some variation between strains, but none displayed a 
significantly elevated retrotransposition rate. These data seem to indicate that the low 
activity previously observed with HIV-ICE is probably not due to improper protease 
cleavage [113], but more likely due to HIV RT interfering with reverse transcription 
catalyzed by natively present Ty1 RT. The variable activity observed in the different 
variants may be only due to the extent to which each mutant interferes with this process. 
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To ensure this is not due to a simple expression issue, and in order to quantify and 
characterize the expression of both Ty1 and HIV reverse transcriptase as part of the ICE 
system, fluorescent fusion proteins were made by adding the YFP gene downstream of 
the reverse transcriptase gene in the optimized retroelement, with a linker region between 
them to allow proper folding and fluorescence.  These constructs were transformed into 
BY4741, and fluorescence was measured by flow cytometry after growth in either 
glucose or galactose. The results (Fig 3-3) indicate that both Ty1 and HIV RT are being 
expressed only on galactose induction, as expected. Unfortunately, this implies that the 
inability to utilize a HIV RT-containing retroelement is not due solely to inadequate 
expression, but that the activity of HIV RT is simply suboptimal in the yeast cell 
environment. 
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Figure 3-3: Fluorescence of RT-YFP Fusion Proteins 
 
Strains expressing either the normal ICE cassette or ICE cassettes containing YFP-linked 
RT fusion proteins, grown in either glucose-containing media (left) or galactose-
containing media (right), and measured by flow cytometry. These results suggest that 
both enzymes are being expressed under galactose exposure, as expected. 
 
3.3.2 Ty1 Reverse Transcriptase Mutagenesis 
With the difficulties in adapting HIV RT into the ICE cassette, another approach 
focused on altering the native Ty1 system instead. One potential strategy is to engineer 
the Ty1 reverse transcriptase to increase the error rate of the while maintaining its 
relatively high transposition rate.  
The first approach focused on creating a library of enzyme variants by performing 
site-specific saturation mutagenesis on several residues. The amino acids in positions 
145, 225, and 226 are highly conserved across different reverse transcriptase enzymes 
and have been identified as playing a key role in fidelity in the homologous region of 
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HIV [116-120].  A full saturation mutagenesis library was created for each of these three 
sites, consisting of 19 variants containing each amino acid substitution. These 57 
plasmids were then transformed independently into the BY4741 ΔRRM3 strain, and the 
transposition rate of each was measured. In addition to assaying transposition rate, 
mutational analysis was conducted by extracting total DNA after galactose induction, 
with URA3 sequences resulting from transposition events amplified via PCR.  PCR 
products were then pooled and next-generation sequencing was performed on the 
mixture. This was done as in the original next-generation sequencing experiments that 
quantified the ICE mutagenesis rate [121](See Chapter 2). 
It was found that while several mutations increased or maintained transposition 
rate, many reduced activity significantly (Fig 3-4). However, an increase in both 
transposition rate and mutation rate was observed in strains with three different point 
mutations in the Ty1 RT: L145S, F225R and F225H.  It is estimated that a system 
incorporating the Ty1 RT with any of these three mutations could potentially increase the 
library of unique transposants by approximately 5-fold. 
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Figure 3-4: Transposition rate and mutation rate of Ty1 RT mutants 
 
 
1.E+07
1.E+08
1.E+09
1.E+10
0.00035
0.00037
0.00039
0.00041
0.00043
0.00045
0.00047
0.00049
0.00051
0.00053
0.00055
Am
p…
W
T 
Ty
1
Gl
y
Gl
u
As
p
Va
l
Al
a
Ar
g
Se
r
Ly
s
As
n
M
et Ile Th
r
Tr
p
Cy
s
Ty
r
Ph
e
Gl
n
Hi
s
Pr
o
Tr
an
sp
os
iti
on
s i
n 
1L
M
ut
at
io
n 
Ra
te
 p
er
 b
p
Mutation Rate
Transpositions in 1L
1.E+07
1.E+08
1.E+09
1.E+10
0.00035
0.00037
0.00039
0.00041
0.00043
0.00045
0.00047
0.00049
0.00051
0.00053
0.00055
Am
p…
W
T 
Ty
1
Gl
y
Gl
u
As
p
Va
l
Al
a
Ar
g
Se
r
Ly
s
As
n
M
et Ile Th
r
Tr
p
Cy
s
Ty
r
Le
u
Gl
n
Hi
s
Pr
o
Tr
an
sp
os
iti
on
s i
n 
1 
L
M
ut
at
io
n 
Ra
te
 p
er
 b
p
Mutation Rate
Transpositions in 1L
A 
B 
 68 
 
Figure 3-4 (continued): The mutation rate (blue, left axis) as assayed by next-generation 
sequencing and the transposition rate (red, right axis) is displayed for each amino acid 
substitution of A) Leu145, B) Phe225, and C) Val226. 
 
Next, these three mutations were transferred to the dKanMX system to 
simultaneously measure in vivo activity and mutagenesis of these systems. As discussed 
in Chapter 2, dKanmx is a non-functional KanMX antibiotic marker constructed by the 
insertion of an artificial stop codon. This is placed as the ICE cargo with each 
independent Ty1 RT variant. After induction, the culture is plated on G418-containing 
media, allowing growth only if the point mutation is reverted. This serves to measure 
both activity and error-rate of the Ty1 RT variants, since the number of colonies will be 
directly related to each.  
At the same time, several additional Ty1 RT variants were created, including 
K93R, R94K, and Y151A. These mutations were chosen by selecting additional residues 
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that have been shown to influence error-ate in HIV RT, and aligning the sequences of the 
two RTs to find homology. For example, the equivalent mutation of Y151A in HIV 
(Y115A) was shown to increase errors ~4-fold [122]. Similarly, the lysine and arginine 
residues at 93 and 94 were both shown to play a role in fidelity [115, 123]. Lastly, two 
double-mutants were made by combining the three previously studied mutations 
described above: L145S and F225R, as well as L145S and F225H.  
These eight Ty1 RT variants were inserted into the ICE cassette containing 
dKanMX cargo, and RT activity and fidelity was measured by inducing with galactose 
followed by subsequent plating on G418-containing media. Unfortunately, none of these 
variants resulted in a higher number of reversion colonies, suggesting that none exhibited 
improved characteristics. It is possible that these mutations may have increased activity 
and simultaneously reduced the error-rate, or increased the error-rate but decreased 
activity; in either case, the number of reversions would not necessarily increase. This 
experiment suggests that the wild-type already results in the largest possible library size. 
Until more study of the Ty1 RT is completed, perhaps including the protein structure 
being elucidated, it is difficult to do any further rational engineering of this enzyme. 
 
3.3.3 Gene Overexpressions for Improvement of Transposition Rate 
 Another potential path explored was the improvement Ty1 activity through strain 
engineering. Previously, a large collection of gene knockouts linked to Ty1 suppression 
were investigated (See Chapter 2). We also explored overexpressing endogenous Ty1 
activating or supporting genes, in the hopes of relieving a bottleneck or supporting higher 
rates of activity. Several genes known to be associated with higher Ty1 activity were 
chosen, including hsx1, pat1, dhh1, kem1, and lsm1 [124]. Each of these genes was 
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independently amplified and cloned to a high-copy plasmid with a strong GPD 
promoter3, and then transformed into the strain that exhibited the highest rate of ICE 
activity: By4741 ΔRRM3 with tRNA overexpression plasmid and an integrated copy of 
the ICE retroelement. These strains were then induced to test transposition rate. In each 
case, the concurrent overexpression had reduced or similar activity compared to the 
control with no concurrent overexpression (Fig 3-5). These results suggest that none of 
these targets improved the transposition rate and thus library size of ICE. 
 
Figure 3-5: Transposition rate with concurrent overexpressions 
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Figure 3-5 (continued): “GRE” denotes an integrated copy of ICE with intron-
interrupted pTEF-URA3cargo, where and IMT4 denotes the high-copy IMT4 plasmid. 
each additional overexpression is included as a second plasmid to the base strain (left-
most); A) displays the overexpression of hsx1 and pat1 while B) shows dhh1, kem1, and 
lsm1. Note that these experiments were carried out on different days with different 
induction times, which may explain the difference in the control strain results. 
 
3.3.4 Integrase Engineering for Improvement of Transposition Rate 
It has been previously observed that during ICE induction, cDNA generated may 
be integrated into the genome at loci other than the original ICE cassette integration.  
Because such genomic integration may generate effects which are not related to the 
function of the enzyme being mutated, it is desirable to minimize the extent of this 
phenomenon.  However, it is known that in Ty1 the integrase and reverse transcriptase 
are processed as a polyprotein which is subsequently cleaved [125].  In an attempt to 
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reduce genomic integration without compromising reverse transcription activity, a Ty1 
integrase mutation previously found to inhibit integrase activity was constructed [126]. 
The construct was then retransformed into a BY4741 strain and the transposition rate test 
was carried out. It was found that total transposition activity was significantly reduced 
when this integrase mutation was present, rendering this mutant unsuitable for the ICE 
system. 
 
3.3.5 Developing a Disassociated Reverse Transcriptase System 
Another effort to improve the ICE transposition rate utilizes a dissociated reverse 
transcriptase system, with trans-acting Ty1 elements that facilitate more efficient 
retrotransposition. One previously reported construct, called “Helper”-Ty1, consisting of 
the 5’ portion of the native Ty1 retroelement, including the reverse transcriptase but 
excluding the 3’ long terminal repeat. It has previously been shown that expression of 
this construct can catalyze the transposition of distal retroelements containing both long 
terminal repeats but not the reverse transcriptase [127]. It was hypothesized that 
overexpressing this element on a plasmid could help catalyze a higher rate of 
retrotransposition of the genomic element, by allowing multiple copies of the reverse 
transcriptase to be expressed without having to include multiple copies of the cargo. The 
element was placed on a vector and co-expressed in cells containing a genomic 
integration of the retroelement with the URA3-intron reporter gene, and then these cells 
were induced at high-OD stationary phase to measure retrotransposition. It was 
determined that although this co-expression did improve transposition at 30oC, it did not 
have this effect at 22oC (Fig 3-6). It is hypothesized that although overexpression of this 
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element may improve retrotransposition when proteolytic processing is inhibited at 30oC, 
this is not the rate limiting step at the more stable 22oC (See Chapter 2). 
 
Figure 3-6: Transposition of genomically-integrated ICE retroelement with co-expression 
of “Helper”-Ty1 
 
Helper-Ty1 is co-overexpressed on a high-copy plasmid; the control strain has no 
plasmid. 
 
It was next hypothesized that this Helper element could instead be used to 
catalyze the retrotransposition of a synthetic retroelement that did not contain the reverse 
transcriptase or other native proteins, but consisting solely of the cargo to be evolved and 
the LTR.  Such a system was also shown to be functional, with the short synthetic 
element denoted a “Mini”-Ty1 [127]. The advantages of such a system would be several: 
the retrotransposition rate could conceivably be higher, since the length of the RNA 
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transcript to be reverse transcribed would be much shorter; the reverse transcriptase gene 
itself would not be reverse transcribed, avoiding any deleterious mutations from 
accumulating that could inhibit a second round of retrotransposition; and finally such a 
system could potentially avoid the re-integration elsewhere in the genome, instead 
favoring recombination with the original shortened element. 
To test this idea, a “mini” retroelement was constructed from the original ICE 
system by removing all native genes upstream of the TEF-URA3 insert, leaving both long 
terminal repeats. Next, this synthetic mini-retroelement was integrated in the genome, 
and a high-copy “Helper” construct was co-transformed. The strain containing only the 
mini-retroelement and a strain with the helper construct co-transformed were both 
assayed with high-OD galactose induction. Unfortunately, both strains had an extremely 
low rate of retrotransposition, near to the background levels previously observed (Fig 3-
7); this indicates the Helper element was probably not significantly catalyzing 
retrotransposition. This result suggests a disassociated reverse transcriptase system is not 
yet ready for use in ICE evolution. 
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Figure 3-7: Transposition of genomically-integrated “mini-“ICE retroelement with co-
expression of “Helper”-Ty1 
 
 
3.3.6 Utilizing Orthogonal T7 RNA Polymerase to Improve Error Rate 
Another strategy investigated was to incorporate the use of T7 RNA polymerase 
to transcribe the mRNA of the ICE cassette, instead of using the native PolII inducible 
promoter pGAL1 to directly transcribe the retroelement. The rationale for this idea relied 
on the highly-characterized nature of T7, including the description of particularly error-
prone variants [128]. If errors could be introduced during transcription as well as during 
reverse transcription, the overall mutation rate of a single ICE cycle could potentially be 
significantly expanded. Since error-prone T7 RNAP variants have been reported to 
exhibit errors at a rate ~10-fold higher than one ICE cycle [128], successfully 
incorporating it would vastly improve the achievable library size. However, it is not clear 
if mRNA transcribed by T7 would be successfully exported from the nucleus and 
localized to the virus-like particles in which Ty1 reverse transcription is catalyzed. Since 
it has been shown that Ty1 mRNA transcribed in trans can be successfully reverse 
0.E+00
1.E+05
2.E+05
3.E+05
4.E+05
5.E+05
6.E+05
7.E+05
8.E+05
9.E+05
1.E+06
1.E+06
Mini Mini + helper
Tr
an
sp
os
iti
on
s i
n 
1 
L
 76 
transcribed [127], it was hypothesized that T7-transcribed mRNA could also be reverse 
transcribed by endogenous Ty1 elements, even if the T7-transcibed mRNA could not be 
translated. 
To test this, the original ICE system was modified to incorporate wild-type T7 
RNAP [129]; the pGAL1 promoter driving expression of the ICE retroelement was 
swapped out for the T7 promoter, and then T7 RNAP was expressed on a high-copy 
plasmid under the control of pGAL1, such that ICE cycles could still be induced by 
growth in galactose culture. Then, transposition was tested by induction as before. 
Interestingly, there were no prototrophic colonies observed, suggesting activity was 
completely eliminated. While it was expected that transposition rate would be reduced, it 
seems that simply incorporating T7 RNAP as-is does not allow for any retrotransposition 
events at all. While it is understood that T7-transcribed mRNA cannot be translated in 
yeast, this experiment suggests that this mRNA cannot even be recognized by the native 
endogenous Ty1 machinery present either. Further engineering must be considered if T7 
would be used in the ICE system. 
 
3.3.7 Utilizing CRISPR-Cas9 to Direct cDNA re-Integration  
As discussed above, it has been observed that the cDNA generated during a cycle 
of ICE can re-integrate into another location in the genome. In order to improve the 
efficiency of the first round of retrotransposition and more efficiently re-direct cDNA 
integration back to the original locus, Cas9 was expressed in conjunction with a gRNA 
specific for the artificial intron of URA3.  Through this strategy, it was hoped that the 
mutated cDNA generated during reverse transcription would site-specifically integrate to 
its original location (through the double-stranded break generated by Cas9) via 
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homologous recombination.  To this end, mutagenesis and Cas9 expression were induced 
simultaneously to yeast encoding a genomic copy of the retroelements through growth on 
galactose.  If Cas9 functioned as desired, each viable cell surviving after induction would 
contain an intact URA3 gene.  However, we observed a large excess of cells which 
contained no intact URA3 gene after induction, resulting in a ~10-fold lower transposition 
rate relative to cells which did not express Cas9.  However, upon analysis of the URA+ 
colonies, it was observed that isolated transposants had replaced the original copy of 
URA3 in the retroelements with the intronless copy in every colony tested, which is in 
contrast to the situation for strains which do not express Cas9 which seem to mainly 
integrate the intronless copy of URA3 elsewhere in the genome.  Thus, although Cas9 
expression can improve the specificity of cDNA re-integration, this specificity comes at 
the cost of a reduced transposition rate and library size. Because of this tradeoff, it was 
determined that Cas9 expression would not be utilized unless re-integration specificity 
became a major limiting factor for ICE in the future. 
 
3.3.8 Characterizing the Effect of the Artificial Intron on Transposition Rate 
The original construct used for assaying rate of retrotransposition utilizes an 
artificial intron in the reverse orientation to allow quantification of transposition events, 
and this artificial intron was designed with multiple restriction sites to allow further 
manipulation. However, in the intron cassettes used for evolution, a slightly different 
artificial intron was utilized, incorporating only one restriction site, making it slightly 
shorter – 73 bp vs 104 bp. Furthermore, the artificial intron in evolution cassettes (see 
Chapter 2) interrupts the start codon of the gene being evolved, while the cassette used 
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for retrotransposition quantification has the intron located in the middle of the URA3 
gene. 
To quantify the effects, if any, the artificial intron length and placement has on the 
rate of retrotransposition, several variants of the reporter system were constructed. First, 
the current artificial intron was simply replaced with the shorter version used in evolution 
cassettes. This construct was then transformed into the By4741 ΔRRM3 strain, and 
retrotransposition was assayed with the galactose induction. This test confirmed that both 
retroelement constructs exhibited the same rate of retrotransposition (Fig 3-8).  
 
Figure 3-8: Transposition rate of ICE system with different intron interrupting URA3 
reporter 
 
The short intron contains a single added restriction site, and is 73 bp; the long intron has 
several, and is 104 bp long. These were tested in the same conditions to demonstrate that 
the intron length does not materially affect transposition. 
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Next, two more constructs were made that incorporated both of the two intron 
versions into the URA3 start codon, in order to test if this effects the rate of 
retrotransposition. These were also transformed into the By4741 ΔRRM3 strain, and 
retrotransposition was assayed with galactose induction. Interestingly, those strains with 
the start codon interrupted were all able to grow on uracil dropout medium, making the 
retrotransposition rate impossible to quantify. It is possible that interrupting the start 
codon with an intron still allows the expression of a slightly shorter open reading frame, 
resulting in at least partial activity even without retrotransposition and intron excision. 
This is an important lesson for the construction of ICE retroelements; it is possible that if 
an artificial intron is placed too close to the start of a gene, a partially-active version may 
still be able to be expressed without retrotransposition. While this is almost certainly 
gene-dependent, future constructs should have artificial introns inserted into the middle 
of the gene to ensure only retrotransposed copies are able to be expressed. 
 
3.3.9 Further Characterization of Induction Culturing Conditions and the Effects 
on Transposition Rate 
Previously, it was established that culturing conditions during galactose induction 
can have significant effects on the overall rate of transposition, with cultures induced at 
high-OD exhibiting retrotransposition rates orders of magnitude higher than those 
cultured at low-OD (see Chapter 2). Several additional culturing conditions were also 
investigated, to determine if it would be possible to manipulate conditions to foster 
further improvement in this activity. 
First, the starting culture OD was simply increased, resulting in more 
concentrated conditions during galactose induction. Cultures were suspended in 
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galactose-containing media at OD=1.0, 2.0 or 4.0, then induced for 1, 3, or 7 days before 
plating. Those cultures induced at higher OD did not exhibit any increase in transposition 
events, with the maximum number of events observed in those cells at OD=1.0, the 
condition used for all evolutionary experiments (Fig 3-9). Interestingly, because there 
were more cells present in the more densely cultured cells, this indicates that the 
transposition rate on a per-cell basis actually decreased at these conditions. These results 
suggest that induction at OD of approximately 1.0 is apparently the optimum condition 
for maximizing retrotransposition. 
 
Figure 3-9: Transposition rate at with induction at different cell densities 
 
Strains with the integrated ICE cassette containing pTEF-URA3-intron as cargo were 
induced in galactose at various initial ODs. Cells were plated on uracil-dropout media 
after 1, 3, and 7 days of induction, and the transposition rate was quantified by counting 
colonies. Interestingly, higher cell density did not lead to more retrotransposition events. 
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Next, a similar experiment was undertaken by altering the media makeup of the 
induction culture. Several variations were tested: using media with twice the 
concentration of galactose (40g/L), media with no YNB, and “minimal” media, 
containing only galactose, auxotrophic amino acids, and YNB. In each case, the rate of 
transposition was reduced from that of the control (Fig 3-10); in fact, removing YNB 
eliminated transposition entirely. Again, these results suggest that induction with standard 
CSM media may maximize retrotransposition. 
 
Figure 3-10: Transposition rates with different induction media composition 
 
Strains with the integrated ICE cassette containing pTEF-URA3-intron as cargo were 
induced in galactose with either a more concentrated carbon source (“2x galactose”, 
which is 40g/L ), no YNB, or a minimal media containing only galactose, auxotrophic 
amino acids, and YNB. None of these conditions improved the overall rate of 
transposition. 
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3.3.10 Effects of mRNA Termination on ICE Transposition 
Another possibility investigated was the potential to increase the rate of 
retrotransposition by increasing levels of mRNA with high-efficiency terminators. It has 
been shown that using different terminators in synthetic biology applications can 
significantly affect activity, potentially by increasing mRNA half-life [130]. It was 
theorized that if ICE mRNA half-life was increased, it could potentially result in a higher 
overall rate of transposition, by allowing more opportunities for reverse transcription 
prior to RNA degradation. To this end, several high-efficiency native terminators were 
inserted into the ICE cassette immediately following the 3’ LTR, including CPS, IDP, 
and PRM [130]. These were transformed into yeast and the transposition rate measured as 
described previously. However, none of these strains exhibited any change in overall rate 
of transposition when compared to the control construct, which contains no explicit 
terminator. These results suggest that the 3’ LTR may act efficiently as a terminator for 
the initial mRNA transcription and adding additional termination sequences does not 
impact the process.  
 
3.4 DISCUSSION AND CONCLUSIONS  
In this work, extensive characterization and investigation of various factors with 
the potential to improve the process of in vivo Continuous Evolution (ICE) was carried 
out. The original ICE system proved a powerful method of creating new libraries in yeast, 
but it could be substantially improved if there were methods to increase the overall 
potential library size. Here, we investigated many potential factors that might be part of 
such a method. While there was no obviously significant improvement, the additional 
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characterization of these factors further elucidates the limitations and process of ICE, and 
informs future directions of research. 
For example, key experiments carried out here investigated simple changes that 
had potential to significantly impact the retrotransposition process, such as the artificial 
intron and the induction conditions. Here it is shown that neither of these factors limit the 
rate of retrotransposition, establishing that the process used in the original experiments 
were close to optimal in this respect. 
Furthermore, multiple concurrent overexpression targets were investigated, 
including native genes that promote retrotransposition and trans-acting Ty1 elements that 
can enable more efficient retrotransposition of the ICE element. Such overexpression 
targets would seem intuitively to offer the most likely path for increasing the rate of 
retrotransposition, and thus the potential library size enabled by ICE; however, we show 
that none of these have a significant effect. This suggests that either the retrotransposition 
process is not rate-limiting or that simply overexpressing supporting genes concurrently 
does not have a significant effect over simple galactose-induced expression. 
Finally, a substantial amount of effort was spent exploring the possibility of 
engineering the Ty1 reverse transcriptase to increase its error rate. This was done mostly 
by sing protein homology to the well-studied HIV reverse transcriptase, since the Ty1 
enzyme has no reported crystal structure. There is some substantial homology, however, 
especially in conserved regions known to affect fidelity. Unfortunately, none of these 
promising targets enabled higher rates of transposition or error-rates, as measured by the 
dKanMX reversion assay. It is certainly possible that several such mutants did reduce 
fidelity, but did so at a cost to processivity of the reverse transcription reaction; such a 
tradeoff would actually reduce the library size. Without further fundamental 
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understanding of the Ty1 system, including more study of the reverse transcriptase 
enzyme, there does not seem to be an opportunity for further engineering. 
These experiments also reveal how the ICE process may be improved. While it 
seems difficult to further optimize the complex retrotransposition process, there remains 
promise in incorporating orthogonal layers of control, such as Cas9. By targeting Cas9 to 
the ICE cargo, we were able to better control cDNA reintegration, which otherwise did 
not seem possible. Future experiments will focus on experimentation with such 
orthogonal systems, including T7 RNA polymerase, which could potentially expand the 
capabilities of ICE significantly. 
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Chapter 4:  Development of Spinach-based Metabolite Biosensors 
4.1 CHAPTER SUMMARY 
Directed evolution techniques are still fundamentally limited by screening 
capabilities, especially for the discovery of non-growth production phenotypes. While 
extremely large libraries of variants can be created, traditional screening techniques for 
metabolite production are low-throughput. Protein-based biosensors help bridge this gap 
but can be difficult and slow to engineer. Here, we develop a novel generalizable method 
for creating Spinach-based RNA biosensors. Spinach is a short RNA aptamer that binds 
to a non-fluorescent dye, creating a fluorescent complex; by combining secondary 
aptamers into its structure it has been shown that this fluorescence can be made 
dependent on the concentration of the secondary aptamer’s target. By expanding this 
capability using a modeling approach in collaboration with Dr. Howard Salis, we 
demonstrate that such a system can be adapted to rapidly create functional in vitro 
biosensors for a wide range of molecules. The approach is validated by applying it to two 
aptamers never before functionalized in a Spinach setting, tyrosine and 2,4-
dinitrotoluene. We further validate the modeling approach by creating a range of tyrosine 
sensors, demonstrating that their functionality matches that predicted by the model. This 
approach enables the rapid creation of novel biosensors for a huge variety of targets that 
will significantly improve directed evolution efforts. 
 
4.2 INTRODUCTION 
Directed evolution for pathway metabolic engineering requires an extremely large 
library of mutations and an equivalently high-throughput screening method in order to 
identify desired variants.  While growth-based selection is often a powerful tool, it can 
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often be limited, especially when the desired goal is to evolve production phenotypes that 
actually inhibit growth.  Traditional techniques such as GC, HPLC, and MS can provide 
excellent data allowing for the selection of mutants improving product generation; 
however, they are low-throughput and costly when compared to in vitro assays.   
As an alternative to growth-based selection, biosensors have been developed to 
link metabolite production to some reporter, often fluorescence [131, 132]. However, 
there remains a lack of generalizable biosensor generation techniques that can be quickly 
and easily adapted to a different or novel target. Generally, biosensors must be 
independently developed for each new target, a process that can be lengthy, difficult, 
costly, and not guaranteed of success. When engineering an entire pathway through 
evolutionary techniques, there may exist the need to screen multiple metabolite 
intermediates; developing novel biosensors for each undoubtedly limits the process. 
To address this, we utilize RNA aptamer biosensors with the potential to be used 
for high-throughput screening of large libraries.  In particular, RNA aptamers linked to 
“Spinach”, a previously constructed RNA molecule capable of inducible fluorescence, 
can be used as sensors of metabolite concentration [133].  Such a sensor links the in vitro 
concentration of the metabolite of interest to fluorescence, which can be rapidly and 
easily assayed. Critically, such a system is generalizable, in that such a sensor can be 
rapidly and easily created for any molecule for which an aptamer has been reported. 
Since there have been hundreds of such aptamers described for a variety of molecules 
[134], the ability to use Spinach-based biosensors is not limited to any one specific 
molecule or even class of molecules.  
Previously, however, creating Spinach-linked sensors has not been 
straightforward. Their function relies on conditional folding: when the metabolite is 
bound, Spinach will properly fold and fluoresce, but when the metabolite is not bound 
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Spinach will not fold correctly. In prior efforts, aptamer sequences that resulted in this 
conditional folding were created through a process of trial-and-error, by manually 
examining predicted folding behavior, creating multiple sequences that could plausibly 
function as desired, and then synthesizing each and testing them, selecting those that 
worked at highest efficiency [133]. 
Here, we improve on the development process for Spinach-based metabolite 
biosensors through a modeling approach, in conjunction with Dr. Howard Salis at Penn 
State Univeristy, in which the optimal sequence for coupling a metabolite-binding 
aptamer to Spinach can be identified computationally. Importantly, this approach can also 
help tune both the sensitivity of such a sensor as well as its brightness, by accurately 
modeling ΔG values of each bound/unbound permutation. This process results in a 
powerful tool for rapidly creating novel biosensors necessary for evolutionary 
engineering of metabolic pathways. 
 
4.3 RESULTS 
4.3.1 Initial Construction of Spinach-Tyrosine Biosensor   
As a proof-of-concept demonstration of Spinach aptamers’ screening capability, 
tyrosine was chosen as a production target. Tyrosine (like other aromatic amino acids) is 
subject to significant, tight regulatory control in yeast and thus the pathway suffers from 
extremely poor yields and titers.  Molecules derived from the shikimate pathway 
(including tyrosine) have multiple uses as polymer precursors, nutritional supplements, 
and therapeutic agents [135]. Importantly, a previously reported Tyrosine aptamer “Tyr1” 
binds relatively tightly to tyrosine, with a Kd of 23uM, a physiologically relevant 
concentration [136]. 
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The first Spinach-Tyrosine sensor was created by simply inserting the Tyr1 
aptamer sequence into the Spinach stem loop as demonstrated previously. Fluorescence 
of this Spinach-Tyr1 aptamer was minimal, however (Fig 4-1), so several variants were 
constructed by altering the “linker” region to disfavor secondary structure. To do this, the 
predicted folding structure of various sequence perturbations were examined using mfold 
[137], again as was reported previously.  Three variants were created in this process, with 
one variant (Tyr1c) significantly brighter than the original aptamer. However, none of the 
three had any sensitivity to tyrosine presence, indicating that the Spinach structure was 
stable irrespective of the Tyr1 aptamer (Fig 4-1). 
  
Figure 4-1: Fluorescence of first series of Spinach-Tyr1 aptamers tested  
 
Blue bars represent samples with RNA, DFHBI, and buffer, but no tyrosine added. Red 
bars represent the same conditions with 1 mM tyrosine present.  
 
Tyr1c was then used as a scaffold for a second round of variants, again altering 
the linker region in base pairs predicted to contribute to secondary structure.  Five 
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second-round variants were made, and several exhibited tyrosine sensitivity, with several 
exhibiting both a high differentiation in signal as well as brightness comparable to 
Spinach aptamers reported (Fig 4-2). 
 
Figure 4-2: Fluorescence of second series of Spinach-Tyr1 aptamers tested 
 
Blue bars represent samples with RNA, DFHBI, and buffer, but no tyrosine added. Red 
bars represent the same conditions with 1 mM tyrosine present. 
 
Next, Tyr1i was further characterized.  It was shown to be sensitive to tyrosine 
concentrations as low as 0.05 mM, with a signal strongly correlated with concentration 
(Fig 4-3a).  The same aptamer could also detect other aromatic amino acids 
phenylalanine and tryptophan as well, again in relation to concentration (Fig 4-3b-c).  
There was no signal in the presence of non-aromatic control leucine, though, confirming 
its suitability as a biosensor for aromatic amino acids.  
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Figure 4-3: Fluorescence of Spinach-Tyr1i with varying concentration of aromatic amino 
acid present 
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Figure 4-3 (continued): Values are normalized to fluorescence observed with the 
metabolite at 1mM. A) tyrosine, B) phenylalanine, and C) tryptophan  
 
Critically, these differing sensitivities to the aromatic amino acids matches the 
original binding affinities measured for the aptamer Tyr1 (Fig 4-4). This important 
finding confirms that incorporating metabolite-binding aptamers into a Spinach-based 
biosensor does not significantly affect the binding properties. This is essential to the 
generalizability of such a system; while many aptamers have been characterized, the 
binding properties must remain consistent when bound to Spinach if they are to be useful 
as biosensors. The results with the Tyr1 system suggest this is the case.  
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Figure 4-4: Comparison of Tyr1 Kd values to Spinach-Tyr1 sensitivities for three 
aromatic amino acids 
 
The Tyr1 aptamer was reported to be much more sensitive to tyrosine and tryptophan 
compared to phenylalanine. When incorporated into Spinach, the resulting fluorescence 
observed matched this observation: a much stronger signal was observed with tyrosine 
and tryptophan when compared to the same concentration of phenylalanine (1mM for 
each). 
 
Finally, these aptamers were also tested using the then-newly available version of 
the DFHBI dye used to detect Spinach aptamers, called DFHBI-1T, which had been 
reported to have a brighter signal [138]. Importantly, the absorbance/emission spectra of 
this system that more closely matched that of GFP, which is very useful in a biosensor, so 
that existing optics system for high-throughput analysis could be utilized. The Spinach-
Tyr1 was adapted to this system by incorporating the relevant point mutations to the 
Spinach sequence, creating Spinach2-Tyr1. When tested, this version of aptamer resulted 
in both a stronger signal and better signal differentiation between negative and positive 
samples than that using the original dye (Fig 4-5).  After this was confirmed, further 
experiments solely utilized Spinach2 with DFHBI-1T. 
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Figure 4-5: Tyr1i tested with either the original Spinach sequence and the dye DFHBI or 
the updated sequence Spinach2 and the dye DFHBI-1T 
 
Each experiment used the same concentration of RNA and the respective dye. 
Fluorescence was read at the peak excitation/emission wavelengths of each dye: 
460/500nm for DFHBI and 482/510 for DFHBI-1T. While the background fluorescence 
of DFHBI-1T is much higher, the signal and the fold-increase over background is also 
much higher. 
 
4.3.2 Modeling Linker Regions of Spinach-Tyrosine Biosensor   
In order to improve the process of creating novel metabolite-spinach biosensors, a 
modeling approach was undertaken in collaboration with Dr. Howard Salis at Penn State 
Univeristy. In this approach, a range of possible “linker” sequences was tested 
computationally to calculate ΔG of binding in each permutation, including the aptamer to 
the dye, the aptamer to the metabolite, and the aptamer to both dye and metabolite. By 
comparing the values for thousands of potential linker sequences, an “optimal” series of 
sequences can be determined by finding linker regions that maximized the change of ΔG 
between binding dye and binding dye and metabolite, called ΔΔG. These sequences 
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should theoretically result in the best sensitivity, with the largest difference in signal 
between when the metabolite is present and absent. 
As a test of this approach, a series of Tyr1-Spinach aptamers were synthesized 
and tested. Seven sequences were selected from those predicted to have the maximum 
ΔΔG; that is, each would exhibit the biggest difference in fluorescence compared when 
tyrosine is present or absent. However, the absolute ΔG of the dye binding in these 
sequences varied from slightly negative to the most negative predicted (Fig 4-6). 
 
Figure 4-6: Predicted ΔG of binding of seven Spinach2-Tyr1 sequences optimized for 
sensitivity to tyrosine 
 
Those with the more negative predicted ΔG should theoretically result in a higher signal, 
while those with the more positive values should result in a lower signal. All were 
predicted to have the same, maximal, ΔΔG, such that there should be a large difference in 
signal when tyrosine is present versus when it is absent. 
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Each of these sequences were next synthesized and tested with no tyrosine present 
and 1 mM tyrosine added (Fig 4-7). As predicted, those with the more negative ΔG of 
dye binding exhibited higher fluorescence. Furthermore, tyrosine increased this 
fluorescence in every case, although the difference was more pronounced in some 
compared to others. 
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Figure 4-7: Fluorescence values with and without tyrosine from optimized series of 
Spinach2-Tyr1 sequences 
 
A) Fluorescence measurement of each aptamer with and without tyrosine present. B) 
these same measurements plotted against the predicted ΔG value from Fig 4-6, and 
demonstrates that, as predicted, the relationship is nearly linear on a log scale. 
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From this series, one sequence, called Tyr1M1, was selected for further 
experiments. It was predicted to have a very negative ΔG, and accordingly was one of the 
brightest aptamers tested. Further, it had the highest ratio of fluorescence between 
samples with tyrosine compared to those lacking tyrosine, with a ~3.5-fold increase. 
 
4.3.3 Optimizing Biosensor Sensitivity 
Initial experiments comparing various Tyrosine-Spinach aptamer sequences 
showed that the best observed resulted in a ~3.5-fold signal ratio between negative and 
positive controls (0 and 1 mM tyrosine respectively). Next, it was investigated if this 
sensitivity could be increased through optimizing assay conditions. Further experiments 
were performed to determine the effects of the concentration of dye and RNA, as well as 
the ratio between them, to optimize for detection of aromatic amino acids. A 
thermodynamic model of this process would predict that reducing the dye concentration 
substantially would increase this ratio.  
Experimental results investigating this found the concentration of RNA had a 
significant effect on overall signal strength, while the ratio between dye and RNA 
impacted the signal ratio, both of which matched predictions (Fig 4-8a). Importantly, 
reducing the concentration of dye vastly improved the signal differentiation between 
negative and positive controls, with an optimal molar ratio of 2.5:1 resulting in an ~8-fold 
increase in fluorescence, again matching predictions (Fig 4-8b).   
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Figure 4-8: Fluorescence of Spinach2-Tyr1M1 at various conditions of dye and RNA 
concentrations 
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Figure 4-8 (continued): A) By varying both dye (DFHBI-1T) and RNA concentration 
one at a time, it could be determined that increasing RNA leads to a higher signal, while 
reducing the dye:RNA ratio leads to improved sensitivity. B) the same data, but with the 
ratio between the signal with tyrosine to the signal without tyrosine, as a function of 
dye:RNA ratio. Again, reducing this ratio leads to significantly higher sensitivity. 
 
 These results are very encouraging for the goal of utilizing these biosensors in a 
high-throughput screen. While the goal of any biosensor is to exhibit the highest 
sensitivity possible, it is often difficult to “tune” this sensitivity without redesigning the 
entire system. With the Spinach-based aptamer systems, the sensitivity can be tuned to 
the necessary level easily, by simply varying the ratio of dye and RNA added. 
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Furthermore, the desired signal can be amplified or reduced easily, by adding higher or 
lower concentrations of RNA.  
  
4.3.4 Expanding Spinach-based Biosensor Modeling to Alternative Aptamers 
Next, this model was expanded to alternative aptamers to demonstrate the 
generalizability of creating novel Spinach-based biosensors. While several metabolite-
binding aptamers have been previously incorporated into the Spinach system, the linker 
regions of each were always tested by trial and error [133, 139], which is inconvenient 
for the rapid generation of a new biosensor. To validate the utility of the modeling 
approach used successfully to improve Tyr1-Spinach, it was next applied to a new 
aptamer that had never yet been incorporated to Spinach. 
A novel aptamer which binds 2,4-dinitrotoluene (DNT), which was developed in 
the Salis lab but has not yet been published, was tested using the same linker modeling 
approach. A single sequence was selected for synthesis, based on the maximum predicted 
differential in ΔG between the metabolite-bound state compared to the unbound state. 
This sequence was synthesized and tested with and without 1mM DNT present. As 
predicted, the Spinach2-DNT fluoresced in the presence of DNT, with a 2.4-fold increase 
over background (Fig 4-9). This success demonstrates the power of the Spinach-linker 
modeling approach; without any expensive and inconvenient trial and error, a Spinach-
DNT sensor was created that exhibits metabolite-dependent fluorescence. This again 
suggests such a system could be expanded to any functional aptamer to rapidly create a 
functional biosensor.  
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Figure 4-9: Fluorescence of Spinach-DNT aptamer with optimized linker region 
 
This aptamer, predicted to have the optimal sequence for both brightness and sensitivity, 
was synthesized and tested with and without 1 mM DNT. It exhibited a 2.4-fold increase 
in fluorescence.  
 
4.4 DISCUSSION AND CONCLUSIONS  
While fluorescent biosensors have been used extensively in biotechnological 
applications, it remains difficult and time-consuming to create novel variations for a new 
target, which is critical in directed evolution of production phenotypes. To address this, 
we take advantage of RNA aptamer sensors linked to “Spinach”, an RNA molecule 
capable of inducible fluorescence dependent on target metabolite concentration.  Such 
sensors can act as transducers, linking the in vitro concentration of the metabolite of 
interest to fluorescence.  
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Here we greatly simplify and improve the process of creating novel Spinach-
based biosensors. Instead of relying on a process of trial-and-error, we model predicted 
free energies to generate sequences that optimally link metabolite-binding aptamers to the 
base Spinach structure. This is demonstrated by optimizing Spinach-Tyr1, an aromatic 
amino acid sensitive biosensor, to vastly increase its sensitivity and signal brightness. It 
was also used to generate a completely novel biosensor using a brand new DNT-binding 
aptamer; a sensitive biosensor was created on the first try, without expensive and time-
consuming synthesis of multiple variations. 
With the success of the Spinach aptamer model thus far, this modeling approach 
can be expanded to even more complex Spinach-based biosensors. One possible next step 
will be to expand the model functionality by using it to calculate optimal sequences of 
multi-domain aptamers, which can bind two or more small molecules. By once again 
optimizing the linking sequence between each domain to result in conditional folding, it 
should be possible to make fluorescence sensitive to the presence of each molecule, and 
tune this sensitivity as desired. If successful, this would result in a multi-input, tunable 
biosensor system that can be expanded to a wide variety of target molecules and proteins. 
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Chapter 5 - Utilizing RNA Aptamers In Droplets (RAPID) Screening to 
Identify Production Phenotypes 
5.1  CHAPTER SUMMARY 
A wide range of microorganisms have been effectively turned into living 
foundries through metabolic engineering and synthetic biology for the production of high 
value chemicals from renewable resources. However, identifying the phenotype of 
individual cell variants remains the main bottleneck to making rapid strain improvements. 
Here we demonstrate a novel high throughput microfluidic droplet screening approach 
using RNA aptamer biosensors, called RNA Aptamer In Droplet (RAPID) Screening. We 
show that a variety of small molecule- and protein-binding aptamers can detect the target 
of interest and act as a signal transducer, linking the concentration to a fluorescent signal, 
and furthermore that this system can be utilized in microfluidic droplets as a high-
throughput biosensor. We demonstrate the utility of these sensors to sort individual yeast 
cells for high-production/secretion phenotypes in microfluidic circuits. These proof-of-
concept applications can potentially be expanded to screen large microbial libraries for a 
wide variety of desirable targets. 
 
5.2  INTRODUCTION 
Synthetic biology embraces a design-build-test cycle to establish novel 
phenotypes.  The benefit of this expanded design and build capacity can only be realized 
through improvements to the downstream test modality.  In this regard, rapid screening of 
phenotypes (especially for the case of metabolite production) are required to reach parity 
with the >109 variant per week rate at which strains can be built through techniques 
including directed evolution.  However, traditional metabolite detection approaches such 
as GC, HPLC, and MS are far too restrictive in throughput to accomplish this goal 
 104 
without brute-force parallelization and high cost.  As alternatives, biosensors may be used 
to link the concentration of a target molecule to fluorescence or a selectable trait such as 
antibiotic resistance, thus enabling a more rapid and quantitative detection [131, 132].  
However, the development of such biosensors is difficult and requires host cell 
modifications that are likewise under positive selection pressure.  In most cases, the 
product of interest will be secreted.  This reality provides an additional challenge for any 
screening process that requires an intrinsic linkage between genotype and phenotype.   
Droplet microfluidics relies on the interaction of immiscible liquids and can be 
used to create isolated picoliter sized reaction vessels in which cells can be encapsulated 
[140-143].  Recently, it has been demonstrated that yeast cells can be encapsulated and 
assayed individually in such droplets [79, 144].  Sorting capacity for these systems can 
reach as high as 108 droplets per hour [145].  In this regard, microdroplet enabled 
screening can address limitations in the test modality by physically entrapping genotype 
and phenotype - thus merging the benefits of single-cell analysis and high-throughput 
processing [144, 146].  Despite these advances, a remaining challenge precluding high-
throughput screening is the capacity to transduce secreted product concentration into a 
detectable signal.  As an alternative to protein-based biosensors, which may have 
difficulty accurately detecting secreted products, RNA aptamers have been explored for 
their potential to enable high-throughput screening. Specifically, RNA aptamers linked to 
“Spinach”, a previously reported RNA molecule capable of inducible fluorescence, can 
be used to metabolite concentration into fluorescence [133].  Hundreds of RNA aptamers 
have reported in the literature with diverse binding kinetics to a host of analytes including 
small molecules and proteins [134]. This is especially useful when the Spinach-based 
biosensors are optimized for sensitivity using modeling techniques, as discussed in 
Chapter 4. 
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To demonstrate the capacity for high-throughput detection of secreted products in 
yeast, we develop and approach for RNA APtamer in Droplets, or “RAPID”.  In this 
scheme, we demonstrate that metabolites produced by yeast cultivated in microdroplets 
can be detected using Spinach-linked aptamters and sorted using a dielectrophretic 
mirofluidic device.  Such an approach can be used to rapidly sort for improved variants in 
large libraries.  Here we demonstrate a proof-of-concept application for engineering the 
yeast Saccharomyces cerevisiae for the overproduction of tyrosine.  We demonstrate the 
isolation of significantly improved variants by using this high-throughput, generalizable 
screening modality that is not reliant on growth-based selection, chemical assays, or 
exogenous enzymes.  Thus, this work establishes a generalizable high-throughput 
screening method applicable for microbe engineering and synthetic biology. 
 
5.3 RESULTS 
5.3.1 Importing RNA Aptamers to Microfluidic Droplets  
Previously, RNA aptamers linked to “Spinach”, a previously constructed RNA 
molecule capable of inducible fluorescence, have been used as sensors of metabolite 
concentration [133]. By inserting other aptamers into one of the stem loops of the 
Spinach aptamer, proper folding (and thus fluorescence) is made dependent on the 
presence and concentration of the second aptamers binding target. This has been 
demonstrated for a wide range of targets, including amino acids, nucleotides, and even 
proteins [134]. In order to co-opt this system as a novel high-throughput screening 
method, the capability of Spinach-based biosensors was extended to microfluidic droplets 
(Fig 5-1).  
 
 106 
Figure 5-1: Spinach-based aptamer biosensors in droplets 
 
A diverse range of Spinach-based aptamers, binding to amino acids, other small 
molecules, or proteins, function as biosensors both in bulk solution and in microfluidic 
droplets. 
  
Spinach-based biosensors for a wide range of targets, including novel targets like 
tyrosine and DNT, were created and tested, and then imported into microfluidic droplets. 
In each case, it was shown that the inducible fluorescence was maintained in a 
microfluidic droplet environment. These results confirm that a variety of aptamer 
biosensors can be utilized in conjunction with microfluidic droplets to create a novel 
high-throughput screening platform. 
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5.3.2 Validating Spinach-based Biosensors in Conjunction with Yeast 
First, the most robust tyrosine-binding aptamer designed, Tyr1M1, was tested 
using the supernatant of yeast cultures after centrifugation, to approximate the conditions 
inside a microfluidic droplet with a single cell. Multiple strains engineered to varied 
levels of aromatic amino acid production were tested. These were independently first 
precultured in complete media, then washed and resuspended in a minimal media lacking 
aromatic amino acids. Several strains were tested, including one previously engineered to 
overproduce aromatic amino acids [4], along with three novel evolved strains that have 
been shown to overproduce even higher levels of aromatic amino acids (unpublished 
work). After incubation with the Tyr1M1 aptamer, fluorescence was measured (Fig 5-2). 
Each of the samples sourced from overproducing strains all did in fact result in a higher 
signal compared to that of the wild-type strain. Furthermore, when the WT sample was 
spiked to 1 mM tyrosine, the signal matched the positive control of 1 mM tyrosine, 
confirming that the aptamer functions correctly when mixed with media in which yeast 
cells have been incubated. 
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Figure 5-2: Tyrosine concentration in cell culture supernatants, tested either by Tyr1M1 
aptamer or by chemical derivitization assay 
 
Each point represents a different strain of yeast, with the wild-type labeled “WT” and a 
negative control solution labeled “NC”. A strong positive correlation demonstrates that 
the Tyr1M1 can accurately detect higher tyrosine that has been produced and secreted 
into the media of growing cells. 
 
5.3.3 Encapsulation and Screening of Tyrosine-Overproducing Yeast Strains 
Next, RAPID was used to evolve a tyrosine overproduction phenotype by 
enabling the detection of high-producing and –secreting variants. Production of tyrosine 
is subject to tight regulatory control in yeast, and thus compounds derived from the 
aromatic amino acid pathway can suffer from poor yield.  Molecules derived from the 
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shikimate pathway (including tyrosine) have multiple uses as polymer precursors, 
nutritional supplements, and therapeutic agents [135].  
While the RAPID Screening method could theoretically be applied to any library 
of mutants, we first explored mutagenizing a single biosynthetic enzyme: the DAHP 
synthase gene aro4. This enzyme has been well characterized, and it is known to be 
regulated through feedback inhibition by tyrosine. Furthermore, it was shown that such 
feedback inhibition can be removed through several point mutations previously reported, 
including the single point-mutation of K229L [147]; strains expressing this mutant have 
been shown to produce and secrete elevated levels of tyrosine [148]. Two libraries were 
made for the evolution of this gene: one was derived from the wild-type gene and one 
from the K229L mutant. To increase the chances of finding a beneficial mutant, the 
library derived from wild-type aro4 used targeted mutagenesis to induce mutations only 
in the region of the protein known to control feedback inhibition, resulting in a library 
called ARO4-Reg. By investigating both libraries, it was hoped to replicate the discovery 
of novel feedback-reduced aro4 variants as well as to improve the current best variant 
known. Importantly, the same screening method could be used to screen libraries made 
by mutagenizing other genes, pathways, transcription factors, or even the entire genome. 
These libraries were then screened in droplets using the Spinach-Tyr1M1 
aptamer; the purified RNA was added to the culture media just prior to encapsulation, 
such that it could detect the concentration of secreted tyrosine from each cell (see 
Methods). After an incubation period, the droplets were sorted to isolate the top 
fluorescent, by gating to isolate the brightest ~0.1% of droplets. The sorted populations 
were then recovered in fresh media and grown to stationary phase, and then re-
encapsulated as before to quantify the sorting efficiency. The relative tyrosine production 
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of this population was again measured by aptamer-mediated fluorescence compared to 
the original library, clearly demonstrating the relative enrichment (Fig 5-3). 
Figure 5-3: Distribution of aptamer-mediated fluorescence in pre-sort library compared to 
post-sort culture 
 
A) is the library with aro4 mutagenized in the regulatory region (ARO4-Reg), B) is a 
library of mutagenized aro4K229L. Both demonstrate significant enrichment. 
 
  In addition, the bulk sorted cultures were tested for tyrosine production using a 
derivatization assay [149] (see Methods). Cultures from both sorts exhibited higher levels 
of tyrosine production compared to the original library (Fig 5-4). Thus, the sorting 
efficiency was demonstrated by two orthogonal measurements, confirming the aptamer-
mediated fluorescence functioned as intended. 
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Figure 5-4: Secreted tyrosine concentrations in bulk sorted cultures for two libraries, 
ARO4-Reg and ARO4-K229L 
 
In each, the “Control” bar indicates a culture expressing either aro4 or aro4K229L. The 
“Library” bar is a bulk culture of the pre-sorted library; these are significantly lower, 
presumably due to the presence of empty vector background and deleterious mutations. 
The “Sorted” bar is a bulk culture of the post-sorted library, recovered in fresh media. In 
both libraries, the sorted bulk is significantly enriched in tyrosine producers. 
 
5.3.4 Validation of Tyrosine Over-Production from Sorted Mutants 
After the initial sort, individual mutants were isolated and re-transformed to a 
fresh strain of yeast, in order to eliminate any strain adaptations that arose during the 
microfluidic encapsulation and sorting. These strains were then grown and incubated, and 
the media was assayed for secreted tyrosine concentration using a derivatization assay 
[149] (see Chapter 8: Materials and Methods).  
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For the ARO4K229L library, the collection of individual clones isolated from the 
sort were significantly enriched in tyrosine over-producers compared with clones 
containing randomly mutated sequences obtained from the unsorted library (Fig 5-5b, 
p<0.05, Mann-Whitney U test). 
 
Figure 5-5: Tyrosine secretion from clones expressing aro4 mutants 
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Figure 5-5 (continued): Control vectors (green), randomly mutated (yellow), or isolated 
from sorted culture (blue). A) contains clones from ARO4-Reg library, and B) from 
ARO4-K229L Library 
 
In addition, both libraries revealed novel variants that were significantly improved 
over their base sequence. In fact, the best from each library (ARO4-L and -BH, derived 
from aro4K229L and wild-type aro4 respectively) both conferred improved tyrosine 
production compared to aro4K229L, which until now has been the mutant which enabled 
the highest production of aromatic amino acids. Interestingly, both of these two novel 
variants contain mutations in the same region, which is known to control tyrosine 
feedback inhibition; this gives some clue as to the mechanism of mutation. ARO4-L has 
two coding point mutations in addition to the K229L scaffold from which it was derived: 
T46A and T207I. ARO4-BH has three coding mutations: H230Y, K252N, and V262I. 
H230Y is particularly interesting, since this is adjacent to the lysine at 229 known to have 
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significant effects. This mutation was tested independently, and was found to recapitulate 
the increased tyrosine expression (Fig 5-6). 
Figure 5-6: Tyrosine secretion from clones expressing aro4 mutants derived from ARO4-
BH 
 
The mutation H230Y alone recapitulates the increase in production of the triple-mutant 
ARO4-BH. 
 
Next, the growth rate of strains expressing these mutant aro4 genes was 
characterized, in both complete media and minimal media lacking aromatic amino acids. 
Importantly, the growth rates of these strains were not significantly different from cells 
expressing the wild-type gene (Fig 5-7). This demonstrates that such a phenotype could 
not have been identified through growth based selection; high-throughput screening was 
necessary. 
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Figure 5-7: Growth rates of strains expressing aro4 variants 
 
Blue bars represent complete YSC media, while red bars represent minimal media 
containing only glucose, auxotrophic amino acids, and YNB. There is no significant 
growth difference between cells expressing wild-type aro4 and the high-producing 
mutant versions, either with or without aromatic amino acids present.  
 
While further investigation of these novel mutations is certainly warranted, here 
they serve as an important proof-of-concept for this system. Never before has it been 
possible to screen aro4 mutants in a high-throughput manner; all previous beneficial 
mutations relied on a known crystal structure and an understanding of protein dynamics 
[150], both of which are lacking for the vast majority of enzymes of interest. The success 
in identifying previously unknown beneficial aro4 mutations using this screen 
definitively demonstrates that Spinach-based aptamers in droplets is a powerful tool for 
metabolic engineering and directed evolution. 
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5.4 DISCUSSION AND CONCLUSIONS 
Here we have demonstrated that metabolites produced and secreted by yeast can 
be detected and sorted using Spinach-linked aptamers in conjunction with a 
dielectrophretic microfluidic device. In this, we have created the potential for a rapid, 
high-throughput screen that can easily enable sorting of large libraries. This proof-of-
concept system further expands the potential for directed evolution techniques to evolve 
an even wider array of phenotypes in a rapid and high-throughput process.  
Importantly, by demonstrating and optimizing an aptamer-based selection screen 
to rapidly detect metabolite concentrations in vitro, we have further shown that this 
platform is potentially generalizable to a vast array of targets.  Challenges do remain, 
especially if an aptamer has not yet been developed for a target analyte or if the aptamer 
has not yet been linked to Spinach. These processes are almost certainly target specific, 
and may be more difficult for some than for others. However, we demonstrate that it is 
quite possible to quickly import and adopt a novel aptamer into this system. Further, by 
importing multiple aptamer sensors to a microfluidic system for the first time, we were 
able to create a novel and powerful platform for screening finally commensurate with 
possible diversity generation. 
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Chapter 6 - Creation of Novel Pathway Engineering Tools Using Viral 
2A Cleavage Sites 
6.1 CHAPTER SUMMARY 
In directed evolution of pathways, it is difficult or cumbersome to express and 
evolve multiple enzymes simultaneously, requiring that a significant proportion of 
synthesized and mutagenized DNA consist of regulatory elements. Viral 2A sequences 
enable multi-protein expression and mutagenization in a single cassette by encoding co-
translation polypeptide cleavage. By inserting these sequences between pathway 
enzymes, it is possible to evolve an entire pathway simultaneously, as was done for the 
xylose catabolic pathway in Chapter 2. Here we engineer these sites by creating a novel, 
secretion tag-based high-throughput assay allowing rapid quantification of 2A efficiency. 
Further, we use this assay to discover novel sequence elements that significantly improve 
cleavage efficiency. However, challenges remain in successfully applying 2A sites for 
expression of metabolic engineering relevant contexts. In many cases, fusion proteins 
retain activity, rendering the 2A cleavage superfluous; in others, the remnant 2A peptide 
post-cleavage can affect activity. The characterization of these novel high-activity 2A 
sites offers a powerful new tool for future pathway engineering efforts. 
 
6.2 INTRODUCTION 
In order to effectively engineer pathways of enzymes, novel tools need to be 
developed for the efficient simultaneous expression of multiple proteins. Commonly, 
heterologous pathways constructed in yeast use a promoter and terminator motif for each 
individual gene, often using multiple vectors. This can be disadvantageous for several 
reasons. First, while there are an expanding number of regulatory elements being 
characterized, there remains a small number that are desirable for repeat use, especially 
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those that result in strong or inducible expression. This can be especially true for non-
model organisms in which only a handful of regulatory elements are well-characterized 
[151]. This often leads metabolic engineering efforts to repeatedly use the same 
promoters and terminators, resulting in a high probability of homologous recombination 
and thus genomic instability. Second, the use of multiple regulatory elements for each 
gene necessitates a large fraction of synthesized DNA to be non-coding. For extensive 
metabolic engineering applications, this can significantly increase the cost and difficulty 
of synthesis and transformation. Finally, in an evolutionary engineering approach, it is 
very difficult to co-evolve multiple genetic parts; often, each gene or part needs to be 
mutagenized individually, making it impossible to discover synergistic double mutations. 
While these limitations can be addressed partially with the use of fusion proteins, this is 
often unworkable, either due to protein folding complications or to non-localized function 
(eg cytoplasm vs mitochondria). Further, these limitations are not often known 
beforehand.  
Here, we aim to engineer novel pathway engineering tools that allow co-
expression of multiple proteins with a single promoter and terminator. Such a tool 
enables rapid and simple pathway engineering, while minimizing the sequence length 
needed. For evolutionary engineering of pathways, such tools would allow the 
mutagenesis of an entire multi-gene pathway, without concurrent mutagenesis of the 
regulatory regions, vastly increasing the likelihood of generating beneficial mutations in 
the coding region. 
These novel tools are based on viral 2A sequences. These short sequences are 
about 20 amino acids in length and are found encoded in viral genomes to allow 
translation of single large polypeptides, which self-cleave into multiple smaller proteins. 
When a ribosome translates a 2A sequence, the nascent polypeptide quickly cleaves to 
 119 
form a separate protein, while translation continues downstream to form a second protein 
[72]. In this way, 2A sequences allow a single promoter to drive expression of an open 
reading frame encoding multiple proteins. Furthermore, these sequences have been 
previously shown to be active in Saccharomyces cerevisiae [73, 74].  
While such sequences have great potential as tools for metabolic and evolutionary 
engineering in yeast, several challenges remain. One significant issue is that polypeptide 
cleavage is not perfect; uncleaved polypeptide always remains present. If an aim requires 
co-expression of multiple proteins, each additional 2A site reduces the fraction of fully 
cleaved proteins. Further, this results in heterogeneity of expression, with various 
mixtures of cleaved and uncleaved polypeptides present in the cell.  
Unfortunately, 2A activity is not well understood. Several unique 2A sequences 
have been characterized, but their cleavage activity is not uniform [74]. However, it is 
unknown which factors affect activity. While four 2A sequences active in yeast have a 
conserved active site including a C-terminal NPGP domain, the N-terminal sequence 
differs greatly between the four, in sequence and even in length. Previous tests in our lab 
have demonstrated that even codon usage affects activity; while P2A was shown to 
promote active cleavage in yeast, changing 22 of its 66 nucleotides with silent mutations 
resulted in a complete loss of activity [152].  
A second challenge in using 2As for pathway engineering is the difficulties in 
using them to build multi-enzyme cassettes. Replicating 2A sequences multiple times 
leads to the same chance of homologous recombination instability discussed above, while 
at the same time is obviously disadvantageous to use less active 2A sequences simply to 
avoid homology. Since silent codon modification can also affect activity, there is no ideal 
option for the use of 2A sites in multi-gene pathways. 
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In an effort to engineer these tools for their use in pathway engineering, we 
worked to create novel or synthetic 2A sequences that are optimized for high activity in 
yeast. Furthermore, we aimed to identify multiple, sequentially diverse sequences that are 
uniform in high cleavage activity. Such a set of tools would significantly improve 
pathway engineering and the directed evolution of these pathways. 
 
6.3 RESULTS 
6.3.1 Creating Quantitative Assay of 2A Activity Using Secretion Tag 
Previously, multiple 2A sites have been tested and characterized in 
Saccharomyces cerevisiae. For example, P2A, derived from porcine teschovirus-1, has 
been shown to be highly active compared to others [72]. However, there remains no easy 
way to quantify or directly compare different 2A sequences head-to-head; currently 
activity is evaluated by Western blot relative band intensities, which can be inaccurate.  
To evaluate and compare 2A sites for pathway engineering applications, a novel 
assay was first developed using a secretion tag. In this assay, an N-terminal secretory 
signal was paired with a fluorescent protein [153]; with this signal active, the protein is 
secreted into the media, resulting in relatively low cell fluorescence as measured by flow 
cytometry. A 2A sequence can then be inserted between the secretory signal sequence 
and the fluorescent protein. If such a sequence is effective at cleavage, we expect the 
secretory signal will be removed and degraded, resulting in high cell fluorescence; 
otherwise, the entire protein will be secreted, resulting in low cellular fluorescence (Fig 
6-1). Such an assay represents a significant improvement for quantifying 2A activity: it 
allows direct quantitative comparison of 2A sequence efficiency, and it allows rapid 
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turnaround to test novel sequences, relying only on the relatively high-throughput flow 
cytometry. 
 
Figure 6-1: Schematic demonstrating how a secretion tagged yellow-fluorescent protein 
can be used to assay 2A activity 
 
 
If the 2A is inactive, YFP will be secreted from the cell, resulting in low cell fluorescence 
(left). If the 2A is active, the tag will be cleaved during protein synthesis, and the YFP 
will be retained by the cell (right). Cell fluorescence can then be measured quickly and 
quantitatively using flow cytometry. 
 
To demonstrate this assay’s utility, four native 2A sequences were inserted (P2A, 
F2A, T2A, E2A), as well as a non-functional control made by mutating the active site of 
P2A (called P2Ad [154]). These plasmids were then transformed into yeast and assayed 
by flow cytometry (Fig 6-2). As expected, cells expressing the secretion tagged YFP 
exhibited low cell fluorescence, roughly 5% of the fluorescence of those cells expressing 
YFP with the same promoter. Inserting P2A between the secretion tag and the YFP gene, 
though, increased the fluorescence significantly, by ~9-fold. However, this value was 
only ~50% of the positive control, presumably due to only partial cleavage activity. 
Inactive 2A 
Low Cell Fluorescence 
Active 2A 
High Cell Fluorescence 
Secretion Tag YFP 2A 
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Furthermore, the other three native 2As tested had variable activity, which when rank 
ordered matched the same relative activities observed previously. Finally, the P2Ad 
construct matched the negative control, suggested that the 2A sequence itself did not 
materially affect fluorescence without active cleavage. 
 
Figure 6-2: Cell fluorescence as measured by flow cytometry of cells expressing YFP 
with a TEF promoter 
 
Sec-YFP is the same construct with the secretion tag added to the N-terminus of YFP, 
resulting in secretion of YFP and low cell fluorescence. The next five are the same 
constructs with various 2A sequences inserted between the secretion tag and YFP. 
 
These results were very encouraging for several reasons. First, this assay was 
established as a quantitative and high-throughput way to assay 2A sequence activity. 
Second, the fact that the relative activities measured corresponded to the relative 
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activities previously observed by Western blot served to validate that the assay does in 
fact measure 2A cleavage. Finally, the fact that P2A exhibited only ~50% of the 
fluorescence of the positive control indicated that 2A cleavage is incomplete, even that of 
the most active sequence known. This implies that it may be possible to find a variant 
sequence that exhibits higher cleavage activity than any known native site. 
As a quick demonstration of the utility of this assay, we next used it to investigate 
2A sequences used in a previous metabolic engineering effort in yeast [74]. In this 
approach, investigators used two T2A sites to assemble a 3-enzyme pathway as one 
genetic cassette. To avoid homologous recombination, they changed the codon usage of 
the second T2A linker. While a Western blot confirmed cleavage was taken place, there 
was no easy way to quantitatively measure the effect codon usage had on the T2A 
activity. We synthesized these two sequences and inserted them into the secretion tag 
assay, and ran them along with the T2A sequence tested above, which had been codon 
optimized for Saccharomyces and was sequentially unique. Interestingly, we observed a 
significant decrease in cleavage activity by our assay with the codon-altered T2A 
sequence (Fig 3-3). This again confirms how critical a quantitative measure of 2A 
activity can be, as it remains unknown which factors, such as codon usage, can have 
significant effects. 
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Figure 6-3: Cell fluorescence as measured by flow cytometry of cells expressing the 
TEF-Sec-2A-YFP system 
 
The codon optimized T2A (left), or two codon-altered version of the same sequence used 
in a previously published study (center and right).  
 
6.3.2 Using Secretion Assay to Sort 2A Sequence Library for Novel High-Activity 
Elements 
Using the secretion tag assay approach, putative 2A sites can be quickly tested for 
effectiveness using flow cytometry; higher cell fluorescence will indicate effective and 
efficient cleavage. This assay can also be used to find novel 2A sequences from a library 
of randomized sequences, since FACS makes it possible to sort out high fluorescent cells 
from a population. In a population of cells, each containing a randomized 2A sequence in 
the secretion tag construct, those exhibiting the highest fluorescence presumably harbor 
2A sequences with the highest activities. Ideally, such a library would reveal both high 
activity sequences as well as novel, non-homologous sequences; both would be useful in 
pathway engineering efforts. 
This library approach was undertaken with several methods. In the first, a library 
was assembled directly using yeast homologous recombination, by co-transforming an 
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insert amplified from a primer with degenerate nucleotides and a backbone with 
homology containing the secretion tag and fluorescent protein. Enough homology was 
included to ensure recombination, such that each cell would contain a unique 2A 
sequence but the same secretion tag and fluorescent protein gene. The 9 amino acids 
consisting of the active site of the 2A sequence was maintained in the homologous 
region, with 27 base pairs directly upstream randomized. When recombined, this would 
presumably result in a completely novel 2A sequence with the same conserved active 
site. This library contained ~1.2 x 105 unique variants, a tiny fraction of the 427 
possibilities (~1.8x1016). While it could not be expected to identify the optimal sequence 
with such an approach, it was theorized that novel sequences dissimilar from the native 
sequences could be identified which exhibited activity; from these, further variations 
could be explored. The highest fluorescent cells were sorted from this population using 
FACS and plasmids were recovered and re-transformed into fresh strains for assaying.  
Several sequences were isolated from this sort that exhibited significantly higher 
fluorescence that control 2A sequences, and comparable to a positive control with no 
secretion tag at all (Fig 6-4a). However, on analysis it was determined that these were not 
simply novel 2A sequences, but instead recombination events of two DNA insert pieces, 
resulting in 2A sequences about double the length of the native. Some of these had two 
complete 2A sequences concatenated, while others contained the complete T2A sequence 
with an incomplete fragment of 2A sequence combined upstream. While it could be 
expected intuitively that including two concatenated 2A sequences would result in high 
activity, it was not clear why those with an incomplete 2A sequence added to the 
upstream end of a complete 2A sequence, called “spacers” hereafter, would increase the 
activity. The “spacer” sequences of two such sequences, denoted d8 and d12, were cloned 
into a separate plasmid without a downstream 2A site, and it was shown that alone they 
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do not impart any cleavage activity (Fig 6-4b). When placed upstream of the complete 
T2A sequence, however, they do. These spacer elements were explored further, which is 
discussed in the next section (6.3.3). 
 
Figure 6-4: 2A activity of library sort isolates, as measured by cell fluorescence from the 
TEF-Sec-2A-YFP assay system  
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Figure 6-4 (continued): A) Leftmost is a control expressing TEF-YFP with no secretion 
tag as a positive control, with the next containing Sec-T2A-YFP as a control comparison 
to a native sequence. c2 is a novel sequence isolated from library, consisting of two 
concatenated full 2A sequences. d8 and d12 are two sequences isolated from library, 
consisting of an incomplete 2A “spacer” sequence upstream of T2A. All three exhibit 
extremely high cleavage activity, comparable to having no secretion tag at all. B) The 
first three points are controls, with d8-Spacer and d12-Spacer consisting of solely the 
incomplete 2A isolated from d8 and d12. These spacer elements exhibit no cleavage 
activity alone, suggesting the high activity of d8 and d12 is not due to multiple active 
sites. 
 
Several additional libraries were then constructed with alternate cloning 
approaches in order to identify novel short 2A sequences as well. Three separate 
additional libraries were made and transformed using Gibson assembly, which would 
theoretically result in significantly reduced recombination of two or more inserts. These 
libraries (containing unique 8 x 105, 6 x 104 and 7  x 104 variants each) were each sorted 
using FACS to isolate the brightest 0.1% of cells. Next, plasmids were isolated from the 
sorted population and re-transformed. While several sequences exhibited some activity, 
none were comparable to the wild-type native 2As (Fig 6-5). 
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Figure 6-5: 2A activity of additional library sort isolates, as measured by cell 
fluorescence from the TEF-Sec-2A-YFP assay system 
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Figure 6-5 (continued): Leftmost of each is a control sequence (either P2A or T2A), 
with a set of sequences isolated from individual library sorts and re-transformed to fresh 
strains. A, B and C represent sequences isolated from three separate independent 
libraries, each individually screened by FACS. 
 
In a final approach to identify novel high-activity 2A sequences, several of the 
most active variants identified above (F6, F9, J3 and J6) were mutagenized by error-
prone PCR to improve this activity. As discussed above, it was hypothesized that the 
sequence space is much too large to identify optimal sequences using this library 
approach. However, it is possible that one of these novel, minimally active sequences 
could be significantly improved to the level of native 2As or better by only 1 or 2 
mutations, yet still be sequentially distinct from any of the native sequences.  
The four sequences to be tested were pooled and a single library was made using 
an error-prone PCR insert to re-mutagenize the variable region of the 2A sequence. The 
library was again made by Gibson assembly, with ~1.12 x 105 unique variants created. 
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This library was again sorted using FACS to isolate the brightest 0.1% of cells. Next, 
plasmids were isolated and sequenced, confirmed to each contain 1-2 coding mutations 
from one of the parent sequences, and unique variants were re-transformed to fresh 
strains and tested. Unfortunately, none of these exhibited any improved activity (Fig 6-6). 
 
Figure 6-6: 2A activity of error-prone library sort isolates, as measured by cell 
fluorescence from the TEF-Sec-2A-YFP assay system 
 
Leftmost is a control using P2A, and the next is a control “F9”, one of the minimally 
active novel 2A sequences used to generate an error-prone library. Remaining are a set of 
sequences isolated from sorted error-prone library generated from these minimally active 
novel 2A sequences.   
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6.3.3 Characterizing Novel 2A Spacer Sequences 
As discussed in section 6.3.2, two novel sequences were isolated from a library 
sort that exhibited significantly increased cleavage activity, and consisted of a complete 
T2A sequence with an upstream “spacer” sequence appended upstream. While these 
spacer elements did not exhibit any cleavage on their own (Fig 6-4b), through some 
unknown mechanism they were able to increase the cleavage activity of a downstream 
2A site. To characterize this effect, both sequences were next cloned into the Sec-2A-
YFP assay system, appended to the other three native 2A sites tested (P2A, E2A, and 
F2A). In all cases, appending either spacer element significantly improved cleavage 
activity by this assay (Fig 6-7). 
 
Figure 6-7: 2A activity of Spacer-appended native 2A constructs, as measured by cell 
fluorescence from the TEF-Sec-2A-YFP assay system 
 
The four native 2A sequences are tested, along with constructs containing the d8 and d12 
spacers appended upstream. For each set, the fluorescence value is normalized to that of 
the native sequence. In each case, the spacer significantly increases activity.   
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These results were very encouraging, as they present a potential option for the use 
of 2A sequences for high-efficiency pathway expression. Each combination of spacer and 
native can exhibit relatively high efficiency, approaching 100%. But by mixing and 
matching spacers with different native 2As, sequential diversity can be established for 
multiple sites. 
 
6.3.4 Utilizing 2A Sequences for Pathway Engineering Applications 
Next, in order to demonstrate the utility of the novel, high-efficiency 2A spacer 
elements described above, several pathway engineering applications were tested. In each, 
a pathway of interest to ongoing metabolic engineering efforts was chosen, and the high-
efficiency 2A sequences were used to demonstrate their utility compared to multiple 
vector approaches. 
 
6.3.4.1 Beta-Carotene Production 
One successful application of 2A sites to the metabolic engineering of 
Saccharomyces cerevisiae is in the production of beta-carotenes [74]. In this effort, genes 
for three heterologous pathway enzymes (crtI, crtE and crtYB) were assembled using 
T2A linkers, as described above (6.3.1). There is strong interest in producing high titers 
of various food-grade beta-carotene compounds in yeast, which can then serve as 
pigments or additives in the food industry [155]. This effort resulted in the successful 
production of beta-carotenes, although titers were not compared to the expression of the 
genes on separate vectors. 
As a demonstration of the utility of the novel 2A spacer sequences, this pathway 
was reconstituted with several variations. First, the same T2A variants used previously 
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was constructed as a control. Next, a negative control was constructed using P2Ad, the 
non-functional mutant variant that does not allow cleavage [154]. Finally, several 
combinations of d8- and d12-spacer linked 2As were inserted into the same pathway. All 
constructs used the same genes and ordering as demonstrated previously. 
Initial tests revealed surprising results: colonies from each individual 
transformation all exhibited similar levels of pigment, including the negative control. 
That is, the same 2A-linked beta-carotene pathway reported to result in activity in 
previous experiments also results in similar activity when constructed without 
polypeptide cleavage. These results suggest that the three-enzyme polypeptide may 
simply function as a fusion protein when expressed with a ~20-amino acid linker. 
Unfortunately, such a control did not seem to be included in the previous experiments 
[74], so it is difficult to determine how much of the beta-carotene production reported 
could be achieved without the 2A sites included. Further experiments were discontinued; 
if such a pathway functions without cleavage, it would not truly demonstrate the utility of 
high-activity 2A sequences.  
 
6.3.4.2 Xylose Consumption 
A second pathway of interest is that of xylose catabolism, which has been studied 
extensively as an industrially relevant and desirable phenotype to develop in 
Saccharomyces [109]. A functional pathway for the efficient catabolism that has been 
previously demonstrated in yeast relies on the xylose isomerase gene xylA from 
Piromyces spp. [17] combined with the overexpression of native xylulokinase xks1 [110]. 
Since co-overexpression of these two enzymes is necessary for efficient activity, this 
pathway serves as an excellent candidate for the demonstration of the utility of high-
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activity 2A sequences. In fact, a 2A-linked xylose catabolism pathway consisting of xylA 
and xks1 was utilized in the ICE evolution of xylose catabolism in Chapter 2.  
First, however, the relevance of 2A activity needed to be demonstrated 
independently, to verify that polypeptide cleavage was limiting. Two constructs were 
made, with the two catabolic genes linked by P2A (as in Chapter 2) or with the two 
linked by P2Ad, the non-functional variant. Both were transformed into yeast and tested 
by growth in xylose-containing media (Fig 6-8). Unfortunately, it appears that again, 
cleavage is not necessary for the activity of these two enzymes, and this could not serve 
as a test case for demonstrating 2A activity.  
 
Figure 6-8: Growth rate of strains expressing xylA and xks1 linked by either P2A (an 
active 2A site) or P2Ad (an inactive variant) 
 
Growth in complete media containing xylose as the sole carbon source. Growth rates 
were similar in both, suggesting cleavage is not necessary for enzyme activity. 
 
Next, several variations of the xylose catabolic pathway were created instead, 
focused on the expression of efficient xylose transports [156].  Because the transporter 
must be localized to the membrane for activity, while the downstream catabolic enzymes 
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were cytoplasmic, it was theorized that 2A cleavage must be necessary for activity (Fig 
6-9).   
 
Figure 6-94: Schematic illustrating use of transporter membranes to demonstrate 2A 
activity through growth 
 
By linking the transporter protein to two other enzymes, it was theorized that 2A 
cleavage activity would be necessary for localization and thus growth. 
Several constructs were made incorporating the xylose transporter in different 
combinations. The first consisted of xylA linked to an efficient xylose transporter 
CiGxs1-FIM [156], and a second included both xylA and xks1 linked to the transporter, as 
shown in Fig 6-9. Two variants were made for each, using either native 2A sequences 
(P2A and T2A for the three-enzyme system) or the non-functional P2Ad sequences. All 
were transformed into yeast lacking all other hexose transporter [157] and tested by 
                                                 
4 Schematic created by Jo Villa 
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growth in xylose-containing media (Fig 6-10). Unfortunately, it still appears that 
cleavage is not necessary for transporter activity in either case, and this would also not 
serve as an ideal test case for demonstrating 2A activity.  
 
Figure 6-10: Growth rate of strains expressing xylA and/or xks1 linked by either P2A and 
T2A (active 2A sites) or P2Ad (an inactive variant) to the xylose transporter 
CiGxs1, 
  
Growth in complete media containing xylose as the sole carbon source. Growth rates 
were similar in both, suggesting that either cleavage is not necessary for enzyme activity, 
or that no activity is present even with cleavage. 
 
6.3.4.3 Aromatic Amino Acid Biosynthesis 
Another current goal relevant to metabolic engineering is the overexpression of 
aromatic amino acids and aromatic amino acid-derived compounds (see Chapter 5). As 
part of the evolutionary engineering efforts described in Chapter 5, several pathways of 
amino acid biosynthetic enzymes were constructed using 2A sequences. One consisted of 
three genes, aro2, aro3, and aro4, which encode chorismate synthase and two versions of 
DAHP synthase respectively. This construct was made as a poly-gene cassette using P2A 
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and T2A to link the three enzymes, in the order listed above, a construct called “AROp”. 
The goal was to co-evolve this cassette using ICE, in order to identify potentially 
synergistic mutations between the three genes. 
However, when expressing this construct in yeast, a very unexpected result was 
observed: expressing the poly-gene 2A construct alone significantly increased aromatic 
amino acid production (Fig 6-11). aro3 and aro4, both encoding DAHP synthase 
variants, are known to be feedback inhibited by phenylalanine and tyrosine, respectively; 
furthermore, it has been shown that several aro4 mutations can remove this feedback 
inhibition [147], leading to significantly elevated production of aromatic amino acids 
when expressed [148]. Through some unknown mechanism, connecting these three genes 
using 2A sites also increased their activity, potentially by disrupting this feedback 
inhibition domain. 
 
Figure 6-11: Tyrosine production measured from several strains containing aromatic 
biosynthetic genes 
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Figure 6-11 (continued): From left: wild-type By4741; By4741 with the three 
biosynthetic genes aro2, aro3, and aro4 knocked out; the ARO2-P2A-ARO3-T2A-ARO4 
poly-gene cassette integrated into the rrm3 locus in the triple knockout strain; the wild-
type aro4 expressed on a high-copy plasmid in the triple knockout strain. The 2A-linked 
poly-gene cassette significantly boosts production over wild-type, while strongly 
overexpressing wild-type aro4 does not increase production even to wild-type levels. 
 
To explore this further, several variations of this gene cassette were constructed. 
One was made by simplifying expression to only aro3 and aro4, linked by a single T2A 
site. A second construct, denoted “ARO3t”, was made by expressing the post-cleavage 
sequence of the ARO3 protein that would result upon successful 2A cleavage from the 
AROp polypeptide. That is, a single proline reside was added to the N-terminus, while a 
20-amino acid long tail was added to the C-terminus (the remaining sequence of T2A 
post-cleavage). Both of these were cloned into a low-copy plasmid, and transformed into 
a double knockout strain lacking aro3 and aro4, and thus with no DAHP synthase 
activity; tyrosine production was again quantified (Fig 6-12). 
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Figure 6-12: Tyrosine production measured from several strains containing AROp 
variants 
 
Wild-type By4741; By4741 with the two biosynthetic genes aro3, and aro4 knocked out; 
the ARO2-P2A-ARO3-T2A-ARO4 poly-gene cassette on a low-copy plasmid in the 
triple knockout strain; ARO3t on a low-copy plasmid in the double knockout strain, and 
ARO3-T2A-ARO4 on a low-copy plasmid in the double knockout strain.  
 
 Interestingly, there is no single clear cause for the significant overproduction 
afforded by the AROp system. ARO3t, the modified ARO3 protein that would result 
from cleavage of AROp, boosts tyrosine production significantly, suggesting that the C-
terminal tail may have some effects on reducing feedback inhibition. Including aro4 with 
a T2A linker boosts production still further, suggesting that it, too, may have some effect. 
However, cells expressing the full AROp system remains the highest producer observed, 
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implying there may be some additional effect from also incorporating the ARO2 protein 
as well.  
While these data certainly merit further investigation for protein engineering and 
aromatic production in yeast, they also imply that such a system would not be useful for 
demonstrating the utility of 2A sites. Unfortunately, the very act of linking the proteins in 
a 2A-linked poly-gene cassette vastly impacts protein activity. If such a cassette were 
used in a directed evolution experiment, it is unlikely that any beneficial mutations could 
be identified that would also apply to the unlinked proteins. Further, in this case protein 
activity seems not to be limited by 2A activity, so employing the novel high-activity 
variants in this system would not illustrate their potential impact. 
 
6.3.4.4 Cinnamic Acid Decarboxylation 
The final system in which high-activity 2A sites were employed to demonstrate 
their utility is in the decarboxylation of cinnamic acid. Engineering more efficient 
decarboxylation is of high interest in several metabolic engineering efforts; for example, 
decarboxylation of PCA remains the limiting step in muconic acid production [4, 158], 
and decarboxylation of cinnamic acid can be used to produce styrene [159]. Cinnamic 
acid decarboxylation was chosen as a demonstration of 2A utility because a recent 
experiment found that co-overexpression of two native genes, pad1 and fdc1, 
significantly improved cinnamic acid decarboxylation, while expression of each 
individually did not [159]. Furthermore, these two genes are not co-localized; PAD1 is 
transported to the mitochondria while FDC1 acts in the cytoplasm. Interestingly, it has 
recently been reported that PAD1 may not directly exhibit decarboxylation activity, but 
instead catalyze the production of a limiting co-factor [160]. Since activity requires 
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overexpression of both genes, and since a fusion protein would be non-functional due to 
co-localization, this system serves as an ideal test case for demonstrating potential 
improvement high-activity 2A sites can afford. 
First, the same two control constructs were made to ensure such a system would 
function as expected: pad1 and fdc1 connected with either the functional P2A or the non-
functional P2Ad. Since cinnamic acid inhibits cell growth, these constructs were 
transformed into yeast and then simply grown in the presence of cinnamic acid to 
compare activity (Fig 6-13). These initial controls demonstrate that growth in cinnamic 
acid is a good measure of activity, since over-expression of each individual gene did not 
allow any growth, while co-overexpression of both simultaneously did. Second, the strain 
expressing pad1-P2A-fdc1 gene did exhibit growth, although not as much as the two 
genes separately expressed. Finally, the same construct with P2Ad exhibited only 
minimal growth, confirming that cleavage is necessary for activity in this system. 
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Figure 6-13: Growth rate of yeast strains expressing various combinations of pad1 and 
fdc1 in cinnamic acid-containing media 
 
Growth in complete media containing an added 0.65 mM cinnamic acid. “PF” strains 
contain pad1 and fdc1 connected with either P2A or P2Ad site; the other three contain the 
same genes expressed individually or concurrently, but each under the control of an 
individual promoter (TEF in all cases) and terminator. 
 
 Next, variations of this cassette were constructed to compare and contrast the 
native 2A sequences with the d8 and d12 spacer elements. This set was assayed in a more 
quantitative fashion; each strain expressing the variation was incubated in a solution with 
1 mM cinnamic acid, and timepoints were taken over 4 days. Each timepoint was then 
assayed for cinnamic acid concentration using HPLC.  
First, the controls performed as expected: strains harboring an empty vector, 
overexpressing either gene individually, or the two linked by non-functional P2Ad, did 
not result in any cinnamic acid degradation, while a strain expressing both concurrently 
resulted in complete degradation (Fig 6-14a). Next, the four native 2A sequences 
exhibited degradation of cinnamic acid commensurate with their relative activities as 
measured by the secreted fluorescent protein assay; that is, P2A and T2A enabled more 
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rapid consumption than E2A and F2A (Fig 6-14a). Finally, several variations of 
improved spacer sequences were tested, including d8-P2A, d12-P2A, and d12-T2A (Fig 
6-14b). Unexpectedly, these performed worse than the native P2A or T2A sequences.  
 
Figure 6-14: Cinnamic acid degradation after incubation with cells expressing various 
combinations of pad1 and fdc1 
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Figure 6-14 (continued): A) p413-TEF is the empty vector; P2Ad is the non-functional 
2A variant; the next four represent the native 2A sequences; PAD1 and FDC1 each 
express a single gene, while “PAD1+FDC1” express both separately. B) The controls are 
the same as in the previous plot, but also including d8- and d12- spacer sequences, 
inserted upstream of either P2A (“-P”) or T2A (“-T”). 
 
It is not clear why the spacer elements did not improve activity in this system, 
where it is seemingly limited by 2A cleavage efficiency. While there are several 
reasonable hypotheses, the fact remains that this system also does not support the idea 
that high-efficiency 2A elements would be useful for this pathway engineering effort. 
With this, further experiments to utilize 2A sequences with the cinnamic acid 
decarboxylation pathway were discontinued. 
 
6.4 DISCUSSION AND CONCLUSIONS 
Here, we characterize and investigate viral 2A sequences for their value in 
pathway expression and evolution. The secretion tag-based assay allows a novel method 
for quantifying 2A activity and allows us to further study which factors affect 2A 
cleavage in a way not previously possible. For example, the assay reveals that codon 
usage can significantly affect activity, something that was assumed to be neutral in prior 
demonstrations [74].  The screen also enabled the discovery of novel spacer elements 
than can significantly improve 2A activity. These sequences hold great promise for the 
expression and evolution of entire metabolic pathways simultaneously. 
However, these data did not support the hypothesis that the spacer elements, 
which seemed to enhance 2A activity by the secretion assay, would always be preferable 
for use in pathway engineering efforts. In fact, in several applications tested, including 
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xylose catabolic pathways, aromatic amino acid biosynthetic pathways, and cinnamic 
acid decarboxylase pathways, the 2A sequences did not actually allow efficient poly-
enzyme expression. In several cases this was due to simply to the superfluous nature of 
the cleavage; if uncleaved fusion proteins retain activity, then 2A cleavage is not limiting 
and the spacer elements are unnecessary for efficient expression. In several other cases, 
however, the use of 2A sequences impacted the enzyme activity. This is presumably due 
to the remaining polypeptide tag remaining post-cleavage, which can potentially disrupt 
folding or activity. While this was not always negative, such as in aromatic amino acid 
production, any such effect will interfere with evolutionary efforts, since beneficial 
mutations may or may not have the same effect when expressed as a single protein. 
While we do not successfully demonstrate the utility of 2A sequences here, the 
challenges remain context-specific. When expressing metabolic pathways, 2A sites 
remain a viable option for concurrent expression and regulatory control. It is important to 
understand these limitations, however, and ensure that the 2A cleavage does not interfere 
with pathway activity. Furthermore, the novel assay remains useful in quantifying 2A 
activity, and future work can explore using this to further understand 2A cleavage and 
improve these sites for more widespread use.  
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Chapter 7 - Conclusions and Future Work 
Taken together, this work has significantly advanced the state of the art for rapid 
evolutionary engineering of Saccharomyces cerevisiae. Novel tools have been developed, 
validated, and expanded to aid and allow the creation of new and valuable strains of 
yeast. Furthermore, these tools can be applied to a wide range of phenotypes, including 
both better and more efficient catabolism as well as production of high-value 
biochemicals. There remains opportunity, however, to continue to develop and expand 
these tools for even greater utility. 
In Chapter 2, in vivo Continuous Evolution (ICE) was demonstrated as a powerful 
new tool for mutagenesis and the creation of libraries in yeast. ICE allows the creation of 
larger and more diverse mutant libraries with only a fraction of the time and effort needed 
for traditional techniques. This system was also well-characterized, demonstrating that 
the optimized synthetic retroelement functions as expected. Its utility was also validated 
by using it to evolve three very different phenotypes: enzyme specificity, in the case of 
ura3; complex tolerance phenotypes, in the case of spt15; and catabolic efficiency, in the 
case of the xylA-xks1 pathway. With these successes, the utility of ICE has been 
demonstrated, and it promises to be a useful tool in a wide range of directed evolution 
experiments and efforts. Since ICE is essentially phenotype-agnostic, future work could 
potentially focus on using it to evolve non-growth phenotypes, to demonstrate its range. 
In addition, using the extremely high library size enabled by a bioreactor, difficult-to-
engineer pathways or genes can be evolved, to demonstrate its power. 
In Chapter 3, further characterization and study of ICE demonstrated how the 
process can be altered or controlled. Certain factors, such as the artificial intron, were 
shown to be non-impactful on the operation of ICE. Other factors, such as media 
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conditions and overexpression of trans “Helper” elements, were shown to have no 
beneficial effects on the operation of ICE mutagenesis. Several efforts have potential to 
expand the ICE system but were not able to be incorporated successfully in initial 
experiments, including integrase engineering, reverse transcriptase engineering, and the 
import of T7 RNA polymerase. Finally, several factors, such as the efforts to use Cas9 to 
target cDNA reintegration, showed promise but were not fully developed. Future work 
should focus on these efforts to better understand how ICE is still limited, and which 
factors could possibly relieve these bottlenecks. Incorporating additional orthogonal 
layers of control, especially by using Cas9 or T7 RNAP, have the potential to greatly 
improve the ICE system, by either allowing targeted re-integration and thus multi-cycle 
mutagenesis or enabling significantly higher error rates during library creation. 
In Chapter 4, we introduced and validated a novel and powerful method for the 
creation of adaptable biosensors using RNA. By expanding the Spinach system to include 
additional secondary aptamers and then optimizing their use in vitro, we show how 
powerful such molecules can be as a screen for metabolite production. Furthermore, by 
creating and refining a model-based approach to design new biosensors, we demonstrate 
how the extremely large array of aptamers already reported can be used and adapted to 
quickly create novel Spinach-based biosensors. The utility was demonstrated by creating 
two completely novel metabolite biosensors: Spinach-Tyr1 aptamers that can detect 
aromatic amino acids, and Spinach-DNT1 that can detect 2,4-dinitrotoluene. This again 
confirms the versatility of such a method. Further work will focus on expanding this 
model to create more complex Spinach-based biosensors. It could, for example, be used 
to incorporate two or more metabolite-binding aptamers into the Spinach scaffold, using 
ΔG modeling to disfavor proper-folding unless all metabolites are present. Such a 
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molecule could function as a synthetic circuit, and its parameters could be easily tuned by 
changing the sequence as the model predicts. 
In Chapter 5, we combine one of the novel Spinach-based biosensors created in 
Chapter 4 with the technology of microfluidic droplets to demonstrate how such 
biosensors can be used to rapidly evolve a secretion/production phenotype. By 
encapsulating yeast in droplets, it is possible to individually assay phenotype on a cell-
by-cell basis at an extremely high rate of through-put. This enables screening for 
production phenotypes faster by orders of magnitude than traditional assay techniques. 
While this technology has previously been used to screen yeast libraries [79, 144], it has 
henceforth relied on very specific screening techniques such as exogenous enzyme-
mediated oxidation. By importing and adapting Spinach-based biosensors to screen 
secretion/production directly, we demonstrate a much more powerful and generalizable 
screening technique, potentially applicable to a huge range of desirable phenotypes. We 
validated this method by evolving production and secretion of the aromatic amino acid 
tyrosine. For tyrosine, we mutagenized aro4 and screened this library, identifying two 
novel mutations superior to any other reported variant. Previously, all aro4 engineering 
has relied on crystal structure and knowledge of the protein dynamics [147]; this 
technique demonstrates for the first time an effective screen for the phenotype of 
interesting. Future work on this technology will focus on expanding it to evolve even 
more secretion or production phenotypes, to take advantage of all the Spinach-based 
biosensors characterized thus far. It will also focus on improving the screen efficiency, by 
optimizing the sorting device, fluorescence detection, and flow-rate, all of which could 
potentially increase the rate and efficiency of a sort by orders of magnitude [79, 145].  
In Chapter 6, we investigated and characterized viral 2A elements, in the process 
discovering novel elements that significantly affect their activity. Such elements, which 
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allow co-translational polypeptide cleavage and thus the expression of multiple proteins 
from a single promoter, have great promise for engineering pathways. We developed a 
novel screen that can quickly and easily assay for 2A activity, which is critical when 
employing this sequences in a new pathway. Furthermore, a library screen of randomized 
2A sites fortuitously discovered “spacer” elements, which can significantly enhance 
cleavage activity. With such elements coupled to relatively low-activity native 2A sites 
characterized thus far, it may be possible to express and evolve entire pathways using 
only a single genetic cassette. Unfortunately, we were not able to apply these novel 2A 
sequences in a metabolic engineering-relevant context. In some pathways, such as those 
used for xylose catabolism or beta-carotene production, cleavage efficiency was not a 
limiting factor; uncleaved 2A sites allowed functional fusion proteins. In others, such as 
cinnamic acid decarboxylase, the high-efficiency 2A sites actually decreased activity, 
potentially due to the significantly longer polypeptide sequence that remains on the C-
terminal end of each cleaved polypeptide. Future work will continue to explore and 
characterize these sequences, in order to understand how and why the spacer elements 
function. Furthermore, additional pathways of interest could be explored for which a 2A 
site, or sites, enable high activity in a single cassette. 
In summary, the work presented here represents a significant advancement in 
developing novel engineering tools for the evolutionary engineering of enzymatic 
pathways in Saccharomyces cerevisiae. These tools are expected to be applicable in a 
wide range of desirable uses, and can be employed as-is for ongoing efforts of strain 
engineering. This work also opens the door to more refinement and advancement of these 
tools, however, and offers a variety of opportunities for further directed evolution efforts.  
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Chapter 8 – Materials and Methods 
8.1 COMMON MATERIALS AND METHODS 
8.1.1 Strains and Media 
Yeast expression vectors were propagated in E. coli DH10β. E. coli strains were 
routinely cultivated in LB medium (10 g L-1 tryptone, 5 g L-1 yeast extract, 10 g L-1 
sodium chloride) (Teknova) at 37°C with 225 RPM orbital shaking. LB was 
supplemented with 100 µg mL-1 ampicillin (Sigma) when needed for plasmid 
maintenance and propagation. Yeast strains for which maintenance of auxotrophic 
markers was unnecessary were propagated in YPD (10 g L-1 yeast extract, 20 g L-1 
peptone, 20 g L-1 glucose), YPG (10 g L-1 yeast extract, 20 g L-1 peptone, 20 g L-1 
galactose), or YPX (10 g L-1 yeast extract, 20 g L-1 peptone, 20 g L-1 xylose). When 
required for plasmid maintenance, yeast strains were cultivated on a yeast synthetic 
complete (YSC) medium containing 6.7 g of Yeast Nitrogen Base (Difco) L-1, 20 g 
glucose L-1 and a mixture of appropriate nucleotides and amino acids (CSM, MP 
Biomedicals, Solon, OH). For YSC medium containing galactose or xylose, glucose was 
omitted from the above recipe and replaced with 20 g L-1 galactose or xylose, 
respectively. All components were supplemented with 1.5% agar for solid media. 
For E. coli transformations, 25 µL of electrocompetent E. coli DH10β [161] were 
mixed with 30 ng of ligated DNA and electroporated (2 mm Electroporation Cuvettes 
(Bioexpress) with Biorad Genepulser Xcell) at 2.5 kV. Transformants were rescued for 
one hour at 37 °C in 1 mL SOC Buffer (Cellgro), plated on LB agar, and incubated 
overnight. Single clones were amplified in 5 mL LB medium and incubated overnight at 
37 °C. Plasmids were isolated (QIAprep Spin Miniprep Kit, Qiagen) and confirmed by 
Sanger sequencing. 
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For yeast transformations, 50 µL of chemically competent S. cerevisiae BY4741 
were transformed with 1 µg of each appropriate purified plasmid according to established 
protocols44, plated on the appropriate medium, and incubated for 3 days at 30 °C. Single 
colonies were picked into 1mL of the appropriate medium and incubated at 30 °C.  
Plasmids were isolated from yeast using a Zymoprep Yeast Miniprep Kit II (Zymo 
Corporation) and transformed into E. coli for further amplification. 
 
8.1.2 Cloning Methods 
8.1.2.1 Ligation cloning procedures   
PCR reactions were performed with Q5 Hot-Start DNA Polymerase (NEB) 
according to manufacturer specifications. Digestions were performed according to 
manufacturer’s (NEB) instructions, with digestions close to the end of a linearized strand 
running overnight and digestions of circular strands running for 1 hour at 37 °C. PCR 
products and digestions were purified with a QIAquick PCR Purification Kit (Qiagen). 
Phosphatase reactions were performed with Antarctic Phosphatase (NEB) according to 
manufacturer’s instructions and heat-inactivated for 15 min at 65 °C. Ligations (T4 DNA 
Ligase, Fermentas) were performed overnight at 22 °C followed by heat inactivation at 
65 °C for 20 min. 
8.1.2.2 Recombination cloning in yeast   
1 ug of each PCR fragment was digested with DpnI and co-transformed into S. 
cerevisiae BY4741 according to the procedure described in [162]. This transformation 
mixture was then plated on the appropriate dropout medium and allowed to grow for 3 
days at 30 °C. Yeast colonies from this plate were scraped and plasmids were extracted 
(Zymoprep Yeast Miniprep Kit, Zymo Research). This plasmid mixture was then 
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transformed into E. coli DH10β and plated. Individual colonies were then amplified in 
liquid culture and plasmids were extracted. Correctly assembled plasmids were 
confirmed through restriction digestion and sequencing. 
8.1.2.3 Gibson assembly 
Isothermal assembly of DpnI digested PCR fragments was performed using the 
procedure of Gibson et al [163]. 
8.1.2.4 Vector and strain construction   
For all knockouts, a loxP-KanMX-loxP deletion cassette was constructed from 
plasmid PUG646. One kilobase of homologous sequence was amplified from the region 
5’ to the desired integration site, and ligated at the 5’ end of the loxP-KanMX-loxP 
module. A second kilobase of homologous sequence amplified from the region 3’ to the 
integration site was then ligated at the 3’ end of the loxP-KanMX-loxP module. The 
whole gene disruption cassette was then amplified and transformed into S. cerevisiae 
BY4741 or CEN.PK2, using a standard lithium acetate transformation method [162] or a 
version optimized for CEN.PK246, respectively. Cells were then plated onto YPD plus 
G418 plates (200 μg mL-1 G418). After one day of growth, microcolonies were replicated 
onto new YPD plus G418 plates. The resulting colonies were amplified in 3 mL 
YPD+G418 and the genomic DNA was extracted using the Wizard Genomic DNA 
Purification kit (Promega). Correct knockouts were confirmed by PCR.  
Confirmed single knockout strains were transformed with the Cre expression 
plasmid pSH4744. Cre recombinase was then induced by incubating cells in YPG 
medium for 24 h. Cells were subsequently streaked onto YPD and replica-plated onto 
YPD plus G418 to isolate colonies in which the G418 marker (KanMX) had been excised. 
The Cre expression plasmid in G418-sensitive colonies was removed by incubating cells 
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in YPD plus 5-FOA for 24 h, thus excising the URA3-marked plasmid and yielding a 
clean version of the knockout strain with a single loxP site in the chromosome. 
Sequential gene knockouts were performed with the same protocol using this clean 
(KanMX-less) strain as a template, yielding a double-knockout strain.  
Genomic integrations into the TRP1 locus were performed with the aid of Cas9p 
[88]. Briefly, the parent strain was transformed with a URA3-marked plasmid expressing 
CAS9 from the pGAL1 promoter and a guide RNA targeted to the TRP1 locus. 
Transformants were then transformed using standard procedures with a PCR product 
containing the retroelement of interest as well as homology to TRP1. This transformation 
mixture was then plated on media containing galactose to induce CAS9 expression. 
Successful knock-ins were confirmed with PCR and the CAS9 plasmid was excised 
through culture in 5-FOA. 
 
8.1.3 Flow Cytometry Analysis 
Yeast colonies were picked in triplicate from glycerol stock, grown in the 
appropriate medium to mid-log phase, and analyzed (LSRFortessa Flow Cytometer, BD 
Biosciences. Excitation wavelength: 488 nm, Detection wavelength: 530 nm). Day-to-day 
variability was mitigated by analyzing all comparable transformants on the same day. An 
average fluorescence and standard deviation was calculated from the mean fluorescence 
values for the biological replicates. Flow cytometry data was analyzed using FlowJo 
software (FlowJo, LLC). 
 
8.2 MATERIALS AND METHODS FOR CHAPTER 2 
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8.2.1 Plasmid Construction 
All plasmids used in this chapter were constructed through yeast recombination 
cloning of PCRs, amplified using primers listed in Appendix A. 
8.2.2 Analysis of transposition efficiency 
For the following, it should be noted that the synthetic Ty1 retrotransposon 
(whether integrated on a plasmid or on the genome) contained an adjacent HIS3 gene 
used for plasmid maintenance and as a selectable marker for genome integration, 
respectively.  Therefore, we cultured all strains in histidine dropout media to facilitate 
media equivalence between all tested strains.  As described in Chapter 2, the synthetic 
Ty1 retrotransposon contained an intron-containing URA3 gene in the reverse orientation 
to provide a URA3+ phenotype if and only if retrotransposition occurs.  Therefore, we 
plated induced cultures on media lacking histidine and uracil to count the number of cells 
containing an intact URA3 gene, and hence which had a parent that underwent 
retrotransposition.  
For low cell density induction, three biological replicates of a yeast strain carrying 
the engineered retrotransposon of interest were used to inoculate 50 mL liquid cultures 
lacking histidine and containing galactose, thus inducing retroelement transcription. After 
3 days of growth at 30 °C, cultures were plated on agar containing glucose and either 
lacking histidine or lacking both histidine and uracil and allowed to grow for 3 days at 30 
°C. Colonies were counted manually or through automated software [164] and counts 
were used as inputs to the Fluctuation Analysis Calculator [165] implementing the Ma, 
Sandri, and Sarkar Maximum Likelihood Estimation method [166]. Calculated mutation 
rates per cell were divided by the time spent in galactose medium to determine the 
transposition rate per cell per generation as well as 95% confidence intervals. This value 
was then used to estimate a library size.  
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For high OD tests with S. cerevisiae, cells were first cultivated in 50 mL liquid 
cultures lacking histidine and containing glucose and then resuspended in 50 mL liquid 
cultures lacking histidine and containing galactose to an initial OD of 1. After 3 days of 
growth at 30 °C, cultures were plated on agar containing glucose and either lacking 
histidine or lacking both histidine and uracil and allowed to grow for 3 days at 30 °C. 
Colonies were counted manually or through automated software [164] and counts were 
averaged. This average was used as an estimate for the number of transpositions which 
occurred during the experiment, and this average was divided by the total number of cells 
which had been exposed to galactose to obtain a per-cell measure of transposition rate. 
 
8.2.3 qPCR Analysis 
For determination of retroelement mRNA and cDNA levels, yeast strains carrying 
the appropriate retroelement were grown to mid-log phase (OD=0.5) in 5 mL YSC 
containing either glucose or galactose and lacking the appropriate amino acids. Total 
RNA was extracted (Ribopure Yeast Kit, Life Technologies) from half of each culture 
and converted to cDNA (High Capacity cDNA Reverse Transcription Kit, Life 
Technologies). Total DNA was extracted (Wizard Genomic DNA Purification Kit, 
Promega) from the other half of the culture. qPCR was conducted using 10ng of either 
cDNA or total DNA (FastStart SYBR Green Master, Roche) using primers specific for an 
intronless URA3 (URA3RTPCRF and URA3RTPCRR) and with ALG9 as an internal 
standard (Alg9F and Alg9R). 
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8.2.4 Next-Generation Sequencing 
Ten replicates from BY4741 Δrrm3 plus pGALmTy1-Ty1RT-URA3I-pTEF1 were 
cultivated in 50 mL liquid cultures lacking histidine and containing glucose. After 3 days 
of growth at 30 °C, 1 mL culture was removed and the plasmids were extracted using 
Zymoprep Yeast Plasmid Miniprep Kit II (Zymo Research). The rest of the culture was 
then resuspended in 50 mL liquid cultures lacking histidine and containing galactose to 
an initial OD of 1. After 3 days of growth at 30 °C, 1 mL culture was extracted to obtain 
plasmids, and 1 mL culture was plated on agar containing glucose and either lacking 
histidine or lacking both histidine and uracil and allowed to grow for 3 days at 30 °C. 
Colonies were counted manually or through automated software [164] and counts were 
averaged. This average was then used as an estimate for the number of transpositions 
which occurred during the experiment. Two sequencing primer pairs with different 
barcodes were used to amplify the ampicillin sequence region from fresh pGALmTy1-
Ty1RT-URA3I-pTEF1 plasmid and pGALmTy1-Ty1RT-URA3I-pTEF1 plasmid extracted 
from yeast grown in glucose medium, and 20 barcoded primer pairs amplified the URA3 
sequence region from 20 minipreps of galactose cultures. The PCR products were 
purified and the concentrations were determined by nanodrop. A final concentration of 50 
ng μL-1 sample was prepared by combining 22 PCR purified products, with a 5:2 molar 
basis of ampicillin amplicon to URA3 amplicon. This mixture was then sequenced using 
an Illumina Miseq in 2x250bp paired-end mode.  
Paired-end reads were matched up and error-corrected using pandaseq [167] using 
stringent quality filtering (threshold=0.95). Matched pairs were then divided up based 
upon barcode sequence using sabre [168], allowing for single nucleotide mutations (since 
each barcode differed by at least 2 bp from all other barcodes) and barcodes were 
removed with the trimmingreads.pl script of the NGS QC toolkit [169]. After combining 
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reads originating from the same culture into the same file, alignment to the unmutated 
amplicon was performed using ssaha2 [170]. Custom python scripts were then used to 
extract the total number of mutations identified, their locations on the wild-type 
sequence, and their frequency per mutant. All data originating from URA3 was then 
averaged.  Data was calculated by subtracting the mutation rates of the yeast-derived Amp 
amplicon from those of the averaged URA3 amplicon. 95% confidence intervals for 
mutation counts were computed using the method of the Clopper-Pearson Interval [171]. 
 
8.2.5 Analysis of ICE mutation rate using dKanMX reversion assay 
Strains S. cerevisiae BY4741 trp1::Ty1-Ty1RT-dKanMX-pTEF1 and S. cerevisiae 
BY4741 trp1::dKanMX-pTEF1 were cultured in 2.0 mL YSC−His medium containing 
2% glucose. These cells were then resuspended into 2.0 mL YSC−His containing 2% 
galactose at an optical density of 1.0, in triplicate, for 3 days at 22 °C to induce 
mutagenesis. 1.0 mL of each culture was then plated on YPD containing 400 mg L-1 
G418. After 2 days, colonies were counted to establish the rate of reversion mutations. 39 
colonies from S. cerevisiae BY4741 trp1::Ty1-Ty1RT-dKanMX-pTEF1 were grown, and 
genomic DNA was extracted. From each colony, the dKanMX marker was PCR amplified 
and sequenced to confirm the reversion mutations present. 
 
8.2.6 Evolutionary Strategies 
8.2.6.1 URA3 evolutionary strategy 
During the first round of URA3 evolution, a 50 mL culture containing S. 
cerevisiae BY4741 ∆rrm3 trp1::Ty1-Ty1RT-URA3I-pTEF1 was mutagenized for 3 days 
at 22 °C at stationary phase and then transferred to 500 mL of galactose-containing, 
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uracil-deficient media and allowed to grow. Each day the optical density of this culture 
attained a value greater than one, the culture was re-inoculated into fresh medium 
containing an increased concentration of 5-FOA (0, 0.1, 0.3, 0.5, and 1.0 g L-1). After 
each subculture, genomic DNA was isolated from a sample of bulk culture, and mutants 
were recovered for sequencing.  
For the second round of evolution, a 50 mL culture containing S. cerevisiae 
BY4741 ∆rrm3 trp1::Ty1-Ty1RT-ura3(3-5)I-pTEF1 was mutagenized for 3 days at 22 °C 
at stationary phase and then transferred to 500 mL of galactose-containing, uracil-
deficient media with 0.3 g L-1 5-FOA and allowed to grow. Each day the optical density 
of this culture attained a value greater than one, the culture was re-inoculated into fresh 
medium containing an increased concentration of 5-FOA (0.3, 0.5, 0.7 and 1.0 g L-1). 
After growth in 0.5 g L-1 5-FOA, the culture was split and re-inoculated into either 0.7 or 
1.0 g L-1 5-FOA. After each subculture, genomic DNA was isolated from a sample of 
bulk culture, and mutants were recovered for sequencing. 
 
8.2.6.2 SPT15 evolutionary strategy  
During the first round of SPT15 evolution, 50mL cultures of S. cerevisiae 
BY4741 ∆rrm3 trp1::Ty1-Ty1RT-SPT15I-pTEF1 were precultured in glucose media, 
after which they were induced in YSC−His + 20 g L-1 galactose for 3 days.  Mutated cells 
were then pelleted and incubated in glucose-containing media for ~2 hours to allow 
recovery and time for expression of Spt15 mutants. Next, butanol was added to a final 
concentration of 2.5% and cells were incubated with shaking for 3 hours in sealed flasks 
at 30 °C. At this point, genomic DNA was isolated from a sample of bulk culture and the 
SPT15 gene was recovered for sequencing via PCR. 
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In order to undertake a second round of ICE, cultures of S. cerevisiae BY4741 
∆rrm3 trp1::Ty1-Ty1RT-spt15-B6I-pTEF1 were induced in YSC−His+gal for 3 days, 
pelleted, and incubated in glucose-containing media for ~2 hours to allow recovery and 
time for expression of spt15 mutants. Next, butanol was added to final concentration of 
3.5% and cells were incubated with shaking for 3 hours in sealed flasks at 30 °C. At this 
point, genomic DNA was isolated from a sample of bulk culture, and the SPT15 gene 
was recovered for sequencing via PCR. 
8.2.6.3 Xylose isomerase pathway evolutionary strategy 
Strains S. cerevisiae BY4741∆r-g-x trp1::Ty1-Ty1RT-XylAI-P2A-XKS1-pTDH3* 
and S. cerevisiae BY4741∆r-g-x trp1::Ty1-Ty1RT-XylA3*I-P2A-XKS1-pTDH3* were 
cultured in 50 mL YSC−His medium containing 2% glucose. These cells were then 
resuspended into 50 mL YSC−His containing 2% galactose at an optical density of one 
for 3 days at 22 °C to induce mutagenesis. Several 1 µL aliquots of culture were then 
plated on YSC−His or YPX plates. After 3 days, large colonies were identified. Large 
colonies were picked into a 96-well plate for growth analysis and clones exhibiting strong 
growth were subject to genomic DNA extraction and PCR to sequence mutant pathways. 
In this way, 3 pathway mutants were isolated. 
 
8.2.7 Mutant Isolation 
Genomic DNA from a small (~1 mL) volume of culture was isolated using crude 
total yeast DNA.  For SPT15 and URA3 selections, this DNA was pre-digested with AscI 
(which exists uniquely in our synthetic intron) to enable specific amplification of spliced 
copies of the cargo. In general, unspliced copies of the cargo also amplified due to 
incomplete digestion, and so spliced copies were isolated through gel extraction. Then, 
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this extract was cloned into an expression vector for sequencing.  For xylose pathway 
screening, pTDH3*-XylA(3*) and pTDH3*-XKS1 gene fragments were individually PCR-
amplified from total DNA extractions of isolates and cloned into an expression vector for 
sequencing. 
 
8.2.8 Methods of characterizing ICE mutants 
8.2.8.1 URA3 mutant growth analysis 
First round URA3 mutants were tested by plating on solid media containing 
lacking uracil and containing 0.3 g L-1 5-FOA. After growth for 3 days, colony size was 
measured using a BioRad Gel Dock XR+ (Bio-Rad Laboratories, Inc.) and automated 
image analysis software [164]. After the second round of selection, the maximum rates of 
exponential growth were characterized for first and second-round mutants using a 
Bioscreen C (Growth Curves USA). Briefly, selected strains were inoculated at OD=0.1 
and OD measurements were taken every 15 minutes using continuous shaking for 3 days 
at 30 °C. Growth rates were calculated using a custom MATLAB script (available upon 
request). 
8.2.8.2 SPT15 butanol tolerance testing 
To evaluate the effects of the mutant Spt15-B6 gene, a pTEF1-Spt15-B6 cassette 
was cloned into a low-copy plasmid and transformed into a fresh strain of BY4741 
Δrrm3. Two control strains were also made, containing a blank pTEF1 plasmid and a 
pTEF1-SPT15 wild-type plasmid. Each was grown up in media, and then resuspended in 
fresh media at an OD of approximately 0.05. The actual OD was measured and recorded, 
and then butanol was immediately added to the desired concentration. The culture tubes 
were sealed to prevent evaporation, and the cultures were incubated at 30 °C. At various 
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timepoints, the optical density was measured, and normalized against the original OD of 
each replicate culture. 
For high-butanol testing, the same strains described above were precultured in 
glucose media, then diluted to an OD=0.05 and incubated overnight. The next day, they 
were resuspended at OD=1.0 in media containing either 3.5% or 3.7% butanol. A time-
zero sample was immediately plated to determine the number of cells in the culture. At 
intervals, a small volume was removed and diluted by 100-fold in water, then plated. On 
growth, the colonies were counted to create an estimate of how many cells remained 
alive. Each replicate was normalized to its own time-zero colony count. 
For determination of wild-type or mutant SPT15 expression levels, cells 
expressing either pTEF1-SPT15 or pTEF1-Spt15-B6-1 were grown to early exponential 
phase and total RNA was extracted and converted to cDNA as described above for 
“qPCR Analysis”. qRT-PCR was carried out using primers that spanned the pTEF1 
promoter and the SPT15 gene (primers Spt15-qPCR2f and Spt15-qPCR2r), eliminating 
amplification of endogenous SPT15. SPT15 cycle threshold numbers were compared to 
that of a reference gene (ALG9) as above.  
8.2.8.3 Xylose pathway mutant growth analysis 
Colonies identified from plate-based selection were streaked onto a fresh plate 
and inoculated in 0.5 mL YSC−His+glucose medium for a 96-deepwell plate growth test. 
The original strains without galactose induction were also inoculated in 0.5 mL 
YSC−His+glucose medium in a 96-deepwell plate as controls. All cultures were then 
transferred to 1 mL xylose medium for growth test at an initial OD of 0.01. Growth 
curves were monitored by withdrawing 120 µL culture into a 96-well plate at each time 
point to read OD600nm using a plate reader (Cytation 3, BioTek Instruments, Inc.). 
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Isolates with improved growth rate were picked from the restreaked plate to extract 
genomic DNA as above. Each component of the pathway was then amplified and purified 
or ligated into p413-pTEF1 for sequencing. Mutant strains were then inoculated in 1 mL 
YPX at an initial OD of 0.01 for growth test on a Bioscreen (Bioscreen C, Growth Curves 
USA).  
For xylose isomerase kinetics analysis, mutant or wild type strains were grown 
until mid-exponential growth phase (OD of 0.6 to 0.8) in selective media. Cells were 
collected by centrifuging at 3,000 × g for 5 min at 4 °C. Total protein was extracted using 
Y-PER Plus (dialyzable yeast protein extraction reagent, Thermo scientific), and protein 
concentration was determined using the Pierce BCA protein assay kit (Thermo 
Scientific). Xylose isomerase activity from these cell extracts was determined by 
measuring oxidation of NADH at 340 nm using a spectrophotometer57. Each 1 mL 
reaction contained 100 mM Tris-HCl (pH 7.5), 0.15 mM NADH, 10 mM MgCl2, 2 U 
sorbitol dehydrogenase, and the diluted protein samples. Kinetic parameters were 
determined within a range of 25 to 500 mM xylose. All enzyme assays were performed in 
biological triplicate. 
 
8.2.9 Comparison of in vivo and in vitro mutagenesis  
To compare the ICE-derived ura3 library to one which could be obtained using 
traditional methods, error-prone PCR libraries of ura3 were also constructed. ura3 was 
amplified in an error-prone fashion using the GeneMorph II Mutagenesis kit according to 
manufacturer instructions. This was done in duplicate to achieve either 4.5 – 9.0 
mutations kb-1 (“Medium”) or 9 – 16 mutations kb-1 (“High”). Both were ligated 
separately into a low-copy vector with the pTEF1 promoter, to match the construct made 
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for the ICE library. The mutant plasmid libraries of approximately 105 in size were then 
transformed into E.coli DH10-β using electroporation, which were then harvested from 
petri dishes. The plasmid libraries were then purified and transformed into wild-type 
By4741 yeast as described above. After transformation, the yeast libraries were grown to 
stationary phase. Concurrently, a new ICE-derived library of pTEF1-ura3 was created as 
described above, however with a reduced galactose-induction volume of just 1 mL.  After 
3 days of induction, the two error-prone libraries and the ICE library were each 
resuspended in uracil-deficient media containing 0.3 g L-1 5-FOA to a final OD of 0.05 
and allowed to grow. Each day the optical density of this culture attained a value greater 
than approximately 3.0, the culture was re-inoculated into fresh medium containing an 
increased concentration of 5-FOA (0.3, 0.5, 1.0, 1.5, 2.0 g L-1). At each subculture, a 
sample was plated. For characterization of adaptation, 5 colonies from each plate were 
picked and grown to stationary phase. Their growth rates in media containing various 
concentrations of 5-FOA were characterized using a Bioscreen C (Growth Curves USA). 
Briefly, selected strains were inoculated at OD=0.1 and OD measurements were taken 
every 15 minutes using continuous shaking for 3 days at 30 °C. Growth rates were 
calculated using a custom MATLAB script (available upon request). 
 
8.3 MATERIALS AND METHODS FOR CHAPTER 3 
8.3.1 Plasmid Construction 
 All HIV-RT constructs were made by altering a previously constructed HIV/Ty1 
retroelement [152]. Changes in the primer binding site and protein cleavage site were 
made by inverse PCR, with new or altered sequence included on the 5’ end of the 
oligosaccharide. All primers are listed in Appendix A. 
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 All reverse transcriptase mutants were made by either inverse PCR, as described 
above, or using QuikChange II Site-Directed Mutagensis kit (Agilent) as directed, using 
primers lists in Appendix A. 
  Overexpression vectors were made by PCR amplifying the native gene from wild-
type strains and cloning using restriction digestion.  Terminators were likewise amplified 
from wild-type strains and also cloned in downstream of the 3’ LTR using restriction 
digestion. 
 “Helper” and “Mini” elements were made by inverse PCR, resulting in removing 
sections of plasmids that would not be included (the 3’LTR and the integrase/RT 
respectively). These linearized fragments were then circularized by blunt-end ligation. 
 
8.3.2 Other Analysis 
 Analysis of transposition efficiency, next-generation sequencing, and dKanMX 
reversion was all done as in Chapter 2; See Section 8.2 for additional details. 
 
8.4 MATERIALS AND METHODS FOR CHAPTER 4 
8.4.1 Synthesis of RNA Aptamers 
To construct all RNA sensors, synthetic double-stranded DNA sequences 
(gBlocks) were obtained from IDT, incorporating the Spinach sequence with the Tyrosine 
aptamer  inserted into a stem loop segment as described previously [133], as well as a T7 
promoter sequence allowing transcription of the appropriate sequence. These sequences 
are listed in Appendix A.  DNA templates were separately amplified from each plasmid 
by use of T7p-Spinach2-Fwd and Spinach2r, which created small fragments including a 
T7 promoter sequence allowing in vitro transcription. RNA was produced and purified 
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using the Ampliscibe T7-flash in vitro transcription kit using the appropriate PCR as a 
template (Epicentre).  
To measure sensor fluorescence, RNA was diluted to ~2-10 uM (varying between 
experiments) in 50 mM Tris-HCl, pH 7.5, 125 mM KCl, 5 mM MgCl2, and heat 
denatured at 95oC for 3 minutes. It was then incubated at 37oC for 1-2 hours to allow 
proper folding. Finally, DFHBI or DFHBI-1T (Lucerna) was added to a final 
concentration of 10 uM (again varying between experiments), and the metabolite of 
interest was added to its final concentration. Fluorescence was measured continuously 
after addition of the metabolite, with an excitation wavelength of 460 nm and an emission 
wavelength of 500 nm for DFHBI or an excitation wavelength of 482 nm and an 
emission wavelength of 505 nm for DFHBI-1T. 
 For tests with cells and cell supernatants, cells were precultured in complete 
synthetic medium for at least 2 days. The OD was measured, and each culture was 
centrifuged, washed with water, and finally diluted to the same OD with minimal media, 
which contains 20 g/L glucose, 20 mg/L methionine, 12 mg/L adenine, 20 mg/L uracil, 
20 mg/L histidine, and 100 mg/L leucine. Cells were incubated at 30oC in this media 
overnight, and then centrifuged to pellet. When testing cells or cells supernatants, 
fluorescence was measured for several hours at 30oC and again after an overnight 
incubation, also at 30oC. 
 
 
8.5 MATERIALS AND METHODS FOR CHAPTER 5 
8.5.2 Synthesis of RNA Aptamers  
This was done as in Chapter 4; see section 8.4 for details. 
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8.5.2 Construction of Error-Prone aro4 Libraries 
Two libraries were made for the evolution of aro4: one derived from the wild-type 
gene and one from the K229L mutant, which has been shown to exhibit lower feedback 
inhibition [148]. For the K229L-based library, the mutant gene was PCR amplified in an 
error-prone manner using GeneMorph II kit (Agilent) following the protocol for 
“medium” error-rate (4.5-9 errors per kbp). The amplified product was purified using gel 
extraction, then digested and cloned into a backbone plasmid as described above. The 
mutant plasmid library (~5 x 104 in size) was then transformed into E.coli DH10-β using 
electroporation, which were then harvested from petri dishes. The plasmid libraries were 
then purified and transformed into a strain of yeast with aro3 and aro4 (both of which 
encode DAHP synthase activity) knocked out [4]. After transformation, the yeast libraries 
were grown to stationary phase and glycerol stocked. 
The ARO4-Reg library was made slightly differently. In this, an insert of ARO4 
was target for mutagenesis consisting of 212 bp, centered around the region known to 
code for feedback inhibition activity (bp 576 – 787). This piece was amplified in an error-
prone manner using nucleotide analogs [172], with 20 uM 8-oxo-dGTP and 20 uM dPTP 
to achieve an error-rate of roughly 5-10 per kbp, using ARO4-reg-f with ARO4-reg-r. 
This PCR was purified and re-amplified using Q5 Hotstart polymerase (New England 
Biolabs) to extend the PCR with more homology to ARO4, using ext-ARO4-reg-f with 
ext-ARO4-reg-r. Next, a backbone plasmid was made by inverse PCR of p413-TEF-
ARO4 using ARO4-reg-BB-f and ARO4-reg-BB-r. The plasmid library was made by 
Gibson assembly of these two pieces. Again, rhe mutant plasmid libraries (~1.3 x 105 in 
size) were then transformed into E.coli DH10-β using electroporation, which were then 
harvested from petri dishes. The plasmid libraries were then purified and transformed 
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into By4741 ΔARO3ΔARO4 yeast as described above. After transformation, the yeast 
libraries were grown to stationary phase. 
 
8.5.3 Screening libraries in microfluidic droplet sorting 
Each library was individually grown to saturation from frozen stock in the 
appropriate YSC dropout media over 2-3 days. They were then diluted by mixing in 
100mM Tris (pH 7.5), 200mM KCl, 10mM NaCl, 10mM MgCl2, 10uM RNA aptamer, 
2uM DFHBI-1T (Lucerna, Inc), 1mg/ml of double stranded salmon sperm DNA 
(Thermofisher), to a final cell density of 0.3. At this concentration of cells and size of 
droplets (40um), this results in approximately 1 in 10 droplets containing a single cell and 
1 in 100 containing two cells. This culture was then encapsulated in droplets and 
incubated at room temperature for 48 hours prior to sorting. 
To detect and sort microfluidic droplets using a fluorescence signal, we made use 
of a custom built fluorimeter and microscope. As droplets flow through the microfluidic 
channel, they are exposed to a 473 nm laser to excite individual droplets and the emission 
is measured using a PMT with a 517 nm bandpass filter. Labview software with a user set 
threshold for sorting controlled a field programmable gate array card to apply a voltage to 
a high voltage amplifier (Teck) to dielectrophoretically move the droplet into the sorted 
outlet while unsorted droplets continue unperturbed. Gating was used to sort out the top -
~0.1% of droplets detected. Sorted droplets were opened using perfloruooctanol and 
cultured in dropout media for several days, before being frozen for further assays. 
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8.5.4 Recovering high-producing variants post-sort 
Post-sort, total DNA from post-sort cultures were extracted (Zymo) and re-
transformed to E.coli. Simultaneously, the original library was grown from glycerol stock 
and the same DNA extraction and transformation were carried out. Next, individual 
clones were picked from each, followed by plasmids isolation and sequencing. Those 
plasmids encoding unique mutations were re-transformed into a fresh strain of yeast 
containing the same double knockout of aro3 and aro4. This strategy eliminates any 
possible strain adaptation that may account for high-production. 
  
8.5.5 Assaying Aromatic Amino Acid Production of Cell Cultures 
Cells were precultured in YSC dropout media for at least 2 days. The OD was 
measured, and each culture was centrifuged, washed with water, and finally diluted to 
OD=3.0 with minimal media, which contains 20 g/L glucose, 20 mg/L methionine, 12 
mg/L adenine, 20 mg/L uracil, 20 mg/L histidine, and 100 mg/L leucine. Cells were 
incubated at 30°C in this media for 2 additional days, and then centrifuged to pellet. The 
media supernatant was then measured using a tyrosine derivitization assay. 100 uL of 
supernatant was mixed with an equal volume of solution containing 0.05% (w/v) 1-
nitroso-2-naphthol, 50% ethanol, 10% (v/v) nitric acid and 0.25 g/l (w/v) NaNO2. The 
reaction was catalyzed by incubating at 55°C for 45 minutes, then read by fluorescence 
using an excitation of 485nm and emission of 590nm. A standard curve of tyrosine was 
used to quantify. This procedure is based on an assay described previously [149]. 
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8.5.6 Characterization of Exponential Growth Rates 
Maximum rates of exponential growth were characterized for cells expressing 
mutant aro4 genes using a Bioscreen C (Growth Curves USA). Briefly, selected strains 
were inoculated into the appropriate media, either complete (YSC-Histidine) or minimal 
(20 g/L glucose, 20 mg/L methionine, 12 mg/L adenine, 20 mg/L uracil and 100 mg/L 
leucine), at OD=0.1 and OD measurements were taken every 15 minutes using 
continuous shaking for 3 days at 30 °C. Growth rates were calculated using a custom 
MATLAB script (available upon request). 
 
8.6 MATERIALS AND METHODS FOR CHAPTER 6 
8.6.1 Plasmid Construction 
The Sec-2A-YFP assay plasmids were constructed in series. First, YFP was 
amplified and cloned into a low-copy vector with the TEF promoter using Gibson 
assembly. Next, the SecG sequence was inserted upstream of the YFP by inverse PCR: 
the entire plasmid was amplified, with the SecG sequence appended by inclusion on the 
primers. This fragment was then circularized using blunt-end ligation. All of the 
variations of this plasmid, including swapping the different 2A sites, were done by 
Gibson assembly. The plasmid libraries were made by amplifying a primer with 
degenerate nucelotides (rand2A) to result in overlap to a backbone PCR. For the first 
library, these two pieces were transformed to yeast directly for assembly through 
homologous recombination. For the next three attempts, the two pieces were assembled 
using Gibson Assembly, then transformed into E.coli DH10-β using electroporation, 
which were then harvested from petri dishes. The plasmid libraries were then purified and 
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transformed into wild-type By4741 yeast as described above. After transformation, the 
yeast libraries were grown to stationary phase. 
The beta-carotene pathway described was assembled previously [152]. All 
variations were made by PCR amplifying the plasmid backbone and individual 2A 
sequences with overlap, then assembled using Gibson Assembly. 
Of the other pathways explored, each construct was made similarly: native genes 
(xks1, aro2, aro3, aro4, pad1, fdc1) were amplified from the wild-type genome. The 2A 
sites were amplified with homology and the full plasmids were assembled with Gibson 
assembly. 
 All primers used are listed in Appendix A. 
8.6.2 Aromatic Amino Acid Biosynthetic Pathway Engineering 
 For these experiments, each construct was expressed in the relevant knockout 
strain; those expressing aro3 and aro4 in the double-knockout strain [4], and those 
expressing aro2, aro3, and aro4 in a triple-knockout strain. To make this triple knockout, 
the double-knockout strain was transformed with a cassette PCR-amplified containing the 
URA3 gene and homology to the aro2 locus. These strains were plated on uracil-deficient 
media, and clones were tested by PCR confirmation to confirm deletion. 
 
8.6.3 Cinnamic Acid Quantification 
Cinnamic acid was quantified using a ThermoScientific UltiMate 3000 HPLC 
system, and an Agilent Eclipse Plus C18 column (3.0 x 150mM, 3.5 uM pore size). The 
mobile phase was a mix of 1% acetic acid in acetonitrile and 1% acetic acid in water at a 
flow rate of 0.3 mL/min. Flow began with a 40:60 v/v ratio and ramped for 3 minutes to 
55:45, followed by an additional 6 minutes of isocratic flow. The UV-Vis detector was 
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operated at 278 nm, with isothermal conditions at 25oC. Cinnamic acid was diluted in 
water to make a standard curve. 
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Appendix A – Primers 
Table A-1: Primers used in Chapter 2 (IDT) 
Primer Name Sequence 
GalCas9F AAAAGTATCAACAAAAAATTGTTAATATACCTCTATACT
TTAACGTCAAGGAGAAAAAACCCCGGATATGGACAAGA
AGTACTCCATTGG 
CYC1tCas9R AGGGCGTGAATGTAAGCGTGACATAACTAATTACATGAT
CACACCTTCCTCTTCTTCTTG 
Cas9CYC1tF AGGGCTGACCCCAAGAAGAAGAGGAAGGTGTGATCATG
TAATTAGTTATGTCACGCTTAC 
gRNACYC1tR AAGTGGCACCGAGTCGGTGGTGCTTTTTTTGTTTTTTATGT
CTCGAGCGTCCCAAAACCT 
gRNAF TGTACGCATGTAACATTATACTGAAA 
gRNAR AAAACGACGGCCAGTGAG 
PacIP416F /5PHOS/GG-TTAATTAA-GGTACCCAATTCGCCCT 
NotICYCtR /5PHOS/GCGGCCGC-CGAGCGTCCCAAAACCT 
NotIgRNAF GG-GCGGCCGC-AGACATAAAAAACAAAAAAAGCACCA 
PacIgRNAR GG-TTAATTAA-
CTTTGAAAAGATAATGTATGATTATGCTTTCA 
SacIGalF CCCCCC-GAGCTC-ACGGATTAGAAGCCGCC 
SpeXbaIGalR GG-ACTAGT-TCTAGA-GGTTTTTTCTCCTTGACGTTAAAG 
GalpF1 CTCACTAAAGGGAACAAAAGCTGGAGCTCCTAGTACGGA
TTAGAAGCCGC 
Gal1pFixR2 TATACTAGAAGTTCTCCTCGAGGCGGTAGAGGAATAAGA
AGTAATACAAACCGAAAATGT 
GalpF2 CAGCTATGACCATGATTACGCCAAGCGCGCAATTAACCC
TCACTAAAGGGAACAAAAGCT 
GalpR2 TTCCATTGTTGATAAAGGCTATAATATTAGGTATACAGA
ATATACTAGAAGTTCTCCTCG 
TyH3GenomeF GCGCGGGCAAAGCCCAAAAG 
TyH3GenomeR TGCGCAAGCCCGGAATCGAA 
TyH3PCRF1 TATCAACAATGGAATCCCAACAATTATCTCAACATTCAC
CCAATTCTCATGGTAGCGCCT 
TyH3PCRR1 GAACGGTTTCAATTGGAGAAATTGGAACAGCCTTCAAAG
CTGCAATCAGGTGAATTCGTT 
TyH3PCRF2 CTTCTAGTATATTCTGTATACCTAATATTATAGCCTTTATC
AACAATGGAATCCCAACAA 
TyH3PCRR2 ACTTTTGGACCATCCATACCTGGTTTCAACTTAACTGGAA
CGGTTTCAATTGGAGAAATT 
TyH3PCRF3 CTCGAGGAGAACTTCTAGTATATTCTGTATACCTAATATT
ATAGCC 
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TyH3FlankR ACTTTTGGACCATCCATACCT 
HIVnoATGF GCTTTGAAGGCTGTTCCA 
HIVRThomR ACCGATTATTTAAAGCTGCAGCCCAAGCTTATCGATTTAC
AAGATCTTTCTAATACCGGC 
URA3F TTGTAAATCGATAAGCTTGGGCTGCAGCTTTAAATAATC
GGTGTTAGTTTTGCTGGCCGC 
URA3AIR GCAGAAAAGCCTCCTTTAGTCCATATTAACATACCCGCG
ATGAAGGTTACGATTGGTTGA 
URA3R AAAAAATGAGCAGGCAAGATAAACGAAGGCAAAGATGT
CGAAAGCTACATATAAGGAACG 
URA3AIF CTCGAATTTTTACTAACAAATGGTATTATTTATAACAGCC
GCCCATGTCTCTTTGAGCAA 
AInoass2F TCTAGAGGATCCCCGGGTACCGAGCTCGAATTTTTACTA
ACAAATGGTATTATTTATAAC 
AInoass3F GTATGTTAATATGGACTAAAGGAGGCTTTTCTGCAGGTC
GACTCTAGAGGATCCCCGGG 
LTRF1 TGTACTAGAGGATCTATTACATTATGGGTGGTATGTTGGA
ATAGAAATCAACTATCATCT 
LTRR1 CGCGCGTAATACGACTCACTATAGGGCGAATTGGGTACC
TGAGAAATGGGTGAATGTTGA 
PPTNotIF GCGGCCGCGATCTATTACATTATGGGTGGTATGT 
LTRflankR AGGGTTTTCCCAGTCACG 
HISpromF CTTTGCCTTCGTTTATCTTGCC 
HISpromR ACCACCCATAATGTAATAGATCGCGGCCGCCTCTAGTAC
ACTCTATATTTTTTTATGCCT 
P416F GGTACCCAATTCGCCCT 
P416R GAGCTCCAGCTTTTGTTCC 
Ty1RTHDF1 CCGTTCACCTTCAATCGATGCTTCTCCACCGGAAAATAAT
TCATCGCACAATATTGTTCC 
Ty1RTHDR1 AAAGCTGCAGCCCAAGCTTATCGATCTAATGAATCCATT
TGTTAGTTAATAGTTTAAATG 
Ty1RTHDF2 CGCAGATAAGTGACCAAGAGACTGAGAAAAGGATTATA
CACCGTTCACCTTCAATCGATG 
Ty1RTHDR2 CATATTTGAGAAGATGCGGCCAGCAAAACTAACACCGAT
TATTTAAAGCTGCAGCCCAAG 
RTmutF TCAACAGTAAGAAAAGATCATTAGAAGA 
RTmutR GGAAGGGATGCTAAGGTAGAG 
HistermR CACCGATTATTTAAAGCTGCAGCCC 
LTRTEFF2 TACCACCCATAATGTAATAGATCGCGGCCGC-
ATAGCTTCAAAATGTTTCTACTCCTTTT 
URA3TEFR2 GCACGTTCCTTATATGTAGCTTTCGACAT-
AAACTTAGATTAGATTGCTATGCTTTCTTT 
RT-URA3-BBf ATAAGCTTGGGCTGCAGC 
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RT-URA3-BBr CGATCTAATGAATCCATTTG 
RT-eGFPf CATTTAAACTATTAACTAACAAATGGATTCATTAG-
TGCGTAAAGGAGAAGAACTTTTCAC 
RT-eGFPr CCGATTATTTAAAGCTGCAGCCCAAGCTTATCGAT-
TTAAACTGCTGCAGCGTAG 
RT-LacZf CATTTAAACTATTAACTAACAAATGGATTCATTAG-
TGACCATGATTACGGATTCAC 
RT-LacZr CCGATTATTTAAAGCTGCAGCCCAAGCTTATCGAT-
TTATTTTTGACACCAGACCAACTGG 
RT-CAN1f CATTTAAACTATTAACTAACAAATGGATTCATTAG-
TGACAAATTCAAAAGAAGACGC 
RT-CAN1r CCGATTATTTAAAGCTGCAGCCCAAGCTTATCGAT-
CTATGCTACAACATTCCAAA 
Lacz-URA3-BBf TAAATCGATAAGCTTGGGCTGC 
Lacz-URA3-BBr TTGACACCAGACCAACTGG 
LacZ-eGFPf CATTACCAGTTGGTCTGGTGTCAAAAATAA-
TGCGTAAAGGAGAAGAACTTTTCAC 
LTRCYCF2 CTATTCCAACATACCACCCATAATGTAATAGATCGCGGC
CGC-ATTTGGCGAGCGTTGGT 
URA3CYCR2 GTAGCAGCACGTTCCTTATATGTAGCTTTCGACAT-
TTAGTGTGTGTATTTGTGTTTGCG 
LTRGPDF2 ACCACCCATAATGTAATAGATCGCGGCCGC-
AGTTTATCATTATCAATACTCGCCATTTC 
URA3GPDR2 GAGTAGCAGCACGTTCCTTATATGTAGCTTTCGACAT-
ATCCGTCGAAACTAAGTTCTGG 
PPTNotIF GCGGCCGC-GATCTATTACATTATGGGTGGTATGT 
reGREsptR TAACTAACAAATGGATTCATTAGATCGATAAGCTTGGGC
TGCAGCTTTAAATAATCGGTG-
TCACATTTTTCTAAATTCACTTAGCACAGG 
reGREsptF TGTTATAAATAATACCATTTGTTAGTAAAAATTCGGCGCG
CCAAAAGCCTCCTTTAGTCCATATTAACATAC-
TGGCCGATGAGGAACGTT 
reGREtefF GATGATAGTTGATTTCTATTCCAACATACCACCCATAATG
TAATAGATCGCGGCCGC-
ATAGCTTCAAAATGTTTCTACTCCTTTTTTACT 
reGREtefR CTAAAGGAGGCTTTTGGCGCGCCGAATTTTTACTAACAA
ATGGTATTATTTATAACAG-
TAAACTTAGATTAGATTGCTATGCTTTCTTTC 
Intronura3(3-5)F ATATGGACTAAAGGAGGCTTTTGGCGCGCCGAATTTTTA
CTAACAAATGGTATTATTTATAACAG-
GCCTATAGGTTCCTTTGTTACTTCT 
LTRTEFF2 TACCACCCATAATGTAATAGATCGCGGCCGC-
ATAGCTTCAAAATGTTTCTACTCCTTTT 
Ty1URA3F CATTTAAACTATTAACTAACAAATGGATTCATTAGATCG
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ATAAGCTTGGGCTGCAGCTTTAAATAATCGGTG-
TTAGTTTTGCTGGCCGCA 
Intronura3(3-5)R ATAATACCATTTGTTAGTAAAAATTCGGCGCGCCAAAAG
CCTCCTTTAGTCCATATTAACATAC-
CTTTTGATGTTAGCAGAATTGTCATG 
(m)GAXnewintronF CATCCCTGCGTCTACAGC 
(m)GAXnewintronR TGTAAATCTATTTCTTAAACTTCTTAAATTCTACTTTTATA
GTTAGTCTTTTTTTTAGTTTTAAAACA-
CCAGAACTTAGTTTCGACGGAT 
(m)GA3XnewintronXylA3for TGGTAGCACCAGAACCTTGATAC 
TART-FullMCSF CC-
TTAATTAACCGCGGGGATCCCCCGGGGCGGCCGCGATCT
ATTAC 
TART-FullMCSR CC-
TTAATTAACCTGCAGGGAATTCCTAATGAATCCATTTGTT
AGTTAATAGTTTAAATGT 
NotITEFF ATAAGAAT-GCGGCCGC-
ATAGCTTCAAAATGTTTCTACTCCTT 
XmaITEFR TCCC-CCCGGG-AAACTTAGATTAGATTGCTATGCTTTCT 
SacIIXylAR C-CCGCGG-TTATTGATACATCGCGACAATAGCC 
XmaIXylAF TCCC-CCCGGG-ATGGCTAAAGAATATTTCCCTCAAA 
PacIXKS1F CC-TTAATTAA-ATGTTGTGTTCAGTAATTCAGAGAC 
EcoRIXKSR G-GAATTC-TTAGATGAGAGTCTTTTCCAGTTCG 
P2AXKS1F /5PHOS/CAAGATGGTGATGTTGAAGAAAATCCAGGACCA-
TTGTGTTCAGTAATTCAGAGACAGA 
P2AXylAR /5PHOS/TTTTAATAAAGAAAAGTTGGTAGCACCAGAACC-
TTGATACATCGCGACAATAGCC 
XylAMCSintronF GCGCCGAATTTTTACTAACAAATGGTATTATTTATAACAG
T-CCCGGGAAACTTAGATTAGATTGC 
XylAMCSintronR GCCAAAAGCCTCCTTTAGTCCATATTAACATACTGGCTAA
AGAATATTTCCCTCAAATTC 
XmaIGPDR TCCC-CCCGGG-ATCCGTCGAAACTAAGTTCTGG 
NotImegaGPDF ATAAGAAT-GCGGCCGC-
ATAGCTTCAAAATGTTTCTACTCCTT 
(m)GA3XnewintronRTfor ACCAAGAAGAACATTGCTGATGTG 
(m)GA3XnewintronP2Arev TGAATATGGAAAGAAGAATGGAGAACCGAAACAAACCT
CAGGAAAACAAGAACTATACGAGGCTATTA-
TCGCGATGTATCAAGGTTCTGG 
XmaIXylA3F TCCC-CCCGGG-ATGGCTAAAGAATATTTCCCTCAAA 
XylAGPDnointronF TTTGAATTTGAGGGAAATATTCTTTAGCCATATCCGTCGA
AACTAAGTTCTGGTGTTTTA 
XylAGPDnointronR TAAAACACCAGAACTTAGTTTCGACGGATATGGCTAAAG
AATATTTCCCTCAAATTCAAA 
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GREnewF TTTCACAGGTAGTTCTGGTCCATTGGTGAAAGTTTGCGGC
TTGCAGAGCACAGAGGCCGCAGAATGT-
GAACAAAAGCTGGAGCTCCTAGT 
GREnewR ACGAAATTTGCTATTTTGTTAGAGTCTTTTACACCATTTG
TCTCCACACCTCCGCTTACATCAACACCA-
CTTGGCCTCCTCTAGTACACT 
XbaIXKS1 CCCCCC-TCTAGA-ATGTTGTGTTCAGTAATTCAGAGA 
XKS1XhoI CCCCCC-CTCGAG-TTAGATGAGAGTCTTTTCCAGTTC 
GRE3KOfor GTAATATAAATCGTAAAGGAAAATTGGAAATTTTTTAAA
GATAGCTTCAAAATGTTTCTA 
GRE3KOrevnew TTGTTCATATCGTCGTTGAGTATGGATTTTACTGGCTGGA-
TTAAGCAAGGATTTTCTTAA 
MRE115'F CCCCCC-CGTACG-TCTTTCCAACAAACCAAGCG 
MRE115'R CCCCCC-GTCGAC-AGTCGAGTTTTATCGGATCTGAGC 
MRE113'F CCCCCC-ACTAGT-
TTGTACTTGATCCCTATATTATATTATATCCTATTTATAAC
C 
MRE113'R CCCCCC-CCGCGG-AGTTCTATTGTGTGTCCAGGC 
pUG6KOPCRnewF CCAGCTGAAGCTTCGTACG 
pUG6KOPCRnewR CCGGCAGATCCGCGG 
CAC35'F CCCCCC-CGTACG-GTGGTTTGTTGTCTGTCTGG 
CAC35'R CCCCCC-GTCGAC-
CTTTGAAACTAAATTTGTATATTGTTTGTCAGAA 
CAC33'F CCCCCC-ACTAGT-CCTAAACGTTCCTTGAAGCCA 
CAC33'R CCCCCC-CCGCGG-GTTCGGCTTTGGACATTTCG 
BYHIR35'F CCCCCC-CGTACG-ACTAGCAATGATTCCGTTTTACATTT 
BYHIR35'R CCCCCC-GTCGAC-
AATAAGCTTTATCTAGAATCTGTGTTGAGG 
BYHIR33'F CCCCCC-ACTAGT-GATGACCATATTTTGGAAGAAGTGTG 
BYHIR33'R CCCCCC-CCGCGG-
CAAATCTTTATCGTAATCAGATAATTTTTCCAA 
CAC25'F CCCCCC-CGTACG-AGAAAGGTCCTCAGATTGAGC 
CAC25'R CCCCCC-GTCGAC-TGTCCTGCCCCTTTGCT 
CAC23'F CCCCCC-ACTAGT-
TTTTTAATATATTTAATGCGGTACATAAGAATGCC 
CAC23'R CCCCCC-CCGCGG-TCACGAGAGATGAGTCCACC 
BefICE2F ATGATTCACTGTCACTTAGTGAGC 
AftACE2R CTAAGAGTCTGTTTAGATCAACAGTCT 
BefRRM1F CATAGAACCGAGTGTAACACCA 
AftRRM1R AGGATTCTCCGAATAACCTCTAGC 
APL25'F CCCCCC-CGTACG-TATCCTGATGGAGCACTTCG 
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APL25'R CCCCCC-GTCGAC-AGTTGAAACTGTTTTTTAAGTGCAGT 
APL23'F CCCCCC-ACTAGT-CTATAAACGTCCGTTGTAGTGAACT 
APL23'R CCCCCC-CCGCGG-CCTGACATCTTTGGACGTGG 
IMT4p CCG-GAGCTC-AACATCCAGT 
IMT4t GGC-GGTACC-TTATAGTCTATAGCTTAAAT 
sup4p CCG-GAGCTC-ACCATCTTGG 
IMT4p CCG-GAGCTC-AACATCCAGT 
XbaITAL1for CCG-TCTAGA-ATGTCCTCCAACTCCCTTGAAC 
XhoITAL1rev CCCG-CTCGAG-TTAGAATCTGGCTTCCAATTGTTCC 
SacItefTAL1for CCG-GAGCTC-ATAGCTTCAAAATGTTTCTACTC 
SacITAL1cyc1rev GGC-GAGCTC-CAAATTAAAGCCTTCGAGCGTCC 
MCS-Fwd-SpeI G-ACTAGT-ATGTCTAAAGGTGAAGAATTATTCACTGG 
MCS-Rev-2 CCCCG-CTCGAG-
TTATTTGTACAATTCATCCATACCATGGG 
P2AYFPGlcF ACAAGATGGTGATGTTGAAGAAAATCCAGGACCA-
TCTAAAGGTGAAGAATTATTCACTGG 
P2AstrawGlcR TTTAATAAAGAAAAGTTGGTAGCACCAGAACC-
CTTGTACAGCTCGTCCATGC 
SpeImStrawberryF CC-ACTAGT-ATGGTGAGCAAGGGCG 
EcoRImStrawberryR G-GAATTC-TTTATCGATCGATT-
CTACTTGTACAGCTCGTCCAT 
MCS-Fwd-SalI-2 TAACGC-GTCGAC-
ATGTCTAAAGGTGAAGAATTATTCACTGG 
mStraw-YFPf GATCCCCCGGG-ATGGTGAGCAAGGGCGAG 
mStraw-YFPr ACTCGAGGAATTC-
TTATTTGTACAATTCATCCATACCATGGG 
His3AIgenomeflankF ATCGATAAGCTTGGGCTGC 
ARTR TTAATTCTTAGTATTCCATGTGTCTCGT 
HispromSPT15F AAAAAATGAGCAGGCAAGATAAACGAAGGCAAAG-
ATGGCCGATGAGGAACGT 
HistermSPT15R AAGCTTGGGCTGCAGCTTTAAATAATCGGTG-
TCACATTTTTCTAAATTCACTTAGCACA 
Spt15TEFR AACTCCTTTAAACGTTCCTCATCGGCCAT-
AAACTTAGATTAGATTGCTATGCTTTCTTT 
SPT15intronR GTTAGTAAAAATTCAAAAGCCTCCTTTAGTCCATATTAAC
ATACTGGCCGATGAGGAACG 
SPT15intronF AAATGGTATTATTTATAACAGTAAACTTAGATTAGATTGC
TATGCTTTCTT 
IntronSiteF CGCCGAATTTTTACTAACAAATGGTATTATTTATAACAGT 
IntronSiteR CGCCAAAAGCCTCCTTTAGTCCATATTAAC 
TEFmutssacF CCC-GAGCTC-ATAGCTTCAAAATGTTTCTACTCCTT 
 178 
p416ura3EcoR1rev CCG-GAATTC-TTAGTTTTGCTGGCCGCATC 
XhoISPT15R CCCCG-CTCGAG-TCACATTTTTCTAAATTCACTTAGCACA 
BefCAC2F CGTTTCTGAGAGGTAACTGAGG 
CAC2BegR GATTCTTGCTGTGTATTTGG  
CAC2EndF TGATTTAGCATGGTCTGAGG  
AftCAC2R TTGTTGCTGTTGGTCATTGG 
BefCAC3F ACAACCACTTCACCCAAACCC  
CAC3BegR TTGGGAAGATGTAAATGAGG   
CAC3EndF AAGAAGATGGGTTAGTCAAGC  
AftCAC3R TGGAAATGTTGTAGAGTGGAGG 
BefAPL2F TTCTCAACCATCCAAGTCGG 
APL2BegR CCAACTCAACGCATAAATCC  
APL2EndF TAACGATGATGTGCTATTGG  
AftAPL2R CTTGTTGATCTTTCTTCCCACC 
BefMRE11F ATTGATGGCTGATGACGTGG 
MRE11BegR TTGGTAGAGTGACTTCTTGG  
MRE11EndF CCAACGAGCAAACCCAAACG  
AftMRE11R TGTGTTTGAGGGCTCCTTGG 
BefBYHIR3F TCTACGCGGTCCATAATCTCC  
HIR3BegR ATCTAGCGTAGGAGAAGAATTGC  
HIR3EndF ATTTGACAGCGTTTGCTTGG  
AftBYHIR3R TTGACGCAAAGGAAATGTGG 
BefGRE3F ATGGGCGCATTACTACAAGAAG 
AftGRE3R CTGTTTGACGCACTGATGGGT 
BegGRE3R GACCTTCGGAGATGGCTTTC 
EndGRE3F AACCATCCAGGCAGTACCAC 
URA3RTPCRF ATTGTTAGCGGTTTGAAGCAGGCG 
URA3RTPCRR GAGCCCTTGCATGACAATTCTGCT 
Alg9F ATCGTGAAATTGCAGGCAGCTTGG 
Alg9R CATGGCAACGGCAGAAGGCAATAA 
Spt15-qPCR2f GCAATCTAATCTAAGTTTATGGCCGATGAGGA 
Spt15-qPCR2r GTTGCTGGTTTTGTACCATCTCGATTCTGG 
NGSAmp1F ACTGAT-GCCAACTTACTTCTGACAACG 
NGSAmp1R GCTACC-CCGCCTCCATCCAGTC 
NGSAmp2F CGTACG-GCCAACTTACTTCTGACAACG 
NGSAmp2R TGACAT-CCGCCTCCATCCAGTC 
NGSnointron1F GATACA-ATCGCGGCCGCCC 
 179 
NGSnointron1R GGAACT-AGAATGGGCAGACATTACGAATG 
NGSnointron2F AGTCAA-ATCGCGGCCGCCC 
NGSnointron2R TAACCG-AGAATGGGCAGACATTACGAATG 
NGSnointron3F AGCTTT-ATCGCGGCCGCCC 
NGSnointron3R TACAAG-AGAATGGGCAGACATTACGAATG 
NGSnointron4F GGCTAC-ATCGCGGCCGCCC 
NGSnointron4R AAGCTA-AGAATGGGCAGACATTACGAATG 
NGSnointron5F ATACGA-ATCGCGGCCGCCC 
NGSnointron5R CTGATC-AGAATGGGCAGACATTACGAATG 
NGSnointron6F TTACTG-ATCGCGGCCGCCC 
NGSnointron6R AGTTCC-AGAATGGGCAGACATTACGAATG 
NGSnointron7F ACTTGA-ATCGCGGCCGCCC 
NGSnointron7R GATCTG-AGAATGGGCAGACATTACGAATG 
NGSnointron8F ACATCT-ATCGCGGCCGCCC 
NGSnointron8R AATCGT-AGAATGGGCAGACATTACGAATG 
NGSnointron9F GCCAAT-ATCGCGGCCGCCC 
NGSnointron9R CACTGT-AGAATGGGCAGACATTACGAATG 
NGSnointron10F AGAATC-ATCGCGGCCGCCC 
NGSnointron10R GCCTAA-AGAATGGGCAGACATTACGAATG 
NGSnointron11F CTGCAG-ATCGCGGCCGCCC 
NGSnointron11R ACATCG-AGAATGGGCAGACATTACGAATG 
NGSnointron12F ATCACG-ATCGCGGCCGCCC 
NGSnointron12R CACGTA-AGAATGGGCAGACATTACGAATG 
NGSnointron13F TCACAT-ATCGCGGCCGCCC 
NGSnointron13R TATAGA-AGAATGGGCAGACATTACGAATG 
NGSnointron14F TGCAAA-ATCGCGGCCGCCC 
NGSnointron14R GTGCCA-AGAATGGGCAGACATTACGAATG 
NGSnointron15F TGTTAG-ATCGCGGCCGCCC 
NGSnointron15R ATAGAA-AGAATGGGCAGACATTACGAATG 
NGSnointron16F TCGAAG-ATCGCGGCCGCCC 
NGSnointron16R GAATGA-AGAATGGGCAGACATTACGAATG 
NGSnointron17F TACAGC-ATCGCGGCCGCCC 
NGSnointron17R TCTGAG-AGAATGGGCAGACATTACGAATG 
NGSnointron18F CTATAC-ATCGCGGCCGCCC 
NGSnointron18R AGCTAG-AGAATGGGCAGACATTACGAATG 
NGSnointron19F CGGAAT-ATCGCGGCCGCCC 
NGSnointron19R GCCATG-AGAATGGGCAGACATTACGAATG 
 180 
NGSnointron20F CACGAT-ATCGCGGCCGCCC 
NGSnointron20R GCTCAT-AGAATGGGCAGACATTACGAATG 
SacI-HSXf CC-GAGCTC-GGGTTCATTACAGCAGC 
PstI-HSXr CC-CTGCAG-TATATTTACCATCAACTCCGC 
EcoRITkc1F  G-GAATTC-TTTGAAAGATGATACTCTTTATTTCTAGACAG 
SbfITkc1R  GG-CCTGCAGG-
TATATATATATAACTGTCTAGAAATAAAGAGTATCATCTT 
EcoRITkc5F  G-GAATTC-
TTTGAAAGATGATACTCTTTATTTATATATATATATATAT
ATATATA 
SbfITkc5R  GG-CCTGCAGG-
TATATATATATATATATATATATAAATAAAGAGTATCATC
TTTCAAA 
EcoRITkc8SbfIF  G-GAATTC-
TTTGAAAAAATTTATTAAAAAAAAAATATATA-
CCTGCAGG-CC 
SbfITkc8EcoRIR  GG-CCTGCAGG-
TATATATTTTTTTTTTAATAAATTTTTTCAAA-GAATTC-C 
URA3AICYC1F CCG-GAATTC-CGAGCGTCCCAAAACCTT 
URA3AICYC1Rnew CCG-CCTGCAGG-TCATGTAATTAGTTATGTCACGCTTACA 
URA3AIIDP1F CCG-GAATTC-GATGGTAATGATCCGAACTTGG 
URA3AIIDP1Rnew CCG-CCTGCAGG-TCGAATTTACGTAGCCCAATCTAC 
URA3AIPRM9F CCG-GAATTC-ATTTTCAACATCGTATTTTCCGAAGC 
URA3AIPRM9Rnew CCG-CCTGCAGG-ACAGAAGACGGGAGACACT 
GREcontrol-fwd GTCTGTTATTAATTTCACAGGTAGTTCTGGTCCATTGGTG
AAAGTTTGCGGCTTGCAGAGCACAGAGGCCGCAGAATGT
-GTGATGACAAAACCTCTTCCG 
TART-BB-f T-CAAACAGGAATCGAATGCAACCG 
TART-BB-r AATTGTCCTTTTAACAGCGATCGC 
ip-G418f T-GAAAGAAATGCATAAGCTTTTGC 
ip-G418r AGACTTGTTCAACAGGCC 
G418-stop-f CGAATTCACTGGCCGTCG 
G418-stop-r CAAGCTTGGCGTAATCATGG 
G418-stop2-F GACGTTGTAAAACGACGGCCAGTGAATTCGTCTGTAGCC
CTCAACGGAAA 
G418-stop2-r AGGTCCGCCGGCGTTGGACGAGCGGGTGCAACTAATTGA
CGGGAGT 
JMW-0077  CGAATTCACTGGCCGTCG 
JMW-0078  CAAGCTTGGCGTAATCATGG 
JMW-0092  GACGTTGTAAAACGACGGCCAGTGAATTCGTCTGTAGCC
CTCAACGGAAA 
 181 
JMW-0093  AGGTCCGCCGGCGTTGGACGAGCGGGTGCAACTAATTGA
CGGGAGT 
JMW-0094  TGCACCCGCTCGTCCAACGCCGGCGGACCTCGGTGCAAC
ACTACTTCAACTTC 
JMW-0095  ACAGCTATGACCATGATTACGCCAAGCTTGTTGTTCTCCT
CATTCCAGGTG 
JMW-0101 TCTGTAGCCCTCAACGGAAA 
JMW-0102 TTGTTCTCCTCATTCCAGGTG 
JMW-0163  TGACACCGATTATTTAAAGCTGCAG 
JMW-0164 CTTTGCCTTCGTTTATCTTGCC 
JMW-0165 TATATATATCGTATGCTGCAGCTTTAAATAATCGGTGTCA
GCCTGATCTGTTTAGCTTGC 
JMW-0166 TATACTAAAAAATGAGCAGGCAAGATAAACGAAGGCAA
AGACTGGATGGCGGCGTTAGTA 
JA-211 AAACTTAGATTAGATTGCTATGC 
JA-240 TAAAGCTGCAGCCCAA 
JMW-0210 ATTCATTAGATCGATAAGCTTGG 
JMW-0211 TTGCTCATTAGAAAGAAAGCAT 
JMW-0225 TAGCCAGGAGGAGAGTGACGGCTCCTATGTTGTGTGG 
JMW-0226 ATGACGGAAGATGCTCGGGCGGGGTATCGTATGCTTC 
JMW-0227 GCGGAACCCCTATTTGTTTATT 
JMW-0228 GCTGTTTCCTGTGTGAAATTGTT 
JMW-0229 TTGTGAGCGGATAACAATTTCACACAGGAAACAGCTTTG
CTTCTCTCTTCTTCCTGTG 
JMW-0230 CACACAACATAGGAGCCGTCACTCTCCTCCTGGCTATTG 
JMW-0231 AAGCATACGATACCCCGCCCGAGCATCTTCCGTCATTA 
JMW-0232 GTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCCTTT
TAGGCCCAGAATTAGG 
JMW-0280 TTTGCTTCTCTCTTCTTCCTGTG 
JMW-0281 TCCACAACCAGTTTCATTCG 
 
Table A-2: Primers used in Chapter 3 (IDT) 
Primer Name Sequence 
Quikchange multi - Ty1 RT AA226 
round two 
gtatttaaaaacagtcaagtgacaatttgtttattcvrwgatgatatggtattgtttagcaaa
aatctaaattca 
Quikchange multi - Ty1 RT AA145 
round two 
cctgtcacttgcattagacaataactactatattacacaawdkgacatatcttcggcatattt
g 
Quikchange multi - Ty1 RT AA225 gtatttaaaaacagtcaagtgacaatttgtttandggtagatgatatggtattgtttagcaaa
 182 
round two aatct 
Quikchange - Ty1 RT AA226 -> 
CAG 
tatttaaaaacagtcaagtgacaatttgtttattcCAGgatgatatggtattgtttagcaaaa
atctaaattc 
ARTrev TTATGCAATCAGGTGAATACGTTTCTT 
Ty2600F GTGCAAGT-AGTCGCTGAACGGCTAAAC 
Ty2600R GCGTGCA-CCATGTGCTCGGGAATCC 
QMTy1RTL145Sf cttgcattagacaataactactatattacacaatctgacatatcttcggcatatttgtat 
QMTy1RTL145Sr atacaaatatgccgaagatatgtcagattgtgtaatatagtagttattgtctaatgcaag 
Ty1RTL151Af GC-TTTGTATGCAGACATCAAAGA 
Ty1RTL151Ar TGCCGAAGATATGTCTAATTG 
Ty1RTK93Rf AAAAAG-GACGGTACTCATAAAGCTAG 
Ty1RTR94Kf AGACGTGACGGTACTCATAAAGC 
Ty1RTK93R94rev CTTGTTGAAGATAAACATTGAGT 
YFPfusR 
ATTCCAACATACCACCCATAATGTAATAGATC-
ttatttgtacaattcatccataccatgg 
YFPHARTfusF 
AAGTTGGTTTCTGCCGGTATTAGAAAGATCTTG-
tctaaaggtgaagaattattcactggt 
YFPTARTfusF 
ACATTTAAACTATTAACTAACAAATGGATTCAT-
tctaaaggtgaagaattattcactggt 
YFPlinkerF ggtgacggtgctggtttaattaac-tctaaaggtgaagaattattcactggt 
Ty1RTlinkerR ATGAATCCATTTGTTAGTTAATAGTTTAAATGTTT 
HIVRTlinkerR CAAGATCTTTCTAATACCGGCAGA 
EcoRITkc1F  G-gaattc-TTTGAAAGATGATACTCTTTATTTCTAGACAG 
SbfITkc1R  
GG-cctgcagg-
TATATATATATAACTGTCTAGAAATAAAGAGTATCATCTT 
EcoRITkc5F  
G-gaattc-
TTTGAAAGATGATACTCTTTATTTATATATATATATATATATATATA 
SbfITkc5R  
GG-cctgcagg-
TATATATATATATATATATATATAAATAAAGAGTATCATCTTTCAAA 
EcoRITkc8SbfIF  G-gaattc-TTTGAAAAAATTTATTAAAAAAAAAATATATA-cctgcagg-CC 
SbfITkc8EcoRIR  GG-cctgcagg-TATATATTTTTTTTTTAATAAATTTTTTCAAA-gaattc-C 
EcoRITkc22SbfIF  
G-gaattc-TTTTTAGATGATACTCTTTATTTCTAGACAGTTATATA-
cctgcagg-CC 
SbfITkc22EcoRIR  
GG-cctgcagg-TATATAACTGTCTAGAAATAAAGAGTATCATCTAAAAA-
gaattc-C 
miniTy1-f atcgataagcttgggCTG 
miniTy1-r GTTAACATTGGTGGTGGTC 
HelperTy1-f aattcgccctatagtga 
HelperTy1-r cCTAATGAATCCATTTGTTAG 
 183 
Aintron-f GTATGTTAATATGGACTAAAGG 
Aintron-r CAAATGGTATTATTTATAACAG 
TART-term-f cc-gaattc-tacccaattcgccctatagt 
TART-term-r gg-cctgcagg-ccTGAGAAATGGGTGAATG 
SI-AscI-f 
GTATGTTAATATGGACTAAAGGAGGCTTTTGGCGCGCCGAATTTTTAC
TAACAAATGGTATTATTTATAACAG 
SI-AscI-r 
CTGTTATAAATAATACCATTTGTTAGTAAAAATTCGGCGCGCCAAAAG
CCTCCTTTAGTCCATATTAACATAC 
URA3-ATG-SIf 
CC-GGCGCGCCGAATTTTTACTAACAAATGGTATTATTTATAACAG-
taaacttagattagattgctatgc 
URA3-ATG-Sir 
CC-GGCGCGCCAAAAGCCTCCTTTAGTCCATATTAACATAC-
tgtcgaaagctacatataagg 
URA3-ATG-If 
CC-
CCCGGGTACCGAGCTCGAATTTTTACTAACAAATGGTATTATTTATAAC
AG-taaacttagattagattgctatgc 
URA3-ATG-Ir 
CC-
CCCGGGGATCCTCTAGAGTCGACCTGCAGAAAAGCCTCCTTTAGTCCA
TATTAACATAC-tgtcgaaagctacatataagg 
URA3-ATG-SIf2 
CC-GGCGCGCCGAATTTTTACTAACAAATGGTATTATTTATAACAG-
tCTTTGCCTTCGTTTATCTTG 
URA3-ATG-If2 
CC-
CCCGGGTACCGAGCTCGAATTTTTACTAACAAATGGTATTATTTATAAC
AG-tCTTTGCCTTCGTTTATCTTG 
TART-term2-r gg-gaattcggg-cctgcagg-ccTGAGAAATGGGTGAATG 
DHH1f CC-CCCGGG-ATGGGTTCCATCAATAAT 
DHH1r CC-CTCGAG-TTAATACTGGGGTTGTG 
LSM1f CC-CCCGGG-ATGTCTGCAAATAGCA 
LSM1r CC-CTCGAG-TTAGTACATGTCAGATTTATG 
PAT1f CC-CCCGGG-ATGTCCTTCTTTGGGTTAG 
PAT1r CC-CTCGAG-TTACTTTAGTTCTGATATTTCACC 
SacI-HSXf CC-gagctc-GGGTTCATTACAGCAGC 
PstI-HSXr CC-ctgcag-TATATTTACCATCAACTCCGC 
Ty1INrev TGATCATTGACGATAACAGGTTGAC 
Ty1INfwd TGTGAGAAATTCACTAGCTTCACC 
TART-BB-f aaacttagattagattgctatgc 
TART-BB-r CACCGATTATTTAAAGCTGC 
ip-PRM9-f AATGGATTCATTAGg-ACAGAAGACGGGAGACAC 
ip-PRM9-r actatagggcgaatt-ATTTTCAACATCGTATTTTCCGAAG 
ip-CYC-f AATGGATTCATTAGg-attagttatgtcacgcttaca 
ip-CYC-r actatagggcgaatt-caaattaaagccttcgagc 
 184 
ip-G418f TTTAAATAATCGGTG-ttagaaaaactcatcgagcatc 
ip-G418r ATCTAATCTAAGTTT-atgggtaaggaaaagactcac 
G418-stop-f T-Caaacaggaatcgaatgcaaccg 
G418-stop-r aattgtccttttaacagcgatcgc 
Integrase-end-f GGTATCACGAGACACATGG 
Cyc-beg-f attagttatgtcacgcttacattcac 
GAL1f 
cgcgcaattaaccctcactaaagggaacaaaagctggagc-
AGTACGGATTAGAAGCCGCC 
GAL1r TATAGTTTTTTCTCCTTGACGTTAAAGTATAG 
T7RNAP-f 
ATATACCTCTATACTTTAACGTCAAGGAGAAAAAACTATA-
atgaacacgattaacatcgc 
T7RNAP-r gggagggcgtgaatgtaagcgtgacataactaat-ttacgcgaacgcgaag 
5'LTRf CTCTACCGCCTCGAGGAGAAC 
beforeprom-rev gagctccagcttttgttccc 
T7p-f gcgcgcaattaaccctcactaaagggaacaaaagctggagctc-gccgggaatttaatacg 
T7p-r 
AGGTATACAGAATATACTAGAAGTTCTCCTCGAGGCGGTAGAG-
tctccctatagtgagtc 
  
Table A-3: Primers used in Chapter 4 (IDT) 
Primer Name Sequence 
T7p-Spinach2-Fwd GAAATTAATACGACTCACTATA-GATGTAACTGAATGAAATGG 
Spinach2r GATGTAACTAGTTACGGA 
Table A-4: Primers used in Chapter 5 (IDT) 
Primer Name Sequence 
EcoRI-ARO4-wt-r CCC-gaattc-CTATTTCTTGTTAACTTCTCTTCTTTG 
XmaI-ARO4-f CGC-cccggg-ATGAGTGAATCTCCAATGTTCG 
ARO4-reg-f GCACAGAGAATTGGCCTC 
ARO4-reg-r GCAATTGAGCCTTAGCTTCTG 
ext-ARO4-reg-f GGTGCCAGAACCACCGAATCTCAACT-GCACAGAGAATTGGCCTC 
ext-ARO4-reg-r ATCATTAGACCGTTGGAACCGGCAG-GCAATTGAGCCTTAGCTTCTG 
ARO4-reg-BB-f GCTAAGGCTCAATTGCCTGCC 
ARO4-reg-BB-r CCAATTCTCTGTGCAGTTGAGATTCG 
H230Y-ins-f GGTGCCAGAACCACCGAATC 
H230Y-ins-r ACCACCTCTTAGAATAACGAAGCAG 
 185 
H230Y-BB-f ACACTGCTTCGTTATTCTAAGAGGTGG 
ARO4-reg-BB-r CCAATTCTCTGTGCAGTTGAGATTCG 
 
Table A-5: Primers used in Chapter 6 (IDT) 
Primer Name Sequence 
P2A-f 
TCCTGGATTTTCTTCAACATCACCATCTTGTTTTAATAAAGAAAAGTTG
GTAGCACCAGA 
P2A-r 
TCTGGTGCTACCAACTTTTCTTTATTAAAACAAGATGGTGATGTTGAAG
AAAATCCAGGA 
P2Av3-f 
TCCTGGGTTCTCCTCGACGTCTCCGTCCTGCTTCAACAATGAGAAATTA
GTTGCTCCTGA 
P2Av3-r 
TCAGGAGCAACTAATTTCTCATTGTTGAAGCAGGACGGAGACGTCGA
GGAGAACCCAGGA 
XmaI-YFPf CC-CCCGGG-ATG-tctaaaggtgaagaattattca 
EcoRI-YFPr CC-gaattc-ttatttgtacaattcatccatac 
SecG-YFPf 
ACCAGTGATTTCAACAACAGTGGGTTCAGCTGCTGAAGGTTCATTGGA
TAAGAGAGAAGCT-tctaaaggtgaagaattattcac 
SecG-YFPr 
TGAGCCAAAGCCAATGGCAAAGCAGCGAAAATAGCCAACAACACAAT
CAACACCTT-CATcccgggggatc 
SecG-P2A-f 
AGATGGTGATGTTGAAGAAAATCCAGGACCA-
tctaaaggtgaagaattattcac 
SecGP2Ad-f 
AGATGGTGATGTTGAAGAAAATCCAGGATTT-
tctaaaggtgaagaattattcac 
SecGP2A-r 
TGTTTTAATAAAGAAAAGTTGGTAGCACCAGAACC-
AGCTTCTCTCTTATCCAATG 
E2Af 
AATTAGCCGGTGATGTTGAAAGTAACCCAGGACCA-
tctaaaggtgaagaattattcac 
E2Ar 
TTAATAAAGCATAGTTGGTACATTGACCAGAACC-
AGCTTCTCTCTTATCCAATG 
F2Ar 
TCAACAAATCGAAATTTAAAGTTTGCTTAACACCAGAACC-
AGCTTCTCTCTTATCCAATG 
T2Af 
TTGTGGTGATGTTGAAGAAAATCCAGGACCA-
tctaaaggtgaagaattattcac 
T2Ar 
GTTAATAAAGAGCCACGACCTTCACCAGAACC-
AGCTTCTCTCTTATCCAATG 
P2Ad-f TTT-tctaaaggtgaagaatta 
P2Ad-r TCCTGGATTTTCTTCAACA 
SecG-E2Af 
GCTGAAGGTTCATTGGATAAGAGAGAAGCT-
GGTTCTGGTCAATGTACC 
 186 
SecG-E2Ar ggacaacaccagtgaataattcttcacctttaga-TGGTCCTGGGTTACTTTC 
SecG-YFP-BBf tctaaaggtgaagaattattc 
SecG-YFP-BBr AGCTTCTCTCTTATCCA 
2ArandBB-f GGTGATGTTGAAGAAAATCC 
2ArandBB-r ACCAGAACCAGCTTCTC 
rand2A 
GTTCATTGGATAAGAGAGAAGCTGGTTCTGGT-
NNNNNNNNNNNNNNNNNNNNNNNNNNN-
GGTGATGTTGAAGAAAATCCAGGACCAtcta 
rand2A-r tagaTGGTCCTGGATTTTC 
rand2A-f GTTCATTGGATAAGAGAGAAGC 
rand2A-ext-f 
AGTGATTTCAACAACAGTGGGTTCAGCTGCTGAAG-
GTTCATTGGATAAGAGAGAAGC 
rand2A-ext-r 
caaaattgggacaacaccagtgaataattcttcacctt-
tagaTGGTCCTGGATTTTCTTC 
T2A-beg-f GGTTCTGGTGAAGGTCG 
2A-end-rev TGGTCCTGGATTTTCTTCAAC 
T2A-mid-r ACAAGTTAATAAAGAGCCACG 
2ArandBB2-F GGTGATGTTGAAGAAAATCCAGGAC 
2ArandBB2-r GATAAGAGAGAAGCTGGTTCTGGT 
r2Ad-s-f GCTGAAGGTTCATTGGATAAGAGAGAAG 
r2Ad-s-r aacaccagtgaataattcttcacctttaga-AGCTTCTCTCTGTCCTGGATTTTC 
P2A-f GGTTCTGGTGCTACC 
d-P2A-r 
GTTTTAATAAAGAAAAGTTGGTAGCACCAGAACC-
AGCTTCTCTCTGTCCTGGATTTTC 
E2A-f GGTTCTGGTCAATGTAC 
d-E2A-r 
TTTTAATAAAGCATAGTTGGTACATTGACCAGAACC-
AGCTTCTCTCTGTCCTGGATTTTC 
F2A-f GGTTCTGGTGTTAAGC 
d-F2A-r 
CAAATCGAAATTTAAAGTTTGCTTAACACCAGAACC-
AGCTTCTCTCTGTCCTGGATTTTC 
2Arandlib2-F 
GTTCTGGT-NNNNNNNNNNNNNNNNNNNNNNNNNNN-
GGTGATGTTGAAGAAAATCCAGGAC 
2Arandlib2-r AGGTTCATTGGATAAGAGAGAAGCTG 
XylA-f 
tcgacggattctagaactagtggatcccccgggctgcagg-
ATGGCTAAAGAATATTTCCC 
XylA-r TTGATACATCGCGACAATAG 
XP-P2A-f 
GGAAAACAAGAACTATACGAGGCTATTGTCGCGATGTATCAA-
GGTTCTGGTGCTACCAAC 
XP-P2A-r 
GGAAACCTCTCTTGTCTGTCTCTGAATTACTGAACACAA-
TGGTCCTGGATTTTCTTCAAC 
 187 
XP-P2Ad-r 
GGAAACCTCTCTTGTCTGTCTCTGAATTACTGAACACAA-
AAATCCTGGATTTTCTTCAAC 
XKS1-f TTGTGTTCAGTAATTCAGAG 
XKS1-r 
tctcgaggtcgacggtatcgataagcttgatatcgaatt-
TTAGATGAGAGTCTTTTCCAG 
2Arandlib2-r-fix CAGCTTCTCTCTTATCCAATGAACC 
IF-2ABB-f gttgtcccaattttggttg 
IF-2ABB-r GTTGTTGAAATCACTGGTTG 
BC-bb-f gattacgcgaacatcctc 
BC-bb-r ctgcccttcccatcc 
CrtI-f ggaaaagaacaagatcagg 
CrtI-r gaaagcaagaacaccaac 
CrtYB-d12-F 
gaaagtcttgagtgtggtcatgagcggatgggaagggcag-
GGTTCTGGTATGAACATAGG 
CrtYB-d8-f 
cggaaagtcttgagtgtggtcatgagcggatgggaagggcag-
GGTTCTGGTGTTCACATG 
CrtI-1-r cacgatgatagctgtgggtttatcctgatcttgttcttttcc-TGGTCCTGGATTTTCTTC 
CrtI-2-r cacgatgatagctgtgggtttatcctgatcttgttcttttcc-TGGTCCTGGGTTACTTTC 
CrtI-d12-F 
tggggccgtgatcgctcgatccgttggtgttcttgctttc-
GGTTCTGGTATGAACATAGG 
CrtI-d8-f 
attggggccgtgatcgctcgatccgttggtgttcttgctttc-
GGTTCTGGTGTTCACATG 
CrtE-1-r 
agtaaactcgagtggaattgctgtgaggatgttcgcgtaatc-
TGGTCCTGGATTTTCTTC 
CrtE-2-r 
agtaaactcgagtggaattgctgtgaggatgttcgcgtaatc-
TGGTCCTGGGTTACTTTC 
CrtYB-T2A-f 
cggaaagtcttgagtgtggtcatgagcggatgggaagggcag-
AGAGCAGAAGGAAGGG 
CrtI-T2A-r cacgatgatagctgtgggtttatcctgatcttgttcttttcc-TGGTCCTGGATTCTCC 
CrtI-T2A-f 
gattggggccgtgatcgctcgatccgttggtgttcttgctttc-
AGAGCTGAGGGTAGAGG 
CrtE-T2A-r 
agtaaactcgagtggaattgctgtgaggatgttcgcgtaatc-
AGGACCAGGGTTTTCTTC 
T2A1-f 
AGAGCAGAAGGAAGGGGTTCTTTGTTGACTTGTGGAGATGTTGAGGA
GAATCCAGGACCA 
T2A1-r 
TGGTCCTGGATTCTCCTCAACATCTCCACAAGTCAACAAAGAACCCCTT
CCTTCTGCTCT 
T2A2-F 
AGAGCTGAGGGTAGAGGAAGTCTACTAACATGCGGTGACGTAGAAG
AAAACCCTGGTCCT 
T2A2-r 
AGGACCAGGGTTTTCTTCTACGTCACCGCATGTTAGTAGACTTCCTCTA
CCCTCAGCTCT 
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BCseq1 tgaccgacttcctaccgagg 
BCseq2 tcactctccgtaccatatggaa 
SecG-T2A1f 
AGTGGGTTCAGCTGCTGAAGGTTCATTGGATAAGAGAGAAGCT-
AGAGCAGAAGGAAGGGG 
YFP-T2A1r 
caaaattgggacaacaccagtgaataattcttcacctttaga-
TGGTCCTGGATTCTCCTC 
SecG-T2A2f 
AGTGGGTTCAGCTGCTGAAGGTTCATTGGATAAGAGAGAAGCT-
AGAGCTGAGGGTAGAGG 
YFP-T2A2r 
caaaattgggacaacaccagtgaataattcttcacctttaga-
AGGACCAGGGTTTTCTTC 
BBf aattcgatatcaagcttatcg 
BBr TTGATACATCGCGACAATAG 
Insert (transport)f 
TTGTTGACTTGTGGAGATGTTGAGGAGAATCCAGGACCA-
ggtttggaggacaatagaatg 
Insert (transport)r aatctcgaggtcgacggtatcgataagcttgatatcgaattcta-agatggaacgaagccc 
Insert (T2A1)f 
AGGAAAACAAGAACTATACGAGGCTATTGTCGCGATGTATCAA-
AGAGCAGAAGGAAGGGG 
Insert (T2A1)r 
aacgttgacgaaacgcttaaccattctattgtcctccaaacc-
TGGTCCTGGATTCTCCTC 
BB2r AAATCCTGGATTTTCTTCAAC 
Insertf 
TAAAACAAGATGGTGATGTTGAAGAAAATCCAGGATTT-
ggtttggaggacaatagaatgg 
Insert(trans)r 
TCAACATCTCCACAAGTCAACAAAGAACCCCTTCCTTCTGCTCT-
agatggaacgaagccc 
Insert (T2A1 beta)f 
gcatgtcagcaaggcttggaagtctaagggcttcgttccatct-
AGAGCAGAAGGAAGGGG 
Insert (T2A1 beta)r 
GTTGGAAACCTCTCTTGTCTGTCTCTGAATTACTGAACACAA-
TGGTCCTGGATTCTCCTC 
Insert (Xks)f 
TTTGTTGACTTGTGGAGATGTTGAGGAGAATCCAGGACCA-
TTGTGTTCAGTAATTCAGAG 
Insert (Xks)r 
tctcgaggtcgacggtatcgataagcttgatatcgaatt-
TTAGATGAGAGTCTTTTCCAG 
Insert(XKs1)f 
gagcatgtcagcaaggcttggaagtctaagggcttcgttccatct-
GGTTCTGGTGCTACCAAC 
Insert(XKs1)r 
aatctcgaggtcgacggtatcgataagcttgatatcgaatt-
TTAGATGAGAGTCTTTTCC 
Insert (trans)r 
TCACCATCTTGTTTTAATAAAGAAAAGTTGGTAGCACCAGAACC-
agatggaacgaagccc 
Insert (P2Ad beta)f 
gagcatgtcagcaaggcttggaagtctaagggcttcgttccatct-
GGTTCTGGTGCTACC 
Insert (P2Ad beta)r 
GGAAACCTCTCTTGTCTGTCTCTGAATTACTGAACACAA-
AAATCCTGGATTTTCTTCAAC 
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Trans-r-fix AGATGGAACGAAGCCC 
BB-XKS1-f TTGTGTTCAGTAATTCAGAGACAG 
CiGxs-f ggtttggaggacaatagaatg 
Insert(XKs1)r-fix 
cgaggtcgacggtatcgataagcttgatatcgaatt-
TTAGATGAGAGTCTTTTCCAGTTC 
P2Ad2-trans-f 
AACAAGAACTATACGAGGCTATTGTCGCGATGTATCAA-
GGATCAGGAGCAACTAATTTC 
P2Ad2-trans-r ttgacgaaacgcttaaccattctattgtcctccaaacc-AAAACCAGGGTTCTCCTC 
P2Ad-trans-f tcagcaaggcttggaagtctaagggcttcgttccatct-GGTTCTGGTGCTACCAAC 
P2Ad-trans-r 
AACCTCTCTTGTCTGTCTCTGAATTACTGAACACAA-
AAATCCTGGATTTTCTTCAACATC 
T2A-trans-f 
AACAAGAACTATACGAGGCTATTGTCGCGATGTATCAA-
GGTTCTGGTGAAGGTCGTG 
T2A-trans-r 
ttgacgaaacgcttaaccattctattgtcctccaaacc-
TGGTCCTGGATTTTCTTCAAC 
P2A-trans-r 
AACCTCTCTTGTCTGTCTCTGAATTACTGAACACAA-
TGGTCCTGGATTTTCTTCAAC 
2A-ep-r caccagtgaataattcttcacctttaga 
PAD1-a-f 
aagttttctagaactagtggatcccccgggctgcagg-
ATGCTCCTATTTCCAAGAAGAAC 
PAD1-a-r CTTGCTTTTTATTCCTTCCCAAC 
PAD1-b-f CTCCTATTTCCAAGAAGAACTAATATAGCC 
PAD1-b-r 
tcgaggtcgacggtatcgataagcttgatatcg-
TTACTTGCTTTTTATTCCTTCCCAACG 
FDC1-a-f AGGAAGCTAAATCCAGCTTTAG 
FDC1-a-r 
aggtcgacggtatcgataagcttgatatcg-
TTATTTATATCCGTACCTTTTCCAATTTTC 
FDC1-b-f 
gttttctagaactagtggatcccccgggctgcagg-
ATGAGGAAGCTAAATCCAGCTTTAG 
FDC1-b-r TTTATATCCGTACCTTTTCCAATTTTCATTTAC 
P2A-PF-a-f 
CACGCTGACACTTTTCCTCGTTGGGAAGGAATAAAAAGCAAG-
GGTTCTGGTGCTACCAAC 
P2A-PF-a-r 
GATAAAGTCTCTAAATTCTAAAGCTGGATTTAGCTTCCT-
TGGTCCTGGATTTTCTTCAAC 
P2Ad-PF-a-r 
GATAAAGTCTCTAAATTCTAAAGCTGGATTTAGCTTCCT-
AAATCCTGGATTTTCTTCAAC 
P2A-PF-b-f 
GTTGACAAAGTAAATGAAAATTGGAAAAGGTACGGATATAAA-
GGTTCTGGTGCTACCAAC 
P2A-PF-b-r 
TTTGAAAAAGGCTATATTAGTTCTTCTTGGAAATAGGAG-
TGGTCCTGGATTTTCTTCAAC 
P2Ad-PF-b-r TTTGAAAAAGGCTATATTAGTTCTTCTTGGAAATAGGAG-
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AAATCCTGGATTTTCTTCAAC 
d8/12-2A-f CCAtctaaaggtgaagaattattc 
d8/12-2A-r TCCTGGATTTTCTTCAACATC 
KanMX-qPCR-f ggtgaaaatattgttgatgcgctggc 
KanMX-qPCR-r attcgtgattgcgcctgagc 
ARO4-qPCR-f CCCTTAGTAGTGGTGATAGCAGCA 
ARO4-qPCR-r GGTACCATCGGTACCGTTCTT 
SecG-BB-r AGCTTCTCTCTTATCCAATGAACC 
F6-BB-f GGTTCTGGTCTTCAGCTGATTC 
F9-BB-f GGTTCTGGTTTTTGTACATCAGC 
J3-BB-f GGTTCTGGTTTTCTTGGATGG 
J6-BB-f GGTTCTGGTCTATCTTGGCTC 
d12-I6-r 
CATCACCCCCTCGGTAGGCTAGAATCAGCTGAAGACCAGAACC-
AGCTTCTCTCTGTCCTG 
d12-I9-r 
CATCACCCCAGTAACGTCCAGCTGATGTACAAAAACCAGAACC-
AGCTTCTCTCTGTCCTG 
d12-G3-r 
CATCACCCTTAAAATGGTGTTTCCATCCAAGAAAACCAGAACC-
AGCTTCTCTCTGTCCTG 
d12-G6-r 
CATCACCGTATATCCCCTGGAAGAGCCAAGATAGACCAGAACC-
AGCTTCTCTCTGTCCTG 
 Xyl2r-fix ctcgaggtcgacggtatcgataagcttgatatc-ttactcagggccgtcaatg 
XylA-f CGACGGATA-TGGCTAAAGAATATTTCCCTC 
XylA-r GTTGGTAGCACCAGAACCTTGATACATCGC 
XKS1-r TTAGATGAGAGTCTTTTCCAGTTCGCTTAAGG 
d12-PF-f 
CGCTGACACTTTTCCTCGTTGGGAAGGAATAAAAAGCAAG-
GGTTCTGGTATGAACATAGG 
d8-PF-f 
CACGCTGACACTTTTCCTCGTTGGGAAGGAATAAAAAGCAAG-
GGTTCTGGTGTTCACATG 
P,T2A-PF-r 
CTGGATAAAGTCTCTAAATTCTAAAGCTGGATTTAGCTTCCT-
TGGTCCTGGATTTTCTTC 
T2A-PF-f 
CACGCTGACACTTTTCCTCGTTGGGAAGGAATAAAAAGCAAG-
GGTTCTGGTGAAGGTCG 
F2A-PF-f 
CGCTGACACTTTTCCTCGTTGGGAAGGAATAAAAAGCAAG-
GGTTCTGGTGTTAAGCAAAC 
E2A-PF-f 
CACGCTGACACTTTTCCTCGTTGGGAAGGAATAAAAAGCAAG-
GGTTCTGGTCAATGTACC 
F,E2A-PF-r 
CTGGATAAAGTCTCTAAATTCTAAAGCTGGATTTAGCTTCCT-
TGGTCCTGGGTTACTTTC 
XmaI-ARO3t-f ACA-CCCGGG-ATG-CCAATGTTCATTAAAAACGATCAC 
XhoI-ARO3t-r CGC-ctcgag-CTA-TCCTGGATTTTCTTCAACATC 
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XhoI-ARO4-r CCC-CTCGAG-CTATTTCTTGTTAACTTCTCTTCTTTGTC 
  
dp-TEFf gcgcaattaaccctcactaaagggaacaaaagctgg-atagcttcaaaatgtttctactcc 
dp-CYCr tggaagagtaaaaaaggagtagaaacattttgaagctatg-caaattaaagccttcgagcg 
SacI-TEFf-dp CCC-gagctc-atagcttcaaaatgtttctactcc 
SacI-CYCr-dp CCC-gagctc-caaattaaagccttcgagcg 
d12-PF-f 
AAAACAAGAACTATACGAGGCTATTGTCGCGATGTATCAA-
GGTTCTGGTATGAACATAGG 
d8-PF-f 
GGAAAACAAGAACTATACGAGGCTATTGTCGCGATGTATCAA-
GGTTCTGGTGTTCACATG 
P,T2A-PF-r 
aacgttgacgaaacgcttaaccattctattgtcctccaaacc-
TGGTCCTGGATTTTCTTC 
T2A-PF-f 
GGAAAACAAGAACTATACGAGGCTATTGTCGCGATGTATCAA-
GGTTCTGGTGAAGGTCG 
XmaI-XylA-f ACA-CCCGGG-ATGGCTAAAGAATATTTCCCTC 
XhoI-XylA-r CCC-CTCGAG-CTATTGATACATCGCGACAATAG 
SacI-GPDf-dp CCC-gagctcagtttatcattatcaatactc 
XmaI-CiGXS-f ACA-CCCGGG-ATGggtttggaggacaatag 
XhoI-CiGXS-r CCC-CTCGAG-CTAagatggaacgaagccc 
ARO2f 
CCATCTTGTTTTAATAAAGAAAAGTTGGTAGCACCAGAACC-
ATGAACCACGGATCTGGA 
ARO2r 
ttgctcattagaaagaaagcatagcaatctaatctaagttt-
ATGTCAACGTTTGGGAAAC 
ARO3f 
GTCCTGCTTCAACAATGAGAAATTAGTTGCTCCTGATCC-
TTTTTTCAAGGCCTTTCTTC 
ARO3r 
AAAACAAGATGGTGATGTTGAAGAAAATCCAGGACCA-
ATGTTCATTAAAAACGATCACG 
ARO4f 
atcgataagcttgggCTGCAGCTTTAAATAATCGGTG-
CTATTTCTTGTTAACTTCTCTTC 
ARO4r 
TTGAAGCAGGACGGAGACGTCGAGGAGAACCCAGGACCA-
ATGAGTGAATCTCCAATGTTC 
ARO2KOf 
ATAGTATCGAAAAAAGAAAATAGTATCATAGCACAGAGGC-
tgcaggtcgacaacccttaa 
ARO2KOr 
TAAATATACATAACTCTTGAGGGGTTTTGTTTCTATCT-
ggccactagtggatctgatatc 
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Appendix B – Sequences 
Table B-1: Sequences of Aptamer Templates in Chapter 4  
Aptamer Name Sequence 
Tyr1 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCAGGCAGT
CAACTCGTGCGATCGTGAAAACGGGGCAAGATGGCCTTACAG
CGGTCAATACGGGGGTCATCAGATAGGGAGGCCTCCTGGTTT
GTTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
Tyr1b 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCAgcttgtagg
gGGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCCTC
CTGGTTTGTTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
Tyr1c 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCAgtacaggg
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCCTC
CTGGTTTGTTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
Tyr1d 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCAtttgtacagg
gGGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCCTC
CTGGTTTGTTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
Tyr1e 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCAgtaGaggg
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCCTC
CTGGTTTGTTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
Tyr1f 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCAgtacTggg
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCCTC
CTGGTTTGTTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
Tyr1g 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCAgtaGTggg
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCCTC
CTGGTTTGTTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
Tyr1h 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCAgtacaggg
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCCTC
CTcGTTTGTTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
Tyr1i 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCAgtacaggg
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCCTC
CAGGTTTGTTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
Tyr1j 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCAgtacaggg
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCCTC
CACGTTTGTTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
Tyr1M-1 
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCC 
Tyr1M-2 
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCC 
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Tyr1M-3 
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCC 
Tyr1M-4 
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCC 
Tyr1M-5 
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCC 
Tyr1M-6 
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCC 
Tyr1M-7 
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCC 
DNT1 
 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCATTCCAG
CTCGGTACCATAACACAAGTGGTAGACTATTCTCTGGTACGTG
CGCCCCCGGCCGTATTACGGGAGCACGCCGGCTAAGGGATG
TTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
 
Table B-2: Sequences of Aptamer Templates in Chapter 5 
Aptamer Name Sequence 
Thrombin 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCAGGAACA
AAGCTGAAGTACTTACCTTGTTGAGTAGAGTGTGAGCTCCGTA
ACTAGTTACATC 
Streptavidin 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCACGACCG
ACCAGAATCATGCAAGTGCGTAAGATAGTCGCGGGCCGGGGT
TGTTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
DNT1 
 
GGATGTAACTGAATGAAATGGTGAAGGACGGGTCCATTCCAG
CTCGGTACCATAACACAAGTGGTAGACTATTCTCTGGTACGTG
CGCCCCCGGCCGTATTACGGGAGCACGCCGGCTAAGGGATG
TTGAGTAGAGTGTGAGCTCCGTAACTAGTTACATC 
Tyr1M-1 
GGCAGTCAACTCGTGCGATCGTGAAAACGGGGCAAGATGGC
CTTACAGCGGTCAATACGGGGGTCATCAGATAGGGAGGCC 
SAM 
GACGCGACTGAATGAAATGGTGAAGGACGGGTCCACGAAAG
GATGGCGGAAACGCCAGATGCCTTGTAACCGAAAGGGTTGTT
GAGTAGAGTGTGAGCTCCGTAACTAGTCGCGTC 
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